
<html lang="en"     class="pb-page"  data-request-id="6f22bd6d-22bb-4ade-9496-8caed2a1dd5f"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/jm7009414;issue:issue:10.1021/jmcmar.2008.51.issue-1;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Design, Synthesis, and Anti-inflammatory Properties of Orally Active 4-(Phenylamino)-pyrrolo[2,1-f][1,2,4]triazine p38α Mitogen-Activated Protein Kinase Inhibitors" /></meta><meta name="dc.Creator" content="John  Hynes, Jr." /></meta><meta name="dc.Creator" content="Alaric J.  Dyckman" /></meta><meta name="dc.Creator" content="Shuqun  Lin" /></meta><meta name="dc.Creator" content="Stephen T.  Wrobleski" /></meta><meta name="dc.Creator" content="Hong  Wu" /></meta><meta name="dc.Creator" content="Kathleen M.  Gillooly" /></meta><meta name="dc.Creator" content="Steven B.  Kanner" /></meta><meta name="dc.Creator" content="Herinder  Lonial" /></meta><meta name="dc.Creator" content="Derek  Loo" /></meta><meta name="dc.Creator" content="Kim W.  McIntyre" /></meta><meta name="dc.Creator" content="Sidney  Pitt" /></meta><meta name="dc.Creator" content="Ding Ren  Shen" /></meta><meta name="dc.Creator" content="David J.  Shuster" /></meta><meta name="dc.Creator" content="XiaoXia  Yang" /></meta><meta name="dc.Creator" content="Rosemary  Zhang" /></meta><meta name="dc.Creator" content="Kamelia  Behnia" /></meta><meta name="dc.Creator" content="Hongjian  Zhang" /></meta><meta name="dc.Creator" content="Punit H.  Marathe" /></meta><meta name="dc.Creator" content="Arthur M.  Doweyko" /></meta><meta name="dc.Creator" content="John S.  Tokarski" /></meta><meta name="dc.Creator" content="John S.  Sack" /></meta><meta name="dc.Creator" content="Matthew  Pokross" /></meta><meta name="dc.Creator" content="Susan E.  Kiefer" /></meta><meta name="dc.Creator" content="John A.  Newitt" /></meta><meta name="dc.Creator" content="Joel C.  Barrish" /></meta><meta name="dc.Creator" content="John  Dodd" /></meta><meta name="dc.Creator" content="Gary L.  Schieven" /></meta><meta name="dc.Creator" content="Katerina  Leftheris" /></meta><meta name="dc.Description" content="A novel structural class of p38 mitogen-activated protein (MAP) kinase inhibitors consisting of substituted 4-(phenylamino)-pyrrolo[2,1-f][1,2,4]triazines has been discovered. An initial subdeck sc..." /></meta><meta name="Description" content="A novel structural class of p38 mitogen-activated protein (MAP) kinase inhibitors consisting of substituted 4-(phenylamino)-pyrrolo[2,1-f][1,2,4]triazines has been discovered. An initial subdeck sc..." /></meta><meta name="dc.Publisher" content=" American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 12, 2007" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm7009414" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2008 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm7009414" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm7009414" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm7009414" /></link>
        
    
    

<title>Design, Synthesis, and Anti-inflammatory Properties of Orally Active 4-(Phenylamino)-pyrrolo[2,1-f][1,2,4]triazine p38α Mitogen-Activated Protein Kinase Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm7009414" /></meta><meta property="og:title" content="Design, Synthesis, and Anti-inflammatory Properties of Orally Active 4-(Phenylamino)-pyrrolo[2,1-f][1,2,4]triazine p38α Mitogen-Activated Protein Kinase Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/large/jm-2007-009414_0015.jpeg" /></meta><meta property="og:description" content=" A novel structural class of p38 mitogen-activated protein (MAP) kinase inhibitors consisting of substituted 4-(phenylamino)-pyrrolo[2,1-f][1,2,4]triazines has been discovered. An initial subdeck screen revealed that the oxindole-pyrrolo[2,1-f][1,2,4]triazine lead 2a displayed potent enzyme inhibition (IC50 60 nM) and was active in a cell-based TNFα biosynthesis inhibition assay (IC50 210 nM). Replacement of the C4 oxindole with 2-methyl-5-N-methoxybenzamide aniline 9 gave a compound with superior p38 kinase inhibition (IC50 10 nM) and moderately improved functional inhibition in THP-1 cells. Further replacement of the C6 ester of the pyrrolo[2,1-f][1,2,4]triazine with amides afforded compounds with increased potency, excellent oral bioavailability, and robust efficacy in a murine model of acute inflammation (murine LPS-TNFα). In rodent disease models of chronic inflammation, multiple compounds demonstrated significant inhibition of disease progression leading to the advancement of 2 compounds 11b and 11j into further preclinical and toxicological studies." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm7009414"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm7009414">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm7009414&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm7009414&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm7009414&amp;href=/doi/10.1021/jm7009414" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2008</span><span class="cit-fg-volume">, 51</span><span class="cit-fg-issue">, 1</span><span class="cit-fg-pageRange">, 4-16</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/51/1" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm701020f" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm0707370" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design, Synthesis, and Anti-inflammatory Properties of Orally Active 4-(Phenylamino)-pyrrolo[2,1-<i>f</i>][1,2,4]triazine p38α Mitogen-Activated Protein Kinase Inhibitors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John++Hynes%2C++Jr.">John Hynes, Jr.</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alaric+J.++Dyckman">Alaric J. Dyckman</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shuqun++Lin">Shuqun Lin</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stephen+T.++Wrobleski">Stephen T. Wrobleski</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hong++Wu">Hong Wu</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kathleen+M.++Gillooly">Kathleen M. Gillooly</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steven+B.++Kanner">Steven B. Kanner</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Herinder++Lonial">Herinder Lonial</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Derek++Loo">Derek Loo</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kim+W.++McIntyre">Kim W. McIntyre</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sidney++Pitt">Sidney Pitt</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ding+Ren++Shen">Ding Ren Shen</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David+J.++Shuster">David J. Shuster</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=XiaoXia++Yang">XiaoXia Yang</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rosemary++Zhang">Rosemary Zhang</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kamelia++Behnia">Kamelia Behnia</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hongjian++Zhang">Hongjian Zhang</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Punit+H.++Marathe">Punit H. Marathe</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Arthur+M.++Doweyko">Arthur M. Doweyko</a></span><span class="author-xref-symbol "><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+S.++Tokarski">John S. Tokarski</a></span><span class="author-xref-symbol "><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+S.++Sack">John S. Sack</a></span><span class="author-xref-symbol "><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Matthew++Pokross">Matthew Pokross</a></span><span class="author-xref-symbol "><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Susan+E.++Kiefer">Susan E. Kiefer</a></span><span class="author-xref-symbol "><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+A.++Newitt">John A. Newitt</a></span><span class="author-xref-symbol "><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joel+C.++Barrish">Joel C. Barrish</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John++Dodd">John Dodd</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gary+L.++Schieven">Gary L. Schieven</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Katerina++Leftheris">Katerina Leftheris</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">Departments of Immunology Chemistry, Immunology Biology, Metabolism and Pharmacokinetics, and Molecular Biosciences, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543-4000</span></div><div class="corresp-info"><strong>*</strong> To whom correspondence should be addressed. Phone: (609) 252-4431 . Fax: (609) 252-3993. E-mail: <a href="/cdn-cgi/l/email-protection#b0dadfd8de9ed8c9ded5c3f0d2ddc39ed3dfdd"><span class="__cf_email__" data-cfemail="5933363137773120373c2a193b342a773a3634">[email protected]</span></a></div><div class="corresp-fn" id="afn1">†Department of Immunology Chemistry.</div><div class="corresp-fn" id="afn2">‡Department of Immunology and Inflammation Biology.</div><div class="corresp-fn" id="afn3">§Department of Metabolism and Pharmacokinetics.</div><div class="corresp-fn" id="afn4">⊥Department of Molecular Biosciences.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm7009414&amp;href=/doi/10.1021%2Fjm7009414" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2008</span></span><span class="cit-volume">, 51</span><span class="cit-issue">, 1</span><span class="cit-pageRange">, 4–16</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 12, 2007</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>31 July 2007</li><li><span class="item_label"><b>Published</b> online</span>12 December 2007</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 1 January 2008</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm7009414" title="DOI URL">https://doi.org/10.1021/jm7009414</a></div><div class="article_header-article-copyright"><strong>Copyright © 2008 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4%26pageCount%3D13%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJohn%2BHynes%252C%2BAlaric%2BJ.%2BDyckman%252C%2BShuqun%2BLin%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D51%26issueNum%3D1%26contentID%3Djm7009414%26title%3DDesign%252C%2BSynthesis%252C%2Band%2BAnti-inflammatory%2BProperties%2Bof%2BOrally%2BActive%2B4-%2528Phenylamino%2529-pyrrolo%255B2%252C1-f%255D%255B1%252C2%252C4%255Dtriazine%2Bp38%25CE%25B1%2BMitogen-Activated%2BProtein%2BKinase%2BInhibitors%26numPages%3D13%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D16%26publicationDate%3DJanuary%2B2008">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm7009414"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2130</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">52</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm7009414" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design, Synthesis, and Anti-inflammatory Properties of Orally Active 4-(Phenylamino)-pyrrolo[2,1-f][1,2,4]triazine p38α Mitogen-Activated Protein Kinase Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Hynes&quot;},{&quot;first_name&quot;:&quot;Alaric&quot;,&quot;last_name&quot;:&quot;J. Dyckman&quot;},{&quot;first_name&quot;:&quot;Shuqun&quot;,&quot;last_name&quot;:&quot;Lin&quot;},{&quot;first_name&quot;:&quot;Stephen&quot;,&quot;last_name&quot;:&quot;T. Wrobleski&quot;},{&quot;first_name&quot;:&quot;Hong&quot;,&quot;last_name&quot;:&quot;Wu&quot;},{&quot;first_name&quot;:&quot;Kathleen&quot;,&quot;last_name&quot;:&quot;M. Gillooly&quot;},{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;B. Kanner&quot;},{&quot;first_name&quot;:&quot;Herinder&quot;,&quot;last_name&quot;:&quot;Lonial&quot;},{&quot;first_name&quot;:&quot;Derek&quot;,&quot;last_name&quot;:&quot;Loo&quot;},{&quot;first_name&quot;:&quot;Kim&quot;,&quot;last_name&quot;:&quot;W. McIntyre&quot;},{&quot;first_name&quot;:&quot;Sidney&quot;,&quot;last_name&quot;:&quot;Pitt&quot;},{&quot;first_name&quot;:&quot;Ding&quot;,&quot;last_name&quot;:&quot;Ren Shen&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;J. Shuster&quot;},{&quot;first_name&quot;:&quot;XiaoXia&quot;,&quot;last_name&quot;:&quot;Yang&quot;},{&quot;first_name&quot;:&quot;Rosemary&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Kamelia&quot;,&quot;last_name&quot;:&quot;Behnia&quot;},{&quot;first_name&quot;:&quot;Hongjian&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Punit&quot;,&quot;last_name&quot;:&quot;H. Marathe&quot;},{&quot;first_name&quot;:&quot;Arthur&quot;,&quot;last_name&quot;:&quot;M. Doweyko&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;S. Tokarski&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;S. Sack&quot;},{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;Pokross&quot;},{&quot;first_name&quot;:&quot;Susan&quot;,&quot;last_name&quot;:&quot;E. Kiefer&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;A. Newitt&quot;},{&quot;first_name&quot;:&quot;Joel&quot;,&quot;last_name&quot;:&quot;C. Barrish&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Dodd&quot;},{&quot;first_name&quot;:&quot;Gary&quot;,&quot;last_name&quot;:&quot;L. Schieven&quot;},{&quot;first_name&quot;:&quot;Katerina&quot;,&quot;last_name&quot;:&quot;Leftheris&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2007&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;12&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;volume&quot;:&quot;51&quot;,&quot;pages&quot;:&quot;4-16&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm7009414&quot;},&quot;abstract&quot;:&quot;A novel structural class of p38 mitogen-activated protein (MAP) kinase inhibitors consisting of substituted 4-(phenylamino)-pyrrolo[2,1-f][1,2,4]triazines has been discovered. An initial subdeck screen revealed that the oxindole-pyrrolo[2,1-f][1,2,4]triazine lead 2a displayed potent enzyme inhibition (IC50 60 nM) and was active in a cell-based TNFα biosynthesis inhibition assay (IC50 210 nM). Replacement of the C4 oxindole with 2-methyl-5-N-methoxybenzamide aniline 9 gave a compound with superior p38 kinase inhibition (IC50 10 nM) and moderately improved functional inhibition in THP-1 cells. Further replacement of the C6 ester of the pyrrolo[2,1-f][1,2,4]triazine with amides afforded compounds with increased potency, excellent oral bioavailability, and robust efficacy in a murine model of acute inflammation (murine LPS-TNFα). In rodent disease models of chronic inflammation, multiple compounds demonstrated significant inhibition of disease progression leading to the advancement of 2 compounds 11b and 11j into&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm7009414&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm7009414" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm7009414&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm7009414" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm7009414&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm7009414" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm7009414&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm7009414&amp;href=/doi/10.1021/jm7009414" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm7009414" /></input><a href="/doi/pdf/10.1021/jm7009414" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (505 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm7009414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm7009414%26sid%3Dliteratum%253Aachs%26pmid%3D18072718%26genre%3Darticle%26aulast%3DHynes%26date%3D2008%26atitle%3DDesign%252C%2BSynthesis%252C%2Band%2BAnti-inflammatory%2BProperties%2Bof%2BOrally%2BActive%2B4-%2528Phenylamino%2529-pyrrolo%255B2%252C1-f%255D%255B1%252C2%252C4%255Dtriazine%2Bp38%25CE%25B1%2BMitogen-Activated%2BProtein%2BKinase%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D51%26issue%3D1%26spage%3D4%26epage%3D16%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290658" title="Amides">Amides</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/51/1" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/medium/jm-2007-009414_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/large/jm-2007-009414_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009414&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A novel structural class of p38 mitogen-activated protein (MAP) kinase inhibitors consisting of substituted 4-(phenylamino)-pyrrolo[2,1-<i>f</i>][1,2,4]triazines has been discovered. An initial subdeck screen revealed that the oxindole-pyrrolo[2,1-<i>f</i>][1,2,4]triazine lead <b>2a</b> displayed potent enzyme inhibition (IC<sub>50</sub> 60 nM) and was active in a cell-based TNFα biosynthesis inhibition assay (IC<sub>50</sub> 210 nM). Replacement of the C4 oxindole with 2-methyl-5-<i>N</i>-methoxybenzamide aniline <b>9</b> gave a compound with superior p38 kinase inhibition (IC<sub>50</sub> 10 nM) and moderately improved functional inhibition in THP-1 cells. Further replacement of the C6 ester of the pyrrolo[2,1-<i>f</i>][1,2,4]triazine with amides afforded compounds with increased potency, excellent oral bioavailability, and robust efficacy in a murine model of acute inflammation (murine LPS-TNFα). In rodent disease models of chronic inflammation, multiple compounds demonstrated significant inhibition of disease progression leading to the advancement of 2 compounds <b>11b</b> and <b>11j</b> into further preclinical and toxicological studies.<target id="aff" target-type="temp-target"></target></p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68313" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68313" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The cytokines TNFα and IL-1β are two of the predominant pro-inflammatory mediators associated with systemic inflammatory diseases such as rheumatoid arthritis (RA).<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The use of protein therapeutics which target these cytokines is now the standard of care for the treatment of RA.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Extension of these therapies into additional indications, such as psoriasis and Crohnʼs disease, has increased the utility of the biologic approach to inflammatory disease management. However, the limitations of protein based therapies has stimulated significant research aimed at providing small molecule, orally bioavailable, anti-TNFα and anti-IL-1β agents.</div><div class="NLM_p">p38 Mitogen-activated protein kinase (MAPK) has emerged as an attractive target for chemotherapeutic intervention for the treatment of RA and other inflammatory disorders.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Activation of p38, a serine threonine kinase consisting of 4 isoforms (α,β,γ, and δ), leads to the up-regulation of both TNFα and IL-1β.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Additionally, small molecule p38 blockade in humans dose-dependently inhibited exogenously induced TNFα production, providing validation of the pathway in humans.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Expression of the p38 MAPK isoforms varies across cell types of the immune system, and it is believed that the predominant isoform involved in inflammation is p38α.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Currently, there are several p38α inhibitors undergoing clinical trials for the treatment of RA (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/medium/jm-2007-009414_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/large/jm-2007-009414_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Examples of p38 MAPK inhibitors that have reached in-human studies.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/large/jm-2007-009414_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009414&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We previously reported the in vitro and in vivo evaluation of 1,3,5-triaminotriazines (<b>1</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) as p38α inhibitors.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Further screening of a focused deck of internal compounds revealed the pyrrolo[2,1-<i>f</i>][1,2,4]triazine oxindoles <b>2a</b> and <b>2b</b> as potent inhibitors of p38α with enzyme–inhibitory concentrations (IC<sub>50</sub> values) of 60 and 80 nM, respectively. In a whole cell-based functional assay of lipopolysachharide (LPS) induced TNFα production, both compounds inhibited TNFα biosynthesis (<b>2a</b>, IC<sub>50</sub> 210 nM; <b>2b</b>, IC<sub>50</sub> 570 nM).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/medium/jm-2007-009414_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/large/jm-2007-009414_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Discovery of the pyrrolo[2,1-<i>f</i>][1,2,4]triazine p38 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/large/jm-2007-009414_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009414&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Substituted phenylaminopyrrolo[2,1-<i>f</i>][1,2,4]triazines have previously been used as a template for kinase inhibitor design,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> and it was envisioned that analogs containing the 3-methyl-5-benzamido aniline of <b>1</b> coupled to a pyrrolo[2,1-<i>f</i>][1,2,4]triazine at C4 would provide an alternative class of p38 inhibitors. It is noteworthy that the binding mode of the 1,3,5-triaminotriazine p38α inhibitors has been established via X-ray crystallography (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>, compound <b>1</b> detail), revealing a hydrogen bond between Glu71 and the <i>N</i>-alkoxyamide NH (2.4 Å), in addition to a hydrogen bond between the backbone NH of Asp168 and the <i>N</i>-methoxyamide carbonyl (2.2 Å). A similar binding mode for the proposed pyrrolo[2,1-<i>f</i>][1,2,4]triazine p38α inhibitors (<b>3a</b>, <b>b</b>) can be envisioned; however, the critical Met109 interaction found in most p38α MAP kinase inhibitors is not obvious. Assuming that the aniline of <b>3b</b> binds in an identical pocket as <b>1</b>, two potential Met109 backbone hydrogen bond acceptors can be proposed: the C6 pendant carbonyl oxygen (<b>A</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>) or the pyrrolo[2,1-<i>f</i>][1,2,4]triazine core N1 (<b>B</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). Molecular modeling suggested that both potential binding modes could be accessed with this class of inhibitors.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/medium/jm-2007-009414_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/large/jm-2007-009414_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Proposed binding modes of <b>3b</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/large/jm-2007-009414_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009414&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Compounds <b>3a</b> and <b>3b</b> were synthesized to test our initial hypothesis and were shown to inhibit p38α kinase with IC<sub>50</sub> values of 220 and 1.1 nM, respectively. The more potent <b>3b</b> blocked LPS induced TNFα production with an IC<sub>50</sub> of 160 nM, similar to the potency observed with the oxindole <b>2a</b>. When dosed orally in BALB/c mice at 30 mg/kg, <b>3b</b> failed to inhibit serum TNFα production following i.p. LPS administration (data not shown). The C6 ester was presumed to be a liability for in vivo efficacy, as predicted by the high rate of in vitro metabolism,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> and efforts to stabilize this region of the molecule along with structure−activity relationship (SAR) studies aimed at increasing functional activity and oral efficacy were initiated.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10717" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10717" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Chemistry</h3><div class="NLM_p">Pyrrolo[2,1-<i>f</i>][1,2,4]triazine derivatives <b>3a</b>–<b>f</b>, <b>h</b>, and <b>i</b> were prepared using methods and materials previously described, as shown in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Briefly, the 4-chloro-pyrrolo[2,1-<i>f</i>][1,2,4]triazines <b>4</b>, <b>12</b>, <b>13a</b>, and <b>13b</b> were reacted with various anilines to afford the C4 phenylaminopyrrolo[2,1-<i>f</i>][1,2,4]triazines (eq a and b). Additional analogs addressing the SAR at C6 were synthesized as outlined in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Amino-pyrrole <b>6</b> was synthesized via the electrophilic N-amination of pyrrole <b>5</b> with either <i>O</i>-(2,4-dinitrophenyl)hydroxylamine (DnpONH<sub>2</sub>) or monochloramine.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Cyclization of <b>6</b> in refluxing formamide afforded the 3,4-dihydropyrrolo[2,1-<i>f</i>][1,2,4]triazine-4-one <b>7</b>, which was reacted with POCl<sub>3</sub> to give 4-chloropyrrolo[2,1-<i>f</i>][1,2,4]triazine <b>8</b>. Coupling with aniline <b>9</b> furnished <b>3g</b>, which was hydrolyzed to the corresponding acid <b>10</b> and converted to the amide analogs <b>11a</b>–<b>l</b> via standard amide bond forming conditions.</div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/medium/jm-2007-009414_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/large/jm-2007-009414_0004.jpeg" id="gs1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/large/jm-2007-009414_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009414&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) DnpONH<sub>2</sub> or NH<sub>2</sub>Cl, NaH, DMF, 85%; (b) formamide, 165 °C, 89%; (c) POCl<sub>3</sub>, 110 °C, 3 h, 94%; (d) DMF, DIPEA, 55 °C, 12−18 h; (e) 1 N NaOH, THF, 55 °C; (f) R-NH<sub>2</sub> or R-NH<sub>3</sub>Cl, EDC, HOBt, DMF, DIPEA, rt.</p></p></figure><div class="NLM_p">A small library of C6-aminopyrrolo[2,1-<i>f</i>][1,2,4]triazines was also prepared from acid <b>10</b> as outlined in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. Reaction of <b>10</b> with diphenyl phosphoryl azide (DPPA) furnished the intermediate acyl azide, which was subjected to direct Curtius rearrangement in the presence of various alcohols to furnish the carbamate analogs <b>17a</b>–<b>d</b>. The <i>para</i>-methoxybenzyl carbamate <b>17d</b> was reacted with TFA to furnish the C6 amino analog <b>14</b>. Further reaction with acid anhydrides or ethyl isocyanate gave the reversed amides <b>15a</b>–<b>c</b> and urea <b>16</b>.</div><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/medium/jm-2007-009414_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/large/jm-2007-009414_0005.jpeg" id="gs2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/large/jm-2007-009414_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009414&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) DPPA, TEA, dioxane, 60 °C (ii) ROH, 80 °C; (b) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 93%; (c) (RCO)<sub>2</sub>O, CH<sub>2</sub>Cl<sub>2</sub>, TEA; (d) R—N═C═O, CH<sub>2</sub>Cl<sub>2</sub>, TEA.</p></p></figure><div class="NLM_p">The synthesis of a related series, in which the C5′ carboxamide is converted to a carbamate, is outlined in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. Reaction of chloride <b>8</b> with 3-nitro-6-methyl aniline gave <b>18</b>, which was hydrolyzed and coupled with <i>n</i>-propylamine to furnish <b>19</b>. Compound <b>19</b> was reduced to the C5′ amine <b>20</b> and reacted with chloroformates or acid chlorides to give compounds <b>21a</b>–<b>f</b>. Alternatively, reaction of 4-chloropyrrolotriazine <b>12</b> and ethyl 3-amino-4-methylphenylcarbamate <b>22</b> furnished the methyl ester <b>23</b>. Subsequent hydrolysis afforded <b>24</b>, which was reacted with various amines to provide the analogs <b>22g</b>–<b>i</b>.</div><figure id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/medium/jm-2007-009414_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/large/jm-2007-009414_0006.jpeg" id="gs3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/large/jm-2007-009414_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009414&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 3-nitro-6-methyl aniline, DIPEA, DMF, 55 °C, 86%; (b) (i) 1 N NaOH, THF, MeOH (ii) propyl amine, DMF, EDC, HOBt, 93%; (c) H<sub>2</sub>, 10% Pd/C, MeOH, 95%; (d) ROC(O)Cl, CH<sub>2</sub>Cl<sub>2</sub>, DIPEA; (e) DMF, DIPEA, 55 °C, 81%; (f) 1 N NaOH, THF, MeOH, 65 °C; (g) RNH<sub>2</sub> or RNH<sub>3</sub>Cl, EDC, HOBt, DMF DIPEA, rt.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> In Vitro Pharmacology and SAR</h3><div class="NLM_p">Subsequent to the discovery of <b>3b</b>, the synthesized pyrrolo[2,1-<i>f</i>][1,2,4]triazine analogs were screened and optimized for inhibition of human p38α MAP kinase. Compounds with significant enzyme inhibition (IC<sub>50</sub> < 50 nM) were then evaluated in a cell-based functional assay, where the inhibition of LPS induced TNFα biosynthesis in human peripheral blood mononuclear cells (PBMCs) was determined.</div><div class="NLM_p">The original C4 phenylaminopyrrolo[2,1-<i>f</i>][1,2,4]triazine analogs, <b>3a</b> and <b>3b</b>, provided the framework for establishing a more potent and orally efficacious series. Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> summarizes the C5′ SAR at the outset of our effort. Generation of the primary amide <b>3c</b> resulted in an 80-fold decrease in p38α inhibition relative to <b>3b</b> and only a slight increase relative to methyl amide <b>3a</b>. The C5′ ethyl amide <b>3d</b> had minimal p38α inhibition whereas the <i>N</i>-ethoxyamide <b>3e</b> was slightly less potent than <b>3b</b> in both enzyme and cell-based assays.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first">Table 1. Effect of the C5′-Substituent on Enzymatic and Cellular Activity</p><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/medium/jm-2007-009414_0007.gif" alt="" id="gr8" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle"> </th><th align="center" valign="middle"> </th><th colspan="2" align="center" valign="middle">IC<sub>50</sub> (nM)</th></tr><tr valign="top"><th align="center" valign="middle">cmpd</th><th align="center" valign="middle">R</th><th align="center" valign="middle">p38α<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></th><th align="center" valign="middle">TNFα<a class="ref internalNav" href="#tbl1-fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top"><td align="left" valign="top"><b>3a</b></td><td align="left" valign="top">Me</td><td align="left" valign="top">220</td><td align="left" valign="top">>5000 </td></tr><tr valign="top"><td align="left" valign="top"><b>3b</b></td><td align="left" valign="top">−OMe</td><td align="left" valign="top">1.1</td><td align="left" valign="top">160 </td></tr><tr valign="top"><td align="left" valign="top"><b>3c</b></td><td align="left" valign="top">H</td><td align="left" valign="top">78</td><td align="left" valign="top">>2000 </td></tr><tr valign="top"><td align="left" valign="top"><b>3d</b></td><td align="left" valign="top">Et</td><td align="left" valign="top">24%<a class="ref internalNav" href="#tbl1-fn3" aria-label="c">c</a></td><td align="left" valign="top"> </td></tr><tr valign="top"><td align="left" valign="top"><b>3e</b></td><td align="left" valign="top">−OEt</td><td align="left" valign="top">4.0</td><td align="left" valign="top">380 </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">Compounds were assayed in triplicate unless otherwise noted. Variability around the mean value was <50%.</p></div><div class="footnote" id="tbl1-fn2"><sup>b</sup><p class="last"><i>n</i> = 1 determination.</p></div><div class="footnote" id="tbl1-fn3"><sup>c</sup><p class="last">Percent inhibition at 1 µM (<i>n</i> = 1).</p></div></div></div><div class="NLM_p">While fixing the C5′ substituent as the <i>N</i>-methoxy amide, SAR studies were initiated at C5 and C6 of the pyrrolo[2,1-<i>f</i>][1,2,4]triazine core. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, removal of the C5 methyl group (<b>3f</b>) resulted in a 40-fold decrease in enzyme inhibition with a corresponding loss of functional activity relative to <b>3b</b>. Interestingly, the C6 ethyl ester <b>3g</b> was equipotent to <b>3b</b> in the enzyme inhibition assay and ∼4.5-fold more potent in the LPS−TNFα cell-based assay. This moderate increase in cellular potency suggested that larger alkyl groups or more lipophilic substitution at C6 leads to compounds with improved cellular potency. Increasing the size of the C5 substituent (<b>3h</b>, <b>i</b>) resulted in significantly decreased enzyme inhibition.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first">Table 2. Effect of the C5 and C6 Substituent on Enzymatic and Cellular Activity</p><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/medium/jm-2007-009414_0008.gif" alt="" id="gr9" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle"> </th><th align="center" valign="middle"> </th><th align="center" valign="middle"> </th><th colspan="2" align="center" valign="middle">IC<sub>50</sub> (nM)</th></tr><tr valign="top"><th align="center" valign="middle">cmpd</th><th align="center" valign="middle">R</th><th align="center" valign="middle">R<sup>1</sup></th><th align="center" valign="middle">p38α<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></th><th align="center" valign="middle">TNFα<a class="ref internalNav" href="#tbl2-fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top"><td align="left" valign="top"><b>3b</b></td><td align="left" valign="top">Me</td><td align="left" valign="top">−OMe</td><td align="left" valign="top">1.1</td><td align="left" valign="top">160 </td></tr><tr valign="top"><td align="left" valign="top"><b>3f</b></td><td align="left" valign="top">H</td><td align="left" valign="top">−OMe</td><td align="left" valign="top">42</td><td align="left" valign="top">>2000 </td></tr><tr valign="top"><td align="left" valign="top"><b>3g</b></td><td align="left" valign="top">Me</td><td align="left" valign="top">−OEt</td><td align="left" valign="top">0.9</td><td align="left" valign="top">37 </td></tr><tr valign="top"><td align="left" valign="top"><b>3h</b></td><td align="left" valign="top">Et</td><td align="left" valign="top">−OEt</td><td align="left" valign="top">61%<a class="ref internalNav" href="#tbl2-fn3" aria-label="c">c</a></td><td align="left" valign="top"> </td></tr><tr valign="top"><td align="left" valign="top"><b>3i</b></td><td align="left" valign="top"><i>i</i>-Pr</td><td align="left" valign="top">−OEt</td><td align="left" valign="top">63%<a class="ref internalNav" href="#tbl2-fn3" aria-label="c">c</a></td><td align="left" valign="top"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">Compounds were assayed in triplicate unless otherwise noted. Variability around the mean value was <50%.</p></div><div class="footnote" id="tbl2-fn2"><sup>b</sup><p class="last"><i>n</i> = 1 determination.</p></div><div class="footnote" id="tbl2-fn3"><sup>c</sup><p class="last">Percent inhibition at 1 µM (<i>n</i> = 1).</p></div></div></div><div class="NLM_p">As stated previously, the lack of in vivo efficacy of <b>3b</b> was presumed to be due to the presence of the potentially labile C6 methyl ester and it was anticipated that the ethyl ester <b>3g</b> would encounter a similar fate upon oral dosing. Therefore, a series of C6 amides were prepared. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>, the C6 methyl amide <b>11a</b> was 20-fold less potent in the p38α enzyme inhibition assay relative to <b>3b</b>, whereas the ethyl amide <b>11b</b> (IC<sub>50</sub> 3.1 nM) had increased p38α inhibition.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Additionally, <b>11b</b> was a potent inhibitor of LPS-induced TNFα release in cells (IC<sub>50</sub> 61 nM). These results parallel the previous observation that increased lipophilicity at C6 increases cellular potency (e.g., <b>3b</b> to <b>3g</b>). For example, the propyl and (<i>S</i>)-<i>sec</i>-butyl amides (<b>11c</b>–<b>e</b>) displayed significant p38α enzyme inhibition (IC<sub>50</sub> ≤ 10 nM) and in the LPS−TNFα assay, and <b>11c</b> and <b>11d</b> were nearly equipotent and comparable in activity to <b>11b</b>. In the PBMC TNFα assay, <b>11e</b> was highly potent, (IC<sub>50</sub> < 2 nM) and represented the most active compound prepared in this series. Incorporation of an ether linkage in the C6 amide chain (<b>11f</b>) was less tolerated in the functional assay, whereas large alkyl groups (<b>11g</b>), benzyl amides (<b>11h</b>, <b>j</b>, <b>k</b>), and pyridyl amides (<b>11i</b>) were tolerated in both the biochemical and cellular assays. Interestingly, the (<i>R</i>)-α-methylbenzamide, <b>11k</b>, was shown to be 60-fold less potent in the enzyme inhibition assay and over 200-fold less active in the functional assay relative to the enantiomeric <b>11j</b>. The ability of p38α kinase to discriminate between enantiomeric pairs of small molecule inhibitors has been well established.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> More importantly, the chiral discrimination has been associated with the orientation of the chiral group proximal to the Met109 binding site. It was therefore proposed that the C4-phenylaminopyrrolo[2,1-<i>f</i>][1,2,4]triazine based p38α MAP kinase inhibitors were binding to p38α via a hydrogen bond between the C6 amide carbonyl and the backbone NH of Met109 (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>, binding mode A). This binding mode would allow for the positioning of the C6 substituent out to the enzyme protein surface exposed to the solvent (water) interface. As a further test of this binding model, C6 substituents containing a basic, solubilizing group were prepared. As seen with the morpholino ethyl amide <b>11l</b>, this substitution allows for significant p38α enzyme inhibition (IC<sub>50</sub> 8 nM) and reasonable functional inhibition in cells (IC<sub>50</sub> 72 nM).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first">Table 3. Effect of the C6-Substituent on Enzymatic and Cellular Activity</p><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/medium/jm-2007-009414_0009.gif" alt="" id="gr10" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle"> </th><th align="center" valign="middle"> </th><th colspan="2" align="center" valign="middle" char=".">IC<sub>50</sub> (nM)</th></tr><tr valign="top"><th align="center" valign="middle">cmpd</th><th align="center" valign="middle">R<sup>1</sup></th><th align="center" valign="middle" char=".">p38α<a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></th><th align="center" valign="middle">TNFα<a class="ref internalNav" href="#tbl3-fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top"><td align="left" valign="top"><b>11a</b></td><td align="left" valign="top">Me</td><td align="char" valign="top" char=".">23</td><td align="left" valign="top">580</td></tr><tr valign="top"><td align="left" valign="top"><b>11b</b></td><td align="left" valign="top">Et</td><td align="char" valign="top" char=".">3.1<a class="ref internalNav" href="#tbl3-fn3" aria-label="c">c</a></td><td align="left" valign="top">61<a class="ref internalNav" href="#tbl3-fn4" aria-label="d">d</a></td></tr><tr valign="top"><td align="left" valign="top"><b>11c</b></td><td align="left" valign="top"><i>n</i>-Pr</td><td align="char" valign="top" char=".">0.9</td><td align="left" valign="top">30</td></tr><tr valign="top"><td align="left" valign="top"><b>11d</b></td><td align="left" valign="top"><i>i</i>-Pr</td><td align="char" valign="top" char=".">10</td><td align="left" valign="top">41</td></tr><tr valign="top"><td align="left" valign="top"><b>11e</b></td><td align="left" valign="top">(<i>S</i>)-<i>sec</i>-Bu</td><td align="char" valign="top" char=".">3.0</td><td align="left" valign="top"><2.0</td></tr><tr valign="top"><td align="left" valign="top"><b>11f</b></td><td align="left" valign="top">−(CH<sub>2</sub>)<sub>2</sub>−OMe</td><td align="char" valign="top" char=".">2.2</td><td align="left" valign="top">140</td></tr><tr valign="top"><td align="left" valign="top"><b>11g</b></td><td align="left" valign="top"><i>cyc</i>-pentyl</td><td align="char" valign="top" char=".">8.0</td><td align="left" valign="top">43.0</td></tr><tr valign="top"><td align="left" valign="top"><b>11h</b></td><td align="left" valign="top">−CH<sub>2</sub>−Ph</td><td align="char" valign="top" char=".">0.4</td><td align="left" valign="top">9.6</td></tr><tr valign="top"><td align="left" valign="top"><b>11i</b></td><td align="left" valign="top">−CH<sub>2</sub>−(2-pyr)</td><td align="char" valign="top" char=".">1.2</td><td align="left" valign="top">2.4</td></tr><tr valign="top"><td align="left" valign="top"><b>11j</b></td><td align="left" valign="top">(<i>S</i>)-α-Me-benzyl</td><td align="char" valign="top" char=".">2.2</td><td align="left" valign="top">10</td></tr><tr valign="top"><td align="left" valign="top"><b>11k</b></td><td align="left" valign="top">(<i>R</i>)-α-Me-benzyl</td><td align="char" valign="top" char=".">180</td><td align="left" valign="top">>1000</td></tr><tr valign="top"><td align="left" valign="top"><b>11l</b></td><td align="left" valign="top">morpholino-ethyl</td><td align="char" valign="top" char=".">8.0</td><td align="left" valign="top">72</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>a</sup><p class="last">Compounds were assayed in triplicate unless otherwise noted. Variability around the mean value was <50%.</p></div><div class="footnote" id="tbl3-fn2"><sup>b</sup><p class="last">Compounds were typically assayed in duplicate. Assay variability was measured using a standard control, <60%.</p></div><div class="footnote" id="tbl3-fn3"><sup>c</sup><p class="last"><i>n</i> = 5 determinations.</p></div><div class="footnote" id="tbl3-fn4"><sup>d</sup><p class="last"><i>n</i> = 6 determinations.</p></div></div></div><div class="NLM_p">It was anticipated that reversing the C6 carboxamide to the C6 aminopyrrolo[2,1-<i>f</i>][1,2,4]triazines would provide additional analogs containing a Met109 hydrogen bond acceptor. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, the C6 reversed amide analogs (<b>15a</b>–<b>c</b>), the urea (<b>16</b>), and the carbamates (<b>17a</b>–<b>c</b>) provided an additional series with p38α enzyme inhibition SAR trends similar to those observed in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>. Evaluation of compounds <b>15a</b>–<b>c</b> in the LPS−TNFα PBMC assay revealed that cellular potency was significantly less than the p38α enzyme inhibition. A more pronounced disconnect between enzyme and functional inhibition was observed for <b>16</b>, presumably an indication of poor cellular permeability. Analogous to the corresponding amide SAR, the ethyl and isopropyl carbamates <b>17b</b> and <b>17c</b> had excellent enzyme inhibition and acceptable functional activity.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first">Table 4. Effect of the C6-Amino Substituent on Enzymatic and Cellular Activity</p><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/medium/jm-2007-009414_0010.gif" alt="" id="gr11" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle"> </th><th align="center" valign="middle"> </th><th colspan="2" align="center" valign="middle" char=".">IC<sub>50</sub> (nM)</th></tr><tr valign="top"><th align="center" valign="middle">cmpd</th><th align="center" valign="middle">X</th><th align="center" valign="middle" char=".">p38α<a class="ref internalNav" href="#tbl4-fn1" aria-label="a">a</a></th><th align="center" valign="middle">TNFα<a class="ref internalNav" href="#tbl4-fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top"><td align="left" valign="top"><b>15a</b></td><td align="left" valign="top">Me</td><td align="char" valign="top" char=".">3.6</td><td align="left" valign="top">190</td></tr><tr valign="top"><td align="left" valign="top"><b>15b</b></td><td align="left" valign="top">Et</td><td align="char" valign="top" char=".">13</td><td align="left" valign="top">530</td></tr><tr valign="top"><td align="left" valign="top"><b>15c</b></td><td align="left" valign="top"><i>i</i>-Pr</td><td align="char" valign="top" char=".">13</td><td align="left" valign="top">120</td></tr><tr valign="top"><td align="left" valign="top"><b>16</b></td><td align="left" valign="top">−NH−<i>i</i>-Pr</td><td align="char" valign="top" char=".">12</td><td align="left" valign="top">>2000<a class="ref internalNav" href="#tbl4-fn3" aria-label="c">c</a></td></tr><tr valign="top"><td align="left" valign="top"><b>17a</b></td><td align="left" valign="top">−OMe</td><td align="char" valign="top" char=".">3.3</td><td align="left" valign="top">100</td></tr><tr valign="top"><td align="left" valign="top"><b>17b</b></td><td align="left" valign="top">−OEt</td><td align="char" valign="top" char=".">1.5</td><td align="left" valign="top">26</td></tr><tr valign="top"><td align="left" valign="top"><b>17c</b></td><td align="left" valign="top">−O−<i>i</i>-Pr</td><td align="char" valign="top" char=".">1.2</td><td align="left" valign="top">110</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl4-fn1"><div class="footnote" id="tbl4-fn1"><sup>a</sup><p class="last">Compounds were assayed in triplicate unless otherwise noted. Variability around the mean value was <50%.</p></div><div class="footnote" id="tbl4-fn2"><sup>b</sup><p class="last">Compounds were typically assayed in duplicate. Assay variability was measured using a standard control, <60%.</p></div><div class="footnote" id="tbl4-fn3"><sup>c</sup><p class="last"><i>n</i> = 1.</p></div></div></div><div class="NLM_p">Having identified the C6 amide as an optimal substituent, C5′ reversed amide anilines were investigated. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>, small alkoxy groups (R′ = OMe, OEt) inhibited p38α kinase with moderate inhibition of LPS induced TNFα in PBMCs. Larger C5′ substitutions reduced enzyme inhibition (<b>21c</b>, <b>d</b>). Interestingly, the methoxyacetyl analog <b>21e</b> had moderate activity in both the enzyme and PBMC assays, whereas removal of the chain oxygen (<b>21f</b>) significantly decreased enzyme inhibition. The smaller C5′ ethyl carbamate present in <b>21b</b> was then used to find matched substitutions at C6. As shown in examples <b>21g</b>–<b>i</b>, significant potency enhancements relative to <b>21b</b> were not observed.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first">Table 5. Effect of the C5′-Amino Substituent on Enzymatic and Cellular Activity</p><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/medium/jm-2007-009414_0011.gif" alt="" id="gr12" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle"> </th><th align="center" valign="middle"> </th><th align="center" valign="middle"> </th><th colspan="2" align="center" valign="middle">IC<sub>50</sub> (nM)</th></tr><tr valign="top"><th align="center" valign="middle">cmpd</th><th align="center" valign="middle">R</th><th align="center" valign="middle">R<sup>1</sup></th><th align="center" valign="middle">p38α<a class="ref internalNav" href="#tbl5-fn1" aria-label="a">a</a></th><th align="center" valign="middle" char=".">TNFα<a class="ref internalNav" href="#tbl5-fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top"><td align="left" valign="top"><b>21a</b></td><td align="left" valign="top"><i>n</i>-Pr</td><td align="left" valign="top">−OMe</td><td align="left" valign="top">15</td><td align="char" valign="top" char=".">150</td></tr><tr valign="top"><td align="left" valign="top"><b>21b</b></td><td align="left" valign="top"><i>n</i>-Pr</td><td align="left" valign="top">−OEt</td><td align="left" valign="top">5.5</td><td align="char" valign="top" char=".">69</td></tr><tr valign="top"><td align="left" valign="top"><b>21c</b></td><td align="left" valign="top"><i>n</i>-Pr</td><td align="left" valign="top">−O−<i>i</i>-Pr</td><td align="left" valign="top">680</td><td align="char" valign="top" char="."> </td></tr><tr valign="top"><td align="left" valign="top"><b>21d</b></td><td align="left" valign="top"><i>n</i>-Pr</td><td align="left" valign="top">−OPh</td><td align="left" valign="top">32%<a class="ref internalNav" href="#tbl5-fn3" aria-label="c">c</a></td><td align="char" valign="top" char="."> </td></tr><tr valign="top"><td align="left" valign="top"><b>21e</b></td><td align="left" valign="top"><i>n</i>-Pr</td><td align="left" valign="top">−CH<sub>2</sub>OMe</td><td align="left" valign="top">20</td><td align="char" valign="top" char=".">43</td></tr><tr valign="top"><td align="left" valign="top"><b>21f</b></td><td align="left" valign="top"><i>n</i>-Pr</td><td align="left" valign="top">−Me</td><td align="left" valign="top">230</td><td align="char" valign="top" char="."> </td></tr><tr valign="top"><td align="left" valign="top"><b>21g</b></td><td align="left" valign="top">Et</td><td align="left" valign="top">−OEt</td><td align="left" valign="top">4.7</td><td align="char" valign="top" char=".">72</td></tr><tr valign="top"><td align="left" valign="top"><b>21h</b></td><td align="left" valign="top"><i>i</i>-Pr</td><td align="left" valign="top">−OEt</td><td align="left" valign="top">7.7</td><td align="char" valign="top" char=".">110</td></tr><tr valign="top"><td align="left" valign="top"><b>21i</b></td><td align="left" valign="top">(<i>S</i>)-<i>sec</i>-Bu</td><td align="left" valign="top">−OEt</td><td align="left" valign="top">5.6</td><td align="char" valign="top" char=".">47</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl5-fn1"><div class="footnote" id="tbl5-fn1"><sup>a</sup><p class="last">Compounds were assayed in triplicate unless otherwise noted. Variability around the mean value was <50%.</p></div><div class="footnote" id="tbl5-fn2"><sup>b</sup><p class="last">Compounds were typically assayed in duplicate. Assay variability was measured using a standard control, <60%.</p></div><div class="footnote" id="tbl5-fn3"><sup>c</sup><p class="last">Percent inhibition at 1 µM (<i>n</i> = 1).</p></div></div></div><div class="NLM_p">Subsequent to the recognition of the C6 amide carbonyl as the potential Met109 hydrogen bond acceptor, X-ray structures of <b>11b</b> and <b>11j</b> bound to unphosphorylated p38α were obtained confirming the proposed binding mode in addition to revealing several key binding interactions (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). As previously hypothesized, Glu71 and Asp168 form hydrogen bonds with the C5′ hydroxamate NH (1.61 Å) and carbonyl (1.77 Å), respectively, with <b>11j</b>. Additionally, the Asp168 carboxyl group forms a bridging hydrogen bond via water with N3 of the pyrrolo[2,1-<i>f</i>][1,2,4]triazine core and Lys53. As suggested by the observed SAR, Met109 forms a hydrogen bond (1.6–1.7 Å) with the pendant C6 amide carbonyl oxygen for both <b>11b</b> and <b>11j</b>. Two hydrophobic interactions are also evident from these structures. The C4 aniline occupies the typical hydrophobic pocket accessed by most reported p38α kinase inhibitors and the C6 substituent orients along a hydrophobic surface near the hinge region of the enzyme. Much of the experimentally observed SAR can be rationalized from these structures. Larger C5 substitutions (ethyl, <i>iso</i>-propyl, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, <b>3g</b> and <b>h</b>) are not allowed due to disfavored steric interactions along the His107−Thr106 region surface. Additionally, the broader array of allowed substitution at C6 is due to the orientation of these substituents relative to the solvent exposed protein surface.</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/medium/jm-2007-009414_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/large/jm-2007-009414_0012.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. X-ray cocrystal structure of <b>11b</b> and <b>11j</b> with p38α.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/large/jm-2007-009414_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009414&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Kinase Selectivity Profile for Select Analogs</h3><div class="NLM_p last">Advanced compounds (<b>11b</b>–<b>e</b>, <b>j</b>, <b>21b</b>) were screened against a panel of kinases (e.g., EMT, LCK, Zap70, IKK-β2, HER-1/2, PKA/C, KDR) for potential off target liabilities. The compounds tested exhibited >2000-fold selectivity for p38α against the various kinases tested, whereas these compounds were less selective against p38β (e.g., <b>11b</b> p38β IC<sub>50</sub> 15 nM). In a broader selectivity screen encompassing G-protein coupled receptors, ion channels and various transporters, these compounds did not demonstrate any off-target interactions when tested at 10 <i>µ</i>M concentrations.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> In Vivo Anti-inflammatory Efficacy and Pharmacokinetics</h3><div class="NLM_p">A murine model of acute inflammation (LPS induced serum TNFα production) was used as a primary screen of oral efficacy for advanced compounds with favorable in vitro pharmacological profiles (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). A single 10 mg/kg dose of <b>11b</b> provided an 80% reduction in circulating TNFα (entry 1). Similarly, <b>11j</b> provided >90% reduction of TNFα production (entry 2). In a dose response study, <b>11b</b> demonstrated an ED<sub>50</sub> of 0.3–1 mg/kg when dosed 30 min prior to LPS challenge. Extending the dosing interval prior to LPS challenge (2 vs 0.5 h), in addition to reducing the compound dose (2 vs 10 mg/kg) provided a reasonable (61%, entry 3) reduction in serum TNFα levels using <b>11b</b>. Other analogs were then screened under these conditions. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>, additional C6 amides (entries 4–7) exhibited similar efficacy to <b>11b</b>. The C6 ethyl carbamate <b>17b</b> (entry 8) was not efficacious in this model, whereas the C5′ ethyl carbamate <b>21b</b> (entry 9) was highly efficacious.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last">Table 6. Inhibition of Circulating TNFα in LPS Challenged Mice</p></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle">entry</th><th align="center" valign="middle">cmpd</th><th align="center" valign="middle" char=".">dose<a class="ref internalNav" href="#tbl6-fn1" aria-label="a">a</a> (mg/kg)</th><th align="center" valign="middle" char=".">dosing interval (min)</th><th align="center" valign="middle">percent inhib<a class="ref internalNav" href="#tbl6-fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top"><td align="left" valign="top">1</td><td align="left" valign="top"><b>11b</b></td><td align="char" valign="top" char=".">10</td><td align="char" valign="top" char=".">−30</td><td align="left" valign="top">80 ± 10<a class="ref internalNav" href="#tbl6-fn3" aria-label="c">c</a></td></tr><tr valign="top"><td align="left" valign="top">2</td><td align="left" valign="top"><b>11j</b></td><td align="char" valign="top" char=".">10</td><td align="char" valign="top" char=".">−30</td><td align="left" valign="top">95 ± 6</td></tr><tr valign="top"><td align="left" valign="top">3</td><td align="left" valign="top"><b>11b</b></td><td align="char" valign="top" char=".">2</td><td align="char" valign="top" char=".">−120</td><td align="left" valign="top">61 ± 13<a class="ref internalNav" href="#tbl6-fn4" aria-label="d">d</a></td></tr><tr valign="top"><td align="left" valign="top">4</td><td align="left" valign="top"><b>11c</b></td><td align="char" valign="top" char=".">2</td><td align="char" valign="top" char=".">−120</td><td align="left" valign="top">60 ± 23</td></tr><tr valign="top"><td align="left" valign="top">5</td><td align="left" valign="top"><b>11d</b></td><td align="char" valign="top" char=".">2</td><td align="char" valign="top" char=".">−120</td><td align="left" valign="top">65 ± 11</td></tr><tr valign="top"><td align="left" valign="top">6</td><td align="left" valign="top"><b>11e</b></td><td align="char" valign="top" char=".">2</td><td align="char" valign="top" char=".">−120</td><td align="left" valign="top">50 ± 30</td></tr><tr valign="top"><td align="left" valign="top">7</td><td align="left" valign="top"><b>11i</b></td><td align="char" valign="top" char=".">2</td><td align="char" valign="top" char=".">−120</td><td align="left" valign="top">62 ± 23</td></tr><tr valign="top"><td align="left" valign="top">8</td><td align="left" valign="top"><b>17b</b></td><td align="char" valign="top" char=".">2</td><td align="char" valign="top" char=".">−120</td><td align="left" valign="top">na<a class="ref internalNav" href="#tbl6-fn5" aria-label="e">e</a></td></tr><tr valign="top"><td align="left" valign="top">9</td><td align="left" valign="top"><b>21b</b></td><td align="char" valign="top" char=".">2</td><td align="char" valign="top" char=".">−120</td><td align="left" valign="top">66 ± 21</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl6-fn1"><div class="footnote" id="tbl6-fn1"><sup>a</sup><p class="last">Using PEG 300 as the vehicle, 6–8 mice per group.</p></div><div class="footnote" id="tbl6-fn2"><sup>b</sup><p class="last">Maximum percent inhibition relative to vehicle group; >50% inhibition is considered active in this study. Variability is expressed as ± standard error of the mean (SEM) for the individual animals in each study unless otherwise noted.</p></div><div class="footnote" id="tbl6-fn3"><sup>c</sup><p class="last">Average of 8 separate studies.</p></div><div class="footnote" id="tbl6-fn4"><sup>d</sup><p class="last">Average of 10 separate studies.</p></div><div class="footnote" id="tbl6-fn5"><sup>e</sup><p class="last">na = not active.</p></div></div></div><div class="NLM_p">Prior to evaluation in a chronic RA disease model, several C6 amido pyrrolo[2,1-<i>f</i>][1,2,4]triazine p38α inhibitors were evaluated in 4 h of oral exposure studies in rats. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>, moderate to high levels of systemic drug exposure was observed for compounds of similar (<b>11b</b>, <b>c</b>) and varying (<b>11d</b>–<b>11j</b>) C6 substitution. A partial explanation for the reduced exposure at 0.5 h of <b>11b</b> is the lower intrinsic permeability of <b>11b</b> relative to other compounds as measured in a Caco-2 permeability assay (20 nm/s for <b>11b</b> vs 58 nm/s for <b>11c</b> and 131 nm/s for <b>11j</b>). The C5′ carbamate <b>21b</b> had reduced drug exposure relative to the C6 amide analogs and was not evaluated further. Incubation of several analogs in rat and human liver microsomes indicated that low (rat) to moderate (human) levels of parent drug would be metabolized in the liver.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last">Table 7. Rat Exposure Data Following Oral Administration (10 mg/kg) of Select Compounds<a class="ref internalNav" href="#tbl7-fn1" aria-label="a">a</a></p></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead valign="bottom"><tr valign="top"><th align="center" valign="bottom">cmpd</th><th align="center" valign="bottom" char=".">plasma level (0.5 h, µM)<a class="ref internalNav" href="#tbl7-fn2" aria-label="b">b</a></th><th align="center" valign="bottom" char=".">AUC<a class="ref internalNav" href="#tbl7-fn5" aria-label="c">c</a> (µM·h)</th><th align="center" valign="bottom" char=".">RLM<a class="ref internalNav" href="#tbl7-fn3" aria-label="d">d</a></th><th align="center" valign="bottom" char=".">HLM<a class="ref internalNav" href="#tbl7-fn4" aria-label="e">e</a></th></tr></thead><tbody><tr valign="top"><td align="left" valign="top"><b>11b</b></td><td align="char" valign="top" char=".">0.8</td><td align="char" valign="top" char=".">0.7</td><td align="char" valign="top" char=".">100</td><td align="char" valign="top" char=".">69</td></tr><tr valign="top"><td align="left" valign="top"><b>11c</b></td><td align="char" valign="top" char=".">6.6</td><td align="char" valign="top" char=".">2.1</td><td align="char" valign="top" char=".">82</td><td align="char" valign="top" char=".">83</td></tr><tr valign="top"><td align="left" valign="top"><b>11d</b></td><td align="char" valign="top" char=".">3.8</td><td align="char" valign="top" char=".">3.7</td><td align="char" valign="top" char="."> </td><td align="char" valign="top" char="."> </td></tr><tr valign="top"><td align="left" valign="top"><b>11e</b></td><td align="char" valign="top" char=".">4.3</td><td align="char" valign="top" char=".">9.2</td><td align="char" valign="top" char=".">96</td><td align="char" valign="top" char=".">62</td></tr><tr valign="top"><td align="left" valign="top"><b>11i</b></td><td align="char" valign="top" char=".">3.4</td><td align="char" valign="top" char=".">2.8</td><td align="char" valign="top" char="."> </td><td align="char" valign="top" char="."> </td></tr><tr valign="top"><td align="left" valign="top"><b>11j</b></td><td align="char" valign="top" char=".">2.1</td><td align="char" valign="top" char=".">2.1</td><td align="char" valign="top" char=".">90</td><td align="char" valign="top" char=".">72</td></tr><tr valign="top"><td align="left" valign="top"><b>21b</b></td><td align="char" valign="top" char=".">0.4</td><td align="char" valign="top" char=".">0.7</td><td align="char" valign="top" char="."> </td><td align="char" valign="top" char="."> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl7-fn1"><div class="footnote" id="tbl7-fn1"><sup>a</sup><p class="last">Vehicle: 9/0.5/0.5 water/EtOH/Tween 80.</p></div><div class="footnote" id="tbl7-fn2"><sup>b</sup><p class="last">Average of 2 rats.</p></div><div class="footnote" id="tbl7-fn5"><sup>c</sup><p class="last">AUC<sub>0-4h</sub>, average of 2 rats.</p></div><div class="footnote" id="tbl7-fn3"><sup>d</sup><p class="last">Rat liver microsome incubation, percent remaining of parent drug at 10 min, (<i>n</i> = 1).</p></div><div class="footnote" id="tbl7-fn4"><sup>e</sup><p class="last">Human liver microsome incubation, percent remaining of parent drug at 10 min, (<i>n</i> = 1).</p></div></div></div><div class="NLM_p">The rat adjuvant induced arthritis (RAA) disease model was then incorporated into the compound efficacy evaluation paradigm. Accordingly, compounds were evaluated at 10 mg/kg, bid, in this disease model (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). Interestingly, compounds <b>11b</b>, <b>c</b>, <b>d</b>, and <b>j</b> inhibited disease progression equally in this model and the statistical significance between compounds was not observed. Compounds <b>11e</b> and <b>11i</b> were not efficacious in this model.</div><figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/medium/jm-2007-009414_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/large/jm-2007-009414_0013.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Efficacy in the rat adjuvant arthritis model (6–8 mice per group). Terminal paw measurements (mean ± SEM) were as follows: <b>11b</b>, 0.78 ± 0.15 mL; <b>11c</b>, 0.85 ± 0.0.15 mL; <b>11d</b>, 0.83 ± 0.20 mL; <b>11j</b>, 0.86 ± 0.16 mL; vehicle, 1.5 ± 0.17 mL.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/large/jm-2007-009414_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009414&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Subsequently, a discrete pharmacokinetic analysis in mice of <b>11b</b>, <b>11c</b>, and <b>11j</b> was performed in an effort to further differentiate these advanced compounds and as a precursor to chronic studies in mice (Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>). All compounds had good to excellent oral bioavailability and drug exposure over the time course of the study. Moderate to high clearance was observed for all compounds tested.</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last">Table 8. Discrete Pharmacokinetic Properties of Compounds <b>11b</b>, <b>11c</b>, and <b>11j</b> in Mice<a class="ref internalNav" href="#tbl8-fn1" aria-label="a">a</a></p></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle">PK parameter</th><th align="center" valign="middle" char="."><b>11b</b></th><th align="center" valign="middle" char="."><b>11c</b></th><th align="center" valign="middle" char="."><b>11j</b></th></tr></thead><tbody><tr valign="top"><td align="left" valign="top">% <i>F</i><sub>po</sub></td><td align="char" valign="top" char=".">79</td><td align="char" valign="top" char=".">97</td><td align="char" valign="top" char=".">34</td></tr><tr valign="top"><td align="left" valign="top"><i>C</i><sub>max</sub> (µM)<a class="ref internalNav" href="#tbl8-fn2" aria-label="b">b</a></td><td align="char" valign="top" char=".">3.1 ± 0.6</td><td align="char" valign="top" char=".">18 ± 1.9</td><td align="char" valign="top" char=".">3.7 ± 1.8</td></tr><tr valign="top"><td align="left" valign="top"><i>T</i><sub>max</sub> (h)</td><td align="char" valign="top" char=".">0.25</td><td align="char" valign="top" char=".">0.25</td><td align="char" valign="top" char=".">0.5</td></tr><tr valign="top"><td align="left" valign="top"><i>t</i><sub>1/2</sub> (h)</td><td align="char" valign="top" char=".">2.2</td><td align="char" valign="top" char=".">2.5</td><td align="char" valign="top" char=".">1.2</td></tr><tr valign="top"><td align="left" valign="top">MRT (h)</td><td align="char" valign="top" char=".">1.4</td><td align="char" valign="top" char=".">1.0</td><td align="char" valign="top" char=".">0.8</td></tr><tr valign="top"><td align="left" valign="top">CL (mL/min/kg)</td><td align="char" valign="top" char=".">93</td><td align="char" valign="top" char=".">28</td><td align="char" valign="top" char=".">31</td></tr><tr valign="top"><td align="left" valign="top"><i>V</i><sub>SS</sub> (L/kg)</td><td align="char" valign="top" char=".">7.6</td><td align="char" valign="top" char=".">1.6</td><td align="char" valign="top" char=".">1.5</td></tr><tr valign="top"><td align="left" valign="top">AUC<sub>0–8h</sub> (µM·h)</td><td align="char" valign="top" char=".">3.6</td><td align="char" valign="top" char=".">13</td><td align="char" valign="top" char=".">3.8</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl8-fn1"><div class="footnote" id="tbl8-fn1"><sup>a</sup><p class="last">Vehicle: 9/0.5/0.5 water/EtOH/Tween 80; dose 5 mg/kg i.v., 10 mg/kg p.o.; 3 mice per group.</p></div><div class="footnote" id="tbl8-fn2"><sup>b</sup><p class="last">Average ± SEM.</p></div></div></div><div class="NLM_p">C6 amido pyrrolo[2,1-<i>f</i>][1,2,4]triazine analogs <b>11b</b>, <b>11c</b>, and <b>11j</b> were then evaluated in the mouse collagen induced arthritis (mCIA) disease model. As can be seen in Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>, <b>11b</b> provided significant reduction in the measured outcome of disease progression relative to the vehicle group when dosed orally at 3 mg/kg, bid (49% reduction). Compound <b>11c</b> demonstrated reduced efficacy relative to <b>11b</b> in the mouse CIA model at an equivalent dose (3 mg/kg, 29% reduction) which was not statistically significant relative to the vehicle control. Compound <b>11j</b> provided 54% reduction in the measured clinical score albeit at 30 mg/kg, bid.</div><figure id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/medium/jm-2007-009414_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/large/jm-2007-009414_0014.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Efficacy in mouse collagen induced arthritis (6–8 mice per group). Compounds <b>11b</b> and <b>11j</b> achieved statistically significant reduction in clinical score (<i>p</i> < 0.05, Kruskall-Wallis test) vs vehicle (PEG300 or Tween80/EtOH/water 90/5/5). Compound <b>11b</b> was dosed as the monomethanesulfonic acid salt; <b>11c</b> was dosed as the monobisulfate salt; <b>11j</b> was dosed as the monohydrochloride salt. All doses were adjusted to the free base equivalent. The study is inclusive of two separate experiments in which the vehicle and dexamethazone controls were nearly identical. </p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/large/jm-2007-009414_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009414&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73788" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73788" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">A focused screening effort identified the oxindole-pyrrolo[2,1-<i>f</i>][1,2,4]triazines (<b>2a</b>, <b>b</b>) as novel p38 MAPK inhibitors. Replacement of the C4 oxindole with a substituted aniline yielded potent p38α inhibitors. The C5′ alkoxy amide substitution was found to be important for achieving significant enzyme inhibition and whole cell functional activity. SAR studies at C6—which included a survey of amide-, reversed amide-, urea-, and carbamate-linked pyrrolo[2,1-<i>f</i>][1,2,4]triazines—led to compounds with oral efficacy in multiple rodent models of inflammation. The combined in vitro pharmacology, in vivo efficacy, and suitable pharmacokinetics of <b>11b</b> and <b>11j</b> resulted in the selection of both compounds for advanced preclinical studies in higher species. As will be described separately,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> the results of these studies prompted the nomination of amide <b>11b</b> as a candidate for clinical development.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73254" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73254" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Chemistry</h3><div class="NLM_p">All nonaqueous reactions were carried out under an argon or nitrogen atmosphere at room temperature, unless otherwise noted. All commercial reagents and anhydrous solvents were purchased from Aldrich and were used without further purification or distillation, unless otherwise stated. Analytical thin layer chromatography (tlc) was performed on EM Science silica gel 60 F<sub>254</sub> (0.25 mm). Compounds were visualized by UV light and/or stained with either <i>p</i>-anisaldehyde, potassium permanganate, or cerium molybdate solutions followed by heating. Flash column chromatography was performed on EM Science silica gel 60 (particle size of 40−63 µm). Analytical high pressure liquid chromatography (HPLC) and LC-MS analyses were conducted using Shimadzu LC-10AS pumps and a SPD-10AV UV–vis detector set at 220 nm with the MS detection performed with a Micromass Platform LC spectrometer. Analytical HPLC analyses were performed using one of the following conditions: (column A) YMC S5 ODS, 4.6 × 50 mm, 4 min gradient, 10% MeOH/water/0.2% H<sub>3</sub>PO<sub>4</sub> to 90% MeOH/water/0.2% H<sub>3</sub>PO<sub>4</sub>, 4 mL/min flow rate; (column B) Chromalith Speedrod, 4.6 × 50 mm, 4 min gradient, 10% MeOH/water/0.2% H<sub>3</sub>PO<sub>4</sub> to 90% MeOH/water/0.2% H<sub>3</sub>PO<sub>4</sub>, 4 mL/min flow rate; (column C) YMC S5 ODS, 4.6 × 50 mm, 4 min gradient, 10% MeOH/water/0.1% TFA to 90% MeOH/water/0.1% TFA, 4 mL/min flow rate; or (column D) Phenomenex Phenom-Prime, 4.6 × 30 mm, 2 min gradient, 10% MeOH/water/0.1% TFA to 90% MeOH/water/0.1% TFA, 4 mL/min flow rate. Preparative reverse phase (RP) HPLC was performed using two Shimadzu LC-8A pumps, a SPD-10AV UV–vis detector set at 220 nm, and a YMC C18 ODS-A 5 µm, 20 × 100 mm column (eluting at 20 mL/min with a 12 min gradient of 0–100% B where solvent A = 10% MeOH/90% H<sub>2</sub>O/0.1% TFA and solvent B = 90% MeOH/10% H<sub>2</sub>O/0.1% TFA).</div><div class="NLM_p last">NMR (<sup>1</sup>H and <sup>13</sup>C) spectra were recorded on one of the following instruments: JEOL GSX-500 MHz, or Bruker ARX-400 MHz spectrometers and calibrated using an internal reference. High-resolution mass spectra (HMRS) were recorded on a JEOL SX102 mass spectrometer. Elemental analyses were performed by Robertson Microlit Laboratories, and the results obtained are within ±0.4% of the theoretical values.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Methyl4-(2-methyl-5-(methylcarbamoyl)phenylamino)-5-methylpyrrolo[2,1-<i>f</i>][1,2,4]triazine-6-carboxylate (<b>3a</b>). Representative Procedure for the Preparation of an <i>m</i>-Amino-<i>N</i>-substituted Benzamide Intermediate and Subsequent Coupling To Methyl 4-Chloro-5-methylpyrrolo[2,1-<i>f</i>][1,2,4]triazine-6-carboxylate</h3><div class="NLM_p">To a solution of 3-nitro-4-methyl benzoyl chloride (19.9 g, 100 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (115 mL) at 0 °C was added methylamine (100 mmol, 100 mL, 2 M in THF), and the reaction mixture was allowed to warm to room temperature. Stirring was continued for 1 h, and then, a second aliquot of methylamine was added (20 mL, 20 mmol) and the reaction mixture was allowed to stir overnight. The volatile solvents were removed on a rotovap, and the residue was suspended in ethanol (100 mL) and treated with NaOH (0.1 N, 200 mL) to quench the remaining acid halide. The reaction mixture was neutralized with 1 N HCl, and the volatile solvents were removed on a rotovap. Additional water (200 mL) was added, and the resulting solids were stirred rapidly for 2 h and then filtered and rinsed with water to give methyl 3-nitro-4-methyl benzamide (17.2 g, 89% yield).</div><div class="NLM_p">To a solution of methyl 3-nitro-4-methyl benzamide (6.0 g, 30.9 mmol) in EtOH (150 mL) was added 10% Pd-C (380 mg, wet), and the reaction placed under a H<sub>2</sub> atmosphere (43 psi) on a Parr shaker for 3 h. The reaction solution was filtered through celite. This step was repeated on an additional 6 g, and the filtrates were combined and concentrated in vacuo. EtOH (150 mL) was added to slurry the solids, and concentrated HCl (5.4 mL, 65 mmol) was added dropwise; the slurry was then stirred overnight. The slurry was then cooled to ∼5 °C, and the solids were collected by filtration to give methyl 3-amino-4-methyl benzamide hydrochloride (9.52 g, 77% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.89 (br s, 2H), 8.40 (s, 1H), 7.68 (s, 1H), 7.55 (d, <i>J</i> = 7.7 Hz, 1H), 7.23 (d, <i>J</i> = 7.8 Hz, 1H), 2.64 (d, <i>J</i>= 4.4 Hz, 3H), 2.25 (s, 3H); Anal. RP-HPLC <i>t</i><sub>R</sub> = 0.23 min (column A, purity 99.5%); MS (ESI) <i>m</i>/<i>z</i> 165.10 (M + H)<sup>+</sup>.</div><div class="NLM_p last">To a solution of methyl 4-chloro-5-methylpyrrolo[2,1-<i>f</i>][1,2,4]triazine-6-carboxylate <b>12</b> (13.4 mg, 0.059 mmol) in DMF (0.25 mL) was added methyl 3-amino-4-methyl benzamide (9.8 mg, 0.59 mmol), and the reaction mixture stirred at room temperature for 18 h. The solution was filtered, and the filtrate was dissolved in MeOH and purified by preparative HPLC to afford <b>3a</b> (10.3 mg, 37% yield, TFA salt) as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.05 (s, 1H), 7.95 (s, 1H), 7.72 (s, 2H), 7.45 (m, 1H), 3.89 (s, 3H), 2.92 (s, 6H), 2.36 (s, 3H); Anal. RP-HPLC <i>t</i><sub>R</sub> = 3.17 min (column A, purity 99.4%); HRMS for C<sub>18</sub>H<sub>19</sub>N<sub>5</sub>O<sub>3</sub>, (M + H)<sup>+</sup> calcd 354.1566, found 354.1572.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> <i>N</i>-Methoxy-3-amino-4-methyl benzamide hydrochloride (<b>9</b>)</h3><div class="NLM_p">A mixture of commercially available 3-amino-4-methylbenzoic acid (100 g, 0.66 mol) and <i>N</i>-(<i>tert</i>-butoxycarbonyl)anhydride (150 g, 0.68 mol) in THF (1000 mL) was slowly heated to 50 °C overnight. The resulting mixture was cooled to rt, and the solvent was removed on a rotary evaporator. The resulting solids were triturated with hexanes and dried in vacuo to afford 151 g (91%) of the crude BOC-protected aniline as a light pink solid.</div><div class="NLM_p">To the above solid was added EDC (127 g, 0.66 mol), HOBt (90 g, 0.66 mol), and DMF (1000 mL), and the resulting mixture was stirred at rt for 30 min followed by addition of methoxyamine hydrochloride (55 g, 0.66 mol). After stirring for 10 min, the mixture was cooled using an ice bath. DIPEA (250 mL, 1.4 mol) was added at such a rate so as to maintain the internal reaction temperature below 25 °C. After the addition was complete, the ice bath was removed and the reaction was stirred overnight at rt. The reaction mixture was partitioned between 0.5 L of water and 1.5 L of EtOAc, and the resulting layers were separated. The aqueous portion was extracted with additional EtOAc (3 × 400 mL), and the combined organic extracts were washed with water (3 × 300 mL), cold 0.5 N aqueous HCl (2 × 400 mL), and water (500 mL). The product was then extracted with cold 0.5 N aqueous NaOH (3 × 300 mL), and the combined basic aqueous extracts were neutralized to pH = 8 by a slow addition of cold 0.5 N aqueous HCl. The resulting solid which precipitated was collected by filtration and washed with cold water. The wet solid was decolorized in hot EtOH with activated charcoal to give 106 g of white solid as the BOC-protected <i>N</i>-methoxyamide intermediate.</div><div class="NLM_p last">To a slurry of the above solid (91 g, 0.32 mol) in 1,4-dioxane (400 mL) at rt was added a 4 M solution of HCl in dioxane (400 mL), and the resulting mixture was stirred at rt overnight. Diethyl ether (1000 mL) was added, and the precipitated solid was collected by filtration and triturated with a hot EtOH/H<sub>2</sub>O mixture (4:1 v/v). Drying the resulting solid in vacuo afforded <i>N</i>-methoxy-3-amino-4-methyl benzamide hydrochloride <b>9</b> (53 g, 76% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.77 (br s, 1H), 9.00 (br s, 2H), 7.59 (s, 1H), 7.41 (br d, 1H), 7.30 (br d, 1H), 3.70 (s, 3H), 2.31 (s, 3H); Anal. RP-HPLC <i>t</i><sub>R</sub> = 0.36 min (column A, purity 99.5%).</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Methyl 4-(2-methyl-5-(methoxycarbamoyl)phenylamino)-5-methylpyrrolo[2,1-<i>f</i>][1,2,4]triazine-6-carboxylate (<b>3b</b>)</h3><div class="NLM_p last">This compound was prepared according to the procedure outlined as in <b>3a</b> from <i>N</i>-methoxy-3-amino-4-methyl benzamide hydrochloride <b>9</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.06 (s, 1H), 7.82 (s, 1H), 7.68 (m, 2H), 7.45 (m, 1H), 3.89 (s, 3H), 3.83 (s, 3H), 2.91 (s, 6H), 2.35 (s, 3H); Anal. RP-HPLC <i>t</i><sub>R</sub> = 3.20 min (column A, purity 98.7%); HRMS for C<sub>18</sub>H<sub>19</sub>N<sub>5</sub>O<sub>4</sub>, (M + H)<sup>+</sup> calcd 370.1515, found 370.1510.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Methyl 4-(2-methyl-5-carbamoyl-phenylamino)-5-methylpyrrolo[2,1-<i>f</i>][1,2,4]triazine-6-carboxylate (<b>3c</b>)</h3><div class="NLM_p last">This compound was prepared according to the procedure outlined as in <b>3a</b> from commercially available 3-amino-4-methylbenzamide. <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 7.90 (br s, 1H), 7.71 (m, 2H), 7.42 (m, 2H), 3.86 (s, 3H), 2.87 (s, 3H), 2.31 (s, 3H); Anal. RP-HPLC <i>t</i><sub>R</sub> = 3.06 min (column A, purity 97.4%); HRMS for C<sub>17</sub>H<sub>17</sub>N<sub>5</sub>O<sub>3</sub>, (M + H)<sup>+</sup> calcd 340.1410, found 340.1405.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Methyl 4-(2-methyl-5-(ethylcarbamoyl)phenylamino)-5-methylpyrrolo[2,1-<i>f</i>][1,2,4]triazine-6-carboxylate (<b>3d</b>)</h3><div class="NLM_p last">This compound was prepared according to the procedure outlined as in <b>3a</b> starting with ethyl 3-amino-4-methylbenzamide.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a><sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.16 (br s, 1H), 7.92 (s, 1H), 7.83 (br s, 1H), 7.47 (d, <i>J</i> = 7.5 Hz, 1H), 7.23 (d, <i>J</i> = 7.7 Hz, 1H), 3.81 (s, 3H), 3.40 (dq, <i>J</i> = 7.1 Hz, 2H), 2.87 (s, 3H), 2.30 (s, 3H), 1.18 (m, 3H); Anal. RP-HPLC <i>t</i><sub>R</sub> = 3.31 min (column A, purity 98.1%); HRMS for C<sub>19</sub>H<sub>21</sub>N<sub>5</sub>O<sub>3</sub>, (M + H)<sup>+</sup> calcd 368.1723, found 368.1725.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Methyl4-(2-methyl-5-(ethoxycarbamoyl)phenylamino)-5-methylpyrrolo[2,1-<i>f</i>][1,2,4]triazine-6-carboxylate (<b>3e</b>)</h3><div class="NLM_p last">This compound was prepared according to the procedure outlined as in <b>3a</b> from <i>N</i>-ethoxy-3-amino-4-methylbenzamide. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.92 (s, 1H), 7.80 (s, 1H), 7.62 (s, 1H), 7.55 (d, <i>J</i> = 7.6 Hz, 1H), 7.35 (d, <i>J</i> = 8.0 Hz, 1H), 3.91 (t, <i>J</i> = 7.1 Hz, 2H), 3.76 (s, 3H), 2.80 (s, 3H), 2.24 (s, 3H), 1.21 (t, <i>J</i> = 7.0 Hz, 3H); Anal. RP-HPLC <i>t</i><sub>R</sub> = 3.30 min (column A, purity 97.2%, 254 nm); HRMS for C<sub>19</sub>H<sub>21</sub>N<sub>5</sub>O<sub>4</sub>, (M + H)<sup>+</sup> calcd 384.1672, found 384.1675.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Methyl 4-(2-methyl-5-(methoxycarbamoyl)phenylamino)pyrrolo[2,1-<i>f</i>][1,2,4]triazine-6-carboxylate (<b>3f</b>)</h3><div class="NLM_p last">This compound was prepared using the general coupling procedure using <b>9</b> and methyl 4-chloro-pyrrolo[2,1-<i>f</i>][1,2,4]triazine-6-carboxylate <b>4</b>.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.98 (d, <i>J</i> = 1.4 Hz, 1H), 7.73 (s, 1H), 7.68 (s, 1H), 7.57 (d, <i>J</i> = 8.0 Hz, 1H), 7.35 (d, <i>J</i> = 8.0 Hz, 1H), 7.28 (m, 1H), 3.79 (s, 3H), 3.70 (s, 3H), 2.23 (s, 3H); Anal. RP-HPLC <i>t</i><sub>R</sub> = 2.97 min (column A, purity 95.0%); HRMS for C<sub>17</sub>H<sub>17</sub>N<sub>5</sub>O<sub>4</sub>, (M + H)<sup>+</sup> calcd 356.1359, found 356.1375.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Ethyl 4-oxo-5-methyl-1,4-dihydropyrrolo[2,1-<i>f</i>][1,2,4]triazine-6-carboxylate (<b>7</b>)</h3><div class="NLM_p last">A solution of the amino pyrrole <b>6</b> (51.0 g, 212 mmol) in formamide (400 mL) was heated at 120 °C for 20 h. The reaction mixture was cooled and then poured into a rapidly stirring solution of ice−water (2 L) to precipitate the product. The solids were collected by filtration and washed with water (2 × 50 mL) and ether (150 mL) to furnish <b>7</b> (41.6 g, 89% yield) as a tan solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.64 (s, 1H), 7.89 (s, 1H), 7.85 (s, 1H), 4.24 (q, <i>J</i> = 7.1 Hz, 2H), 2.61 (s, 3H), 1.30 (t, <i>J</i> = 7.1 Hz, 3H); <sup>13</sup>C NMR (100 MHz) δ 163.8, 155.5, 140.4, 123.7, 123.2, 118.1, 114.4, 60.0, 14.6, 11.4; Anal. RP-HPLC <i>t</i><sub>R</sub> = 3.19 min (column A, purity 99%); HRMS for C<sub>10</sub>H<sub>11</sub>N<sub>3</sub>O<sub>3</sub>, (M + H)<sup>+</sup> calcd 222.0879, found 222.0876.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Ethyl 4-chloro-5-methylpyrrolo[2,1-<i>f</i>][1,2,4]triazine-6-carboxylate (<b>8</b>)</h3><div class="NLM_p last">A solution of <b>7</b> (41.8 g, 189 mmol) in POCl<sub>3</sub> (400 mL) was heated at 100 °C for 20 h. The reaction mixture was cooled, diluted with dichloromethane (200 mL), poured into ice-cold sat. aqueous NaHCO<sub>3</sub>-dichloromethane (1500−500 mL), and stirred rapidly to ensure quenching of the excess POCl<sub>3</sub>. The solution was filtered through celite, the layers were separated, and the aqueous layer was extracted with dichloromethane (500 mL). The organic extracts were combined, washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo to afford <b>8</b> (42.4 g, 94% yield) as a tan yellow solid which was used without further purification.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Ethyl 4-(2-methyl-5-(methoxycarbamoyl)phenylamino)-5-methylpyrrolo[2,1-<i>f</i>][1,2,4]triazine-6-carboxylate (<b>3g</b>)</h3><div class="NLM_p last">To a solution of <b>9</b> (41.2 g, 190 mmol) in DMF (230 mL) was added DIPEA (33.1 mL, 180.7 mmol, 0.95 equiv), and the reaction vessel was heated to 55 °C. Solid ethyl 4-chloro-5-methylpyrrolo[2,1-<i>f</i>][1,2,4]triazine-6-carboxylate (<b>8</b>) (45.6 g, 190 mmol) was added in several portions over 10 min, and the flask was rinsed with DMF (150 mL) and added to the reaction. The reaction was heated for 10 h at 55 °C and cooled to rt. The mixture was then poured into 1.5 L water diluted to 2.2 L with ice slowly over 10 min. The pH was adjusted to 6, and the solids were stirred for 1 h. The solids were filtered, washed with water (2 × 200 mL), and dried on the filter to give 71.9 g of the crude ester. The solid was then suspended in MeCN (450 mL) and heated with stirring (rotovap) at 50 °C for 1 h. The mixture was cooled and filtered to give 64.2 g product (>99% purity). These solids were then dissolved in hot ethanol (2.8 L), and decolorizing carbon was added (6.4 g) and heated at reflux for 15 min. The mixture was then filtered through a pad of celite, and the reaction flask was rinsed with hot ethanol (1 L). The solution was then concentrated to ∼1 L of ethanol by distillation upon which the product started to crystallize out of solution at a volume of 2.5 L. The solution was cooled and placed in a cold room with stirring for 40 h. The solids were filtered and rinsed with 1/1 EtOH/Et<sub>2</sub>O (500 mL) to give <b>3g</b> (58.5 g, 80% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, rotameric) δ 9.55 (br s, 1H), 8.09 (br s, 1H), 7.93 (s, 2H), 7.82 (s, 1H), 7.44 (m, 1H), 7.22 (m, 1H), 4.28 (q, <i>J</i> = 7.1 Hz, 2H), 3.79 (s, 3H), 2.88 (s, 3H), 2.29 (s, 3H), 1.33 (t, <i>J</i> = 7.1 Hz, 3H); Anal. RP-HPLC <i>t</i><sub>R</sub> = 3.51 min (column A, purity 96.1%); HRMS for C<sub>19</sub>H<sub>21</sub>N<sub>5</sub>O<sub>4</sub>, (M + H)<sup>+</sup> calcd 384.1671, found 384.1672; Anal. calcd C, 59.52; H, 5.52; N, 18.26; found C, 59.44; H, 5.61; N, 18.19.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Ethyl 4-(2-methyl-5-(methoxycarbamoyl)phenylamino)-5-ethylpyrrolo[2,1-<i>f</i>][1,2,4]triazine-6-carboxylate (<b>3h</b>)</h3><div class="NLM_p last">This compound was prepared using the general coupling procedure from <b>9</b> and ethyl 4-chloro-5-ethylpyrrolo[2,1-f][1,2,4]triazine-6-carboxylate <b>13a</b>.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.20 (s, 1H), 8.34 (s, 1H), 8.03 (s, 1H), 7.93 (s, 1H), 7.54 (d, <i>J</i> = 7.1 Hz, 1H), 7.33 (d, <i>J</i> = 7.8 Hz, 1H), 7.20 (s, 1H), 4.36 (q, <i>J</i> = 7.1 Hz, 2H), 3.89 (s, 3H), 3.32 (q, <i>J</i> = 7.7 Hz, 2H), 2.93 (s, 3H), 1.40 (m, 6H); Anal. RP-HPLC <i>t</i><sub>R</sub> = 3.72 min (column A, purity 96.6%); HRMS for C<sub>20</sub>H<sub>23</sub>N<sub>5</sub>O<sub>4</sub>, (M + H)<sup>+</sup> calcd 398.1824, found 398.1822.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Ethyl 4-(2-methyl-5-(methoxycarbamoyl)phenylamino)-5-<i>iso</i>-propylpyrrolo[2,1-<i>f</i>][1,2,4]triazine-6-carboxylate (<b>3i</b>)</h3><div class="NLM_p last">This compound was prepared using the general coupling procedure from <b>9</b> and ethyl 4-chloro-5-iso-propylpyrrolo[2,1-<i>f</i>][1,2,4]triazine-6-carboxylate <b>13b</b>.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a><sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.99 (br s, 2H), 7.82 (s, 1H), 7.45 (br s, 2H), 7.27 (m, 2H), 4.28 (q, <i>J</i> = 7.2 Hz, 2H), 3.81 (s, 3H), 1.97 (s, 3H), 1.50 (d, <i>J</i> = 6.6 Hz, 6H), 1.33 (t, <i>J</i> = 7.2 Hz, 3H); Anal. RP-HPLC <i>t</i><sub>R</sub> = 3.96 min (column A, purity 91.3%); HRMS for C<sub>21</sub>H<sub>25</sub>N<sub>5</sub>O<sub>4</sub>, (M + H)<sup>+</sup> calcd 412.1985, found 412.1995.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 4-(2-Methyl-5-(methoxycarbamoyl)phenylamino)-5-methylpyrrolo[2,1-<i>f</i>][1,2,4]triazine-6-carboxylic acid (<b>10</b>)</h3><div class="NLM_p last">To a suspension of <b>3g</b> (10.5 g, 27.8 mmol) in THF (110 mL) was added 1N NaOH (110 mL, 110 mmol), and the reaction vessel was heated at 55 °C for 16 h. The reaction mixture was cooled, filtered through a medium porosity fritted funnel, and concentrated to remove the THF. 1 N HCl was added to adjust the pH to ∼5–6, and the crude acid was stirred for several hours and then filtered. The solids were washed with water (2 × 200 mL) and then IPA/Et<sub>2</sub>O (1/1, 200 mL) and dried to give the crude acid which was used without further purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, rotameric) δ 12.5 (br s, 1H), 11.68 (m, 1H), 8.79 (s, 1H), 7.20–8.05 (m, 5H), 3.69 (s, 3H), 2.84 (s, 3H), 2.25 (s, 3H); Anal. RP-HPLC <i>t</i><sub>R</sub> = 2.72 min (column A, purity 98.2%); HRMS for C<sub>17</sub>H<sub>17</sub>N<sub>5</sub>O<sub>4</sub>, (M + H)<sup>+</sup> calcd 356.1359, found 356.1349.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> <i>N</i>-Methyl-4-(2-methyl-5-(methoxycarbamoyl)phenylamino)-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide (<b>11a</b>)</h3><div class="NLM_p last">To a solution of <b>10</b> (40 mg, 0.11 mmol), HOBt (19 mg, 0.12 mmol), EDC (24 mg, 0.12 mmol), and methylamine hydrochloride (15 mg, 0.22 mmol) in DMF was added DIPEA (0.069 mL, 0.39 mmol), and the solution was stirred for 2 h. The reaction was concentrated and purified via preparative HPLC to furnish <b>11a</b> (40 mg, 74% yield, TFA salt) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.85 (br s, 1H), 8.75 (br s, 1H), 7.38–8.05 (m, 6H), 3.70 (s, 3H), 2.79 (s, 3H), 2.75 (s, 3H), 2.22 (s, 3H); Anal. RP-HPLC <i>t</i><sub>R</sub> = 2.31 min (column A, purity 92.1%); HRMS for C<sub>18</sub>H<sub>20</sub>N<sub>6</sub>O<sub>3</sub>, (M + H)<sup>+</sup> calcd 369.1675, found 369.1682.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> <i>N</i>-Ethyl-4-(2-methyl-5-(methoxycarbamoyl)phenylamino)-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide (<b>11b</b>). Representative Procedure for the Preparation of the C6 Amides <b>11b</b>–<b>11l</b></h3><div class="NLM_p last">A solution of <b>10</b> (49 g, 139 mmol), HOBt (20.5 g, 152 mmol), EDC (29.2 g, 152 mmol), and ethylamine hydrochloride (22.6 g, 277 mmol) in DMF (225 mL) was stirred for 30 min. DIPEA (48.2 mL, 277 mmol) was added, and the mixture was stirred for 8 h. Water was added (1.35 L), and the mixture was stirred overnight to precipitate the product. The solids were filtered, washed with water (2 × 200 mL), and dried on a filter to give a tan solid which was slurried in hot EtOH (200 mL), cooled, and filtered to give the crude amide. A total of 63.3 g of the above crude solids were dissolved in hot ethanol/water (7/1, 1.7 L), decolorizing carbon was added, and the mixture was heated at reflux for 15 min. The mixture was then filtered through a pad of celite, and the reaction flask was rinsed with hot ethanol (2 × 200 mL). The solution was cooled slowly and allowed to stir overnight. The vessel was then cooled in an ice bath for 3 h, and the solids were filtered and rinsed with ice cold ethanol (100 mL) and water (200 mL) to give 47.5g of <b>11b</b> (77% recovery) as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.94 (m, 2H), 7.72 (s, 1H), 7.65 (app d, <i>J</i> = 6.9 Hz, 1H), 7.45 (d, <i>J</i> = 7.5 Hz, 1H), 3.83 (s, 3H), 3.41 (q, <i>J</i> = 7.2 Hz, 2H), 2.86 (s, 3H), 2.36 (s, 3H), 1.25 (t, <i>J</i> = 7.2 Hz, 3H); Anal. RP-HPLC <i>t</i><sub>R</sub> = 2.57 min (column A, purity 99.2%); HRMS for C<sub>19</sub>H<sub>22</sub>N<sub>3</sub>O<sub>6</sub>, (M + H)<sup>+</sup> calcd 383.1832, found 383.1829; Anal. Calcd C, 59.67; H, 5.79; N, 21.97; found: C, 59.42; H, 5.83; N, 22.00.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> <i>N</i>-<i>n</i>-Propyl-4-(2-methyl-5-(methoxycarbamoyl)phenylamino)-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide (<b>11c</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.18 (s, 1H), 7.78 (m, 3H), 7.54 (d, <i>J</i> = 6.6 Hz, 1H), 3.72 (s, 3H), 3.24 (m, 2H), 2.82 (s, 3H), 2.33 (s, 3H), 1.57 (m, 2H), 0.90 (t, <i>J</i> = 7.3 Hz, 3H); Anal. RP-HPLC <i>t</i><sub>R</sub> = 2.88 min (column A, purity 95.2%); HRMS for C<sub>20</sub>H<sub>24</sub>N<sub>6</sub>O<sub>3</sub>, (M + H)<sup>+</sup> calcd 397.1988, found 397.1995.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> <i>N</i>-<i>iso</i>-Propyl-4-(2-methyl-5-(methoxycarbamoyl)phenylamino)-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide (<b>11d</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.98 (s, 1H), 7.77 (s, 1H), 7.62 (m, 2H), 7.41 (d, <i>J =</i> 8.0 Hz, 1H), 4.10 (m, 1H), 3.71 (s, 3H), 2.76 (s, 3H), 2.27 (s, 3H), 1.16 (d, <i>J</i> = 6.6 Hz, 6H); Anal. RP-HPLC <i>t</i><sub>R</sub> = 2.77 min (column A, purity 97.5%); HRMS for C<sub>20</sub>H<sub>24</sub>N<sub>6</sub>O<sub>3</sub>, (M + H)<sup>+</sup> calcd 397.1988, found 397.1987.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> <i>N</i>-(<i>S</i>)-<i>sec</i>-Butyl-4-(2-methyl-5-(methoxycarbamoyl)phenylamino)-5-methylpyrrolo[2,1-<i>f</i>][1,2,4]triazine-6-carboxamide (<b>11e</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD, rotameric) δ 8.08 (m, 1H), 7.88 (m, 1H), 7.73 (m, 2H), 7.53 (m, 1H), 4.05 (m, 1H), 3.83 (s, 3H), 2.88 (s, 3H), 2.35 (s, 3H), 1.61 (m, 2H), 1.25 (m, 3H), 1.01 (m, 3H); Anal. RP-HPLC <i>t</i><sub>R</sub> = 3.05 min (column A, purity 99.4%); HRMS for C<sub>21</sub>H<sub>26</sub>N<sub>6</sub>O<sub>3</sub>, (M + H)<sup>+</sup> calcd 411.2145, found 411.2161.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> <i>N</i>-(2-Methoxyethyl)-4-(2-methyl-5-(methoxycarbamoyl)phenylamino)-5-methylpyrrolo[2,1-<i>f</i>][1,2,4]triazine-6-carboxamide (<b>11f</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD, TFA salt) δ 7.93 (s, 1H), 7.82 (br s, 1H), 7.62 (m, 2H), 7.42 (d, <i>J</i> = 7.7 Hz, 1H), 3.80 (s, 3H), 3.56 (app dd, <i>J</i> = 14.3, 2.7 Hz, 4H), 3.39 (s, 3H), 2.83 (s, 3H), 2.32 (s, 3H); Anal. RP-HPLC <i>t</i><sub>R</sub> = 2.09 min (column A, purity 96.4%); HRMS for C<sub>20</sub>H<sub>24</sub>N<sub>6</sub>O<sub>4</sub>, (M + H)<sup>+</sup> calcd 413.1937, found 413.1926.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> <i>N</i>-Cyclopentyl-4-(2-methyl-5-(methoxycarbamoyl)phenylamino)-5-methylpyrrolo[2,1-<i>f</i>][1,2,4]triazine-6-carboxamide (<b>11g</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.32 (s, 1H), 8.37 (s, 1H), 7.88 (s, 3H), 7.69 (s, 1H), 7.52 (m, 1H), 7.30 (m, 1H), 7.22 (s, 1H), 5.92 (d, <i>J</i> = 7.1 Hz, 1H), 4.39 (q, <i>J</i> = 7.0 Hz, 1H), 3.90 (s, 3H), 2.86 (s, 3H), 2.37 (s, 3H), 2.10 (m, 2H), 1.74 (m, 2H), 1.51 (m, 2H); Anal. RP-HPLC <i>t</i><sub>R</sub> = 3.15 min (column A, purity 98%); HRMS for C<sub>22</sub>H<sub>26</sub>N<sub>6</sub>O<sub>3</sub>, (M + H)<sup>+</sup> calcd 423.2145, found 423.2154.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> <i>N</i>-Benzyl-4-(2-methyl-5-(methoxycarbamoyl)phenylamino)-5-methylpyrrolo[2,1-<i>f</i>][1,2,4]triazine-6-carboxamide (<b>11h</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD, TFA salt) δ 7.99 (m, 1H), 7.91 (m, 1H), 7.36 (m, 7H), 7.23 (m, 1H), 4.55 (s, 2H), 3.80 (s, 3H), 2.85 (s, 3H), 2.33 (s, 3H); Anal. RP-HPLC <i>t</i><sub>R</sub> = 2.85 min (column A, purity 98.6%); HRMS for C<sub>24</sub>H<sub>24</sub>N<sub>6</sub>O<sub>3</sub>, (M + H)<sup>+</sup> calcd 445.1988, found 445.1981.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> <i>N</i>-(Pyridin-2-ylmethyl)-4-(2-methyl-5-(methoxycarbamoyl)phenylamino)-5-methylpyrrolo[2,1-<i>f</i>][1,2,4]triazine-6-carboxamide (<b>11i</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 8.49 (d, <i>J</i> = 4.4 Hz, 1H), 8.06 (s, 1H), 7.91 (s, 1H), 7.83 (m, 1H), 7.72 (s, 1H), 7.65 (m, 1H), 7.47 (m, 2H), 7.33 (m, 1H), 4.67 (s, 2H), 3.80 (s, 3H), 2.86 (s, 3H), 2.34 (s, 3H); Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.58 min (column A, purity 92.4%); HRMS for C<sub>23</sub>H<sub>23</sub>N<sub>7</sub>O<sub>3</sub>, (M + H)<sup>+</sup> calcd 446.1941, found 446.1933.</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> <i>N</i>-((<i>S</i>)-1-Phenylethyl)-4-(2-methyl-5-(methoxycarbamoyl)phenylamino)-5-methylpyrrolo[2,1-<i>f</i>][1,2,4]triazine-6-carboxamide (<b>11j</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 8.02 (br s, 1H), 7.41 (s, 1H), 7.70 (s, 1H), 7.62 (m, 1H), 7.40 (m, 2H), 7.33 (t, <i>J</i> = 7.7 Hz, 2H), 7.22 (t, <i>J</i> = 7.2 Hz, 1H), 5.21 (q, <i>J</i> = 7.6 Hz, 1H), 3.79 (s, 3H), 2.80 (s, 3H), 2.32 (s, 3H), 1.55 (d, <i>J</i> = 7.2 Hz, 3H); Anal. RP-HPLC <i>t</i><sub>R</sub> = 2.95 min (column A, purity 99.8%); HRMS for C<sub>25</sub>H<sub>26</sub>N<sub>6</sub>O<sub>3</sub>, (M + H)<sup>+</sup> calcd 459.2145, found 459.2139.</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> <i>N</i>-((<i>R</i>)-1-Phenylethyl)-4-(2-methyl-5-(methoxycarbamoyl)phenylamino)-5-methylpyrrolo[2,1-<i>f</i>][1,2,4]triazine-6-carboxamide (<b>11k</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD, TFA salt) δ 8.06 (br s, 1H), 7.84 (s, 1H), 7.65 (m, 2H), 7.44 (d, <i>J</i> = 7.7 Hz, 1H), 7.41 (m, 2H), 7.34 (t, <i>J</i> = 7.2 Hz, 2H), 7.23 (t, <i>J</i> = 7.2 Hz, 1H), 5.22, (q, <i>J</i> = 7.2 Hz, 1H), 3.79 (s, 3H), 2.81 (s, 3H), 2.35 (s, 3H), 1.55 (d, <i>J</i> = 7.2 Hz, 3H); Anal. RP-HPLC <i>t</i><sub>R</sub> = 2.81 min (column A, purity 97%); HRMS for C<sub>25</sub>H<sub>26</sub>N<sub>6</sub>O<sub>3</sub>, (M + H)<sup>+</sup> calcd 459.2145, found 459.2135.</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> <i>N</i>-(2-Morpholinoethyl)-4-(2-methyl-5-(methoxycarbamoyl)phenylamino)-5-methylpyrrolo[2,1-<i>f</i>][1,2,4]triazine-6-carboxamide (<b>11l</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD, TFA salt) δ 7.95 (br s, 1H), 7.76 (s, 1H), 7.61 (m, 2H), 7.42 (d, <i>J</i> = 7.7 Hz, 1H), 4.10 (br m, 4 H), 3.80 (s, 3H), 3.75 (t, <i>J</i> = 6.0 Hz, 2H), 3.40 (t, <i>J</i> = 6.1 Hz, 2H), 3.29 (br m, 4H), 2.87 (s, 3H), 2.31 (s, 3H); Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.39 min (column A, purity 96.9%); HRMS for C<sub>23</sub>H<sub>29</sub>N<sub>7</sub>O<sub>4</sub>, (M + H)<sup>+</sup> calcd 468.2359, found 468.2351.</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 4-Methoxybenzyl 4-(2-methyl-5-(methoxycarbamoyl)phenylamino)-5-methylpyrrolo[2,1-<i>f</i>][1,2,4]triazin-6-ylcarbamate (<b>17d</b>). Representative Procedure for the Preparation of 4-Alkyl 4-(2-methyl-5-(methoxycarbamoyl)phenylamino)-5-methylpyrrolo[2,1-<i>f</i>][1,2,4]triazin-6-ylcarbamates (<b>17a</b>–<b>d</b>)</h3><div class="NLM_p last">To a suspension of <b>10</b> (330 mg, 0.93 mmol) and 4 Å molecular sieves in dioxane (15 mL) at 50 °C was added TEA (323 <i>µ</i>L, 2.3 mmol) and diphenyl phosphoryl azide (503 <i>µ</i>L, 2.3 mmol). The reaction mixture was stirred for 1.5 h at which point <i>p</i>-methoxy benzyl alcohol (1.16 mL, 9.3 mmol) was added, and the reaction temperature was increased to 80 °C for 2 h. The reaction was cooled, diluted with EtOAc, and filtered. After concentrating, the residue was purified via flash chromatography (75% EtOAc/hexane) to afford 4-methoxybenzyl 4-(2-methyl-5-(methoxycarbamoyl)phenylamino)-5-methylpyrrolo[2,1-<i>f</i>][1,2,4]triazin-6-ylcarbamate <b>17d</b> (150 mg, 33% yield) as a pale yellow solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.90 (s, 1H), 8.39 (m, 1H), 7.91 (s, 2H), 7.53 (d, <i>J</i> = 8.8 Hz, 1H), 7.35 (m, 3H), 6.92 (m, 2H), 6.42 (s, 1H), 5.17 (s, 2H), 3.90 (s, 3H), 3.83 (s, 3H), 2.49 (s, 3H), 2.38 (s, 3H); Anal. RP-HPLC <i>t</i><sub>R</sub> = 2.86 min (column A, purity 98%); MS (ESI) <i>m</i>/<i>z</i> 491.30 (M + H)<sup>+</sup>.</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 4-(2-Methyl-5-(methoxycarbamoyl)phenylamino)-5-methylpyrrolo[2,1-<i>f</i>][1,2,4]triazin-6-amine (<b>14</b>)</h3><div class="NLM_p last">Carbamate <b>17d</b> (150 mg) was dissolved in dichloromethane (10 mL), and TFA was added (0.5 mL) The mixture was stirred at rt for 30 min and concentrated to give the crude amine <b>14</b> (126 mg, 93% yield) as a brown oil which was used without further purification.</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 4-(2-Methyl-5-(methoxycarbamoyl)phenylamino)-5-methylpyrrolo[2,1-<i>f</i>][1,2,4]triazin-6-acetamide (<b>15a</b>). Representative Procedure for the Conversion of <b>14</b> To the Amides <b>15a</b>–<b>c</b> and Urea <b>16</b></h3><div class="NLM_p last">To a suspension of <b>14</b> (20 mg, 0.06 mmol) in dichloromethane (3 mL) was added TEA (26 <i>µ</i>L, 0.18 mmol) followed by acetic anhydride (10 mg, 0.1 mmol) and the reaction mixture was stirred for 3 h. Water (2 mL) was added, and the product was extracted with dichloromethane (3 × 10 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to an oil which was purified via flash chromatography (33% EtOAc/hexane) to give <b>15a</b> (5 mg, 23% yield). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.95 (m, 2H), 7.67 (m, 2H), 7.41 (m, 1H), 3.81 (s, 3H), 2.58 (s, 3H), 2.34 (s, 3H), 2.20 (s, 3H); Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.60 min (column A, purity 94%); MS (ESI) <i>m</i>/<i>z</i> 369.23 (M + H)<sup>+</sup>.</div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 4-(2-Methyl-5-(methoxycarbamoyl)phenylamino)-5-methylpyrrolo[2,1-<i>f</i>][1,2,4]triazin-6-propylamide (<b>15b</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.22 (s, 1H), 7.88 (s, 1H), 7.78 (d, <i>J</i> = 8.3 Hz, 1H), 7.72 (s, 1H), 7.75 (d, <i>J</i> = 7.9 Hz, 1H), 3.81 (s, 3H), 2.62 (s, 3H), 2.49 (q, <i>J</i> = 7.5 Hz, 2H), 2.38 (s, 3H), 1.33 (t, <i>J</i> = 7.4 Hz, 3H); Anal. RP-HPLC <i>t</i><sub>R</sub> = 2.33 min (column A, purity 96%); HRMS for C<sub>19</sub>H<sub>22</sub>N<sub>6</sub>O<sub>3</sub>, (M + H)<sup>+</sup> calcd 383.1826, found 383.1816.</div></div><div id="sec4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 4-(2-Methyl-5-(methoxycarbamoyl)phenylamino)-5-methylpyrrolo[2,1-<i>f</i>][1,2,4]triazin-6-<i>iso</i>-butyramide (<b>15c</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.47 (s, 1H), 7.72 (s, 1H), 7.48 (m, 2H), 7.36 (d, <i>J</i> = 7.9 Hz, 1H), 7.24 (m, 1H), 5.50 (br s, 1H), 3.74 (s, 3H), 2.71 (m, 1H), 2.56 (s, 3H), 2.33 (s, 3H), 1.33 (s, 3H), 1.31 (s, 3H); Anal. RP-HPLC <i>t</i><sub>R</sub> = 2.50 min (column A, purity 96.4%); HRMS for C<sub>20</sub>H<sub>24</sub>N<sub>6</sub>O<sub>3</sub>, (M + H)<sup>+</sup> calcd 397.1988, found 397.1977.</div></div><div id="sec4_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 4-(2-Methyl-5-(methoxycarbamoyl)phenylamino)-5-methylpyrrolo[2,1-<i>f</i>][1,2,4]triazin-6-<i>iso</i>-propylurea (<b>16</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 7.81 (br s, 1H), 7.74 (br s, 1H), 7.50 (m, 2H), 7.31 (d, <i>J</i> = 8.2 Hz, 1H), 3.80 (m, 1H), 3.71 (s, 3H), 2.42 (s, 3H), 2.23 (s, 3H), 1.10 (s, 3H), 1.08 (s, 3H); Anal. RP-HPLC <i>t</i><sub>R</sub> = 2.58 min (column A, purity 97.5%); HRMS for C<sub>20</sub>H<sub>25</sub>N<sub>7</sub>O<sub>3</sub>, (M + H)<sup>+</sup> calcd 412.2097, found 412.2089.</div></div><div id="sec4_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> Methyl 4-(2-Methyl-5-(methoxycarbamoyl)phenylamino)-5-methylpyrrolo[2,1-<i>f</i>][1,2,4]triazin-6-ylcarbamate (<b>17a</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.90 (s, 1H), 7.66 (m, 1H), 7.43 (m, 1H), 7.23 (m, 2H), 3.80 (s, 3H), 3.77 (s, 3H), 2.53, (s, 3H), 2.33 (s, 3H); Anal. RP-HPLC <i>t</i><sub>R</sub> = 2.38 min (column A, purity 98%); HRMS for C<sub>18</sub>H<sub>20</sub>N<sub>6</sub>O<sub>4</sub>, (M + H)<sup>+</sup> calcd 385.1624, found 385.1614.</div></div><div id="sec4_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> Ethyl 4-(2-Methyl-5-(methoxycarbamoyl)phenylamino)-5-methylpyrrolo[2,1-<i>f</i>][1,2,4]triazin-6-ylcarbamate (<b>17b</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.90 (br s, 1H), 7.81 (br s, 1H), 7.53 (m, 2H), 7.32 (br d, 1H), 4.20 (q, <i>J</i> = 7.0 Hz, 2H), 3.79 (s, 3H), 2.53 (s, 3H), 2.33 (s, 3H), 1.32 (t, <i>J</i> = 6.9 Hz, 3H); Anal. RP-HPLC <i>t</i><sub>R</sub> = 2.66 min (column A, purity 99%); HRMS for C<sub>19</sub>H<sub>22</sub>N<sub>6</sub>O<sub>4</sub>, (M + H)<sup>+</sup> calcd 399.1781, found 399.1771.</div></div><div id="sec4_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> Isopropyl 4-(2-Methyl-5-(methoxycarbamoyl)phenylamino)-5-methylpyrrolo[2,1-<i>f</i>][1,2,4]triazin-6-ylcarbamate (<b>17c</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.81 (s, 1H), 7.72 (br s, 1H), 7.53 (m, 2H), 7.32 (d, <i>J</i> = 7.9 Hz, 1H), 4.88 (q, <i>J</i> = 6.6 Hz, 2H), 3.71 (s, 3H), 2.43 (s, 3H), 2.33 (s, 3H), 1.23 (s, 3H), 1.22 (s, 3H); Anal. RP-HPLC <i>t</i><sub>R</sub> = 2.87 min (column A, purity 98.5%); HRMS for C<sub>20</sub>H<sub>24</sub>N<sub>6</sub>O<sub>4</sub>, (M + H)<sup>+</sup> calcd 413.1937, found 413.1930.</div></div><div id="sec4_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> Ethyl 4-[(2-Methyl-5-nitro)phenylamino]-5-methylpyrrolo[2,1-<i>f</i>][1,2,4]triazine-6-carboxylate (<b>18</b>)</h3><div class="NLM_p last">To a solution of chloride <b>8</b> (4.0 g, 16.7 mmol) in DMF (50 mL) was added 2-methyl-5-nitro aniline (2.8 g, 18.4 mmol), and the reaction mixture was stirred for 48 h. Water (200 mL) was added slowly via addition funnel, and the resulting suspension was adjusted to pH 7 with NaHCO<sub>3</sub> (sat. aq.). The resulting precipitate was stirred for 2 h, filtered, and washed with water (2 × 25 mL) to afford <b>18</b> (5.09 g, 86% yield) as a pale tan solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD, rotameric) δ 8.57 (s, 1H), 8.17 (m, 1H), 8.07 (s, 1H), 7.81 (m, 2H), 4.37 (m, 2H), 2.95 (s, 3H), 2.44 (s, 3H), 1.41 (m, 3H); Anal. RP-HPLC <i>t</i><sub>R</sub> = 4.04 min (column A, purity 96.6%); MS (ESI) <i>m</i>/<i>z</i> 356.19 (M + H).</div></div><div id="sec4_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> <i>N</i>-<i>n</i>-Propyl-4-[(2-methyl-5-nitro)phenylamino]-5-methylpyrrolo[2,1-<i>f</i>][1,2,4]triazine-6-carboxamide (<b>19</b>)</h3><div class="NLM_p">To a solution of <b>18</b> (825 mg, 2.32 mmol) in THF (2 mL) and MeOH (1 mL) was added 1 N NaOH (6 mL), and the reaction mixture was heated at 60 °C for 24 h. The reaction mixture was then cooled and concentrated to remove the organic solvents. The pH of the solution was adjusted to ∼6 with 1 N HCl, and the resulting solids were filtered, washed successively with water, and dried to afford the crude acid which was used without further purification. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 12.4 (br s, 1H), 7.55–7.86 (m, 5H), 2.79 (s, 3H), 2.28 (s, 3H); Anal. RP-HPLC <i>t</i><sub>R</sub> = 3.40 min (column A, purity 98%); MS (ESI) <i>m</i>/<i>z</i> 328.1 (M + H)<sup>+</sup>.</div><div class="NLM_p last">To a solution of the above acid (2.32 mmol) in DMF (6 mL) was added HOBt (345 mg, 2.6 mmol) and EDC (489 mg, 2.6 mmol), and the resulting mixture was stirred at rt for 1 h. <i>n</i>-Propylamine (0.38 mL, 6.4 mmol) was added, and the reaction was stirred for an additional 4 h. Water was added (25 mL) to precipitate the product, and the solids were stirred rapidly for 10 min, filtered, and washed with additional water (2 × 10 mL). The collected solids were purified via column chromatography (33% EtOAc/hexanes) to give <b>19</b> (0.79 g, 93% yield, 2 steps) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.11 (s, 1H), 7.92 (m, 2H), 7.71 (s, 1H), 7.36 (d, <i>J</i> = 8.4 Hz, 1H), 7.25 (m, 1H), 5.82 (br m, 1H), 3.34 (q, <i>J</i> = 6.7 Hz, 2H), 2.86 (s, 3H), 2.41 (s, 3H), 1.58 (m, 2H), 1.16 (t, <i>J</i> = 7.5 Hz, 3H); MS (ESI) <i>m</i>/<i>z</i> 369.3 (M + H)<sup>+</sup>.</div></div><div id="sec4_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> <i>N</i>-<i>n</i>-Propyl-4-[(2-methyl-5-amino)aminophenyl]-5-methylpyrrolo[2,1-<i>f</i>][1,2,4]triazine-6-carboxamide (<b>20</b>)</h3><div class="NLM_p last">A solution of <b>19</b> (794 mg, 2.16 mmol) and 10% Pd/C (250 mg, wet) in MeOH (20 mL) wad degassed and backfilled with hydrogen gas. The reaction was maintained under a hydrogen atmosphere for 2 h with stirring at which time the reaction solution was filtered and concentrated to give <b>20</b> (691 mg, 95% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.94 (m, 1H), 7.73 (s, 1H), 7.53 (s, 1H), 7.23 (s, 1H), 7.06 (d, <i>J</i> = 8.1 Hz, 1H), 6.53 (dd, <i>J</i> = 8.1, 2.2 Hz, 1H), 5.86 (br m, 1H), 3.43 (q, <i>J</i> = 6.6 Hz, 2H), 2.91 (s, 3H), 2.27 (s, 3H), 1.68 (m, 2H), 1.02 (t, <i>J</i> = 7.3 Hz, 3H); Anal. RP-HPLC <i>t</i><sub>R</sub> = 2.39 min (column A, purity 98%); MS (ESI) <i>m</i>/<i>z</i> 339.2 (M + H)<sup>+</sup>.</div></div><div id="sec4_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> <i>N</i>-<i>n</i>-Propyl-4-[(2-methyl-5-methylcarbamoyl)aminophenyl]-5-methylpyrrolo[2,1-<i>f</i>][1,2,4]triazine-6-carboxamide (<b>21a</b>). Representative Procedure for the Conversion of <b>20</b> to the Carbamates (<b>21a</b>–<b>d</b>)</h3><div class="NLM_p last">To a solution of <b>20</b> (25.2 mg, 0.075 mmol) in dichloromethane (250 <i>µ</i>L) was added DIPEA (14.3 <i>µ</i>L, 0.082 mmol) followed by methyl chloroformate (6.4 <i>µ</i>L, 0.082 mmol). The reaction was stirred for 1 h, and then, IPA was added (1 mL). The resulting solids were collected on a filter and washed with cold IPA (1 mL) to afford, after drying, <b>21a</b> (20.1 mg, 68% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, rotameric) δ 9.64 (s, 1H), 8.56 (s, 1H), 8.09 (m, 2H), 7.78 (s, 1H), 7.52 (m, 1H), 7.31 (m, 1H), 7.18 (d, <i>J</i> = 8.4 Hz, 1H), 3.65 (s, 3H), 3.18 (m, 2H), 2.79 (s, 3H), 2.12 (s, 3H), 1.51 (m, 2H), 0.90 (t, <i>J</i> = 7.4 Hz, 3H); Anal. RP-HPLC <i>t</i><sub>R</sub> = 2.94 min (column A, purity 96.6%); HRMS for C<sub>20</sub>H<sub>24</sub>N<sub>6</sub>O<sub>3</sub>, (M + H)<sup>+</sup> calcd 397.1988, found 397.1955.</div></div><div id="sec4_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> <i>N</i>-<i>n</i>-Propyl-4-[(2-methyl-5-ethylcarbamoyl)aminophenyl]-5-methylpyrrolo[2,1-<i>f</i>][1,2,4]triazine-6-carboxamide (<b>21b</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, rotameric) δ 9.62 (br s, 1H), 8.57 (br s, 1H), 8.08 (m, 2H), 7.78 (s, 1H), 7.59 (m, 1H), 6.89–7.32 (m, 2H), 4.11 (app q, <i>J</i> = 7.1 Hz, 2H), 3.18 (app q, <i>J</i> = 6.5 Hz, 2H), 2.80 (s, 3H), 2.12 (s, 3H), 1.52 (m, 2H), 1.24 (t, <i>J</i> = 7.0 Hz, 3H), 0.95 (t, <i>J</i> = 7.4 Hz, 3H); Anal. RP-HPLC <i>t</i><sub>R</sub> = 3.16 min (column A, purity 99.5%); HRMS for C<sub>21</sub>H<sub>26</sub>N<sub>6</sub>O<sub>3</sub>, (M-H)<sup>+</sup> calcd 409.1988, found 409.2006; Anal. calcd C, 61.45; H, 6.38; N, 20.47; found C, 61.39; H, 6.46; N, 20.49.</div></div><div id="sec4_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> <i>N</i>-<i>n</i>-Propyl-4-[(2-methyl-5-<i>iso</i>-propylcarbamoyl)aminophenyl]-5-methylpyrrolo[2,1-<i>f</i>][1,2,4]triazine-6-carboxamide (<b>21c</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>, rotameric) δ 9.52 (br s, 1H), 8.56 (br s, 1H), 8.07 (m, 2H), 7.77 (s, 1H), 7.60 (m, 1H), 7.16–7.31 (m, 2H), 4.86 (m, 1H), 3.17 (m, 2H), 2.79 (s, 3H), 2.11 (s, 3H), 1.51 (m, 2H), 1.25 (s, 3H), 1.24 (s, 3H), 0.90 (t, <i>J</i> = 7.2 Hz, 3H); Anal. RP-HPLC <i>t</i><sub>R</sub> = 3.38 min (column A, purity 94.9%); HRMS for C<sub>22</sub>H<sub>28</sub>N<sub>6</sub>O<sub>3</sub>, (M + H)<sup>+</sup> calcd 425.2301, found 425.2307.</div></div><div id="sec4_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> <i>N</i>-<i>n</i>-Propyl-4-[(2-methyl-5-phenylcarbamoyl)aminophenyl]-5-methylpyrrolo[2,1-<i>f</i>][1,2,4]triazine-6-carboxamide (<b>21d</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>, rotameric) δ 10.23 (br s, 1H), 8.57 (s, 1H), 8.10 (s, 1H), 8.07 (t, <i>J</i> = 5.5 Hz, 1H), 7.79 (s, 1H), 7.44 (s, 1H), 7.43 (t, <i>J</i> = 6.3 Hz, 2H), 7.35 (m, 1H), 7.23 (m, 3H), 3.18 (m, 2H), 2.80 (s, 3H), 2.15 (s, 3H), 1.51 (m, 2H), 0.90 (t, <i>J</i> = 7.2 Hz, 3H); Anal. RP-HPLC <i>t</i><sub>R</sub> = 3.46 min (column A, purity 91.5%); HRMS for C<sub>25</sub>H<sub>26</sub>N<sub>6</sub>O<sub>3</sub>, (M + H)<sup>+</sup> calcd 459.2145, found 459.2136.</div></div><div id="sec4_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> Ethyl 3-Amino-4-methylphenylcarbamate (<b>22</b>)</h3><div class="NLM_p">To a solution of 3-nitro-4-methyl aniline (2.0 g, 13.1 mmol) in dichloroethane (40 mL) wad added ethyl chloroformate (1.38 mL, 14.4 mmol) followed by DIPEA (2.3 mL, 14.4 mmol). The reaction was stirred for 12 h and then poured into a separatory funnel containing water (75 mL) and dichloromethane (50 mL). The layers were separated, and the organic layer was washed with aqueous NaHCO<sub>3</sub>, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to an oil. The product was purified via column chromatography (20% EtOAc/hexanes) to furnish ethyl-3-nitro-4-methyl phenyl carbamate (2.39 g, 82% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.08 (d, <i>J</i> = 2.3 Hz, 1H), 7.61 (d, <i>J</i> = 7.4 Hz, 1H), 7.32 (s, 1H), 6.74 (s, 1H), 4.30 (q, <i>J</i> = 7.1 Hz, 2H), 2.59 (s, 3H), 1.38 (t, <i>J</i> = 7.1 Hz, 3H); Anal. RP-HPLC <i>t</i><sub>R</sub> = 3.37 min (column A, purity 97.8%); MS (ESI) <i>m</i>/<i>z</i> 225.13 (M + H)<sup>+</sup>.</div><div class="NLM_p last">To a solution of ethyl-3-nitro-4-methyl phenyl carbamate (1.33 g, 5.9 mmol) in MeOH (30 mL) was added 5% Pd/C (480 mg, wet), and the reaction vessel was evacuated and backfilled with hydrogen gas. The reaction was maintained under a hydrogen atmosphere for 2 h with stirring at which time the reaction solution was filtered and concentrated to give <b>22</b> (1.15 g, 99% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.86 (m, 2H), 6.46 (dd, <i>J</i> = 8.0, 2.1 Hz, 1H), 6.36 (s, 1H), 4.13 (q, <i>J</i> = 7.1 Hz, 2H), 3.42 (br s, 2H), 2.04 (s, 3H), 1.22 (t, <i>J</i> = 7.1 Hz, 3H); Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.43 min (column A, purity 98.7%).</div></div><div id="sec4_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> Methyl 4-(2-Methyl-5-(ethoxycarbonylamino)phenylamino)-5-methylpyrrolo[2,1-<i>f</i>][1,2,4]triazine-6-carboxylate (<b>23</b>)</h3><div class="NLM_p last">This compound was prepared according to the procedure outlined for compound <b>18</b> starting from chloride <b>12</b> (248 mg, 1.1 mmol) and ethyl 3-amino-4-methylphenylcarbamate <b>22</b> (235 mg, 1.2 mmol) to provide <b>23</b> (339 mg, 81% yield). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>, rotameric) δ 9.62 (s, 1H), 8.73 (s, 1H), 8.09 (s, 1H), 7.81 (m, 1H), 7.55 (m, 1H), 7.31 (m, 1H), 7.17 (m, 1H), 4.11 (q, <i>J</i> = 7.1 Hz, 2H), 3.80 (s, 3H), 3.33 (s, 3H), 2.82 (s, 3H), 2.11 (s, 3H), 1.24 (m, 3H); Anal. RP-HPLC <i>t</i><sub>R</sub> = 3.51 min (column A, purity 98%); MS (ESI) <i>m</i>/<i>z</i> 384.23 (M + H)<sup>+</sup>.</div></div><div id="sec4_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 4-(2-Methyl-5-(ethoxycarbonylamino)phenylamino)-5-methylpyrrolo[2,1-<i>f</i>][1,2,4]triazine-6-carboxylic acid (<b>24</b>)</h3><div class="NLM_p last">To a solution of <b>23</b> (290 mg, 0.59 mmol) in THF (2 mL) and MeOH (2 mL) was added 1 N NaOH (1.77 mL, 1.77 mmol), and the reaction mixture was heated at 55 °C for 24 h. The reaction mixture was then cooled and concentrated to remove the organic solvents. The pH of the solution was adjusted to ∼6 with 1 N HCl, and the resulting solids were filtered, washed successively with water, and dried to afford the crude acid <b>24</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, rotameric) δ 9.60 (s, 1H), 8.23 (s, 1H), 7.66 (m, 2H), 7.20 (m, 2H), 4.10 (m, 2H), 2.88 (s, 3H), 2.14 (s, 3H), 1.24 (br m, 3H); Anal. RP-HPLC <i>t</i><sub>R</sub> = 3.07 min (column A, purity 98.5%); MS (ESI) <i>m</i>/<i>z</i> 370.28 (M + H)<sup>+</sup>.</div></div><div id="sec4_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> <i>N</i>-Ethyl-4-[(2-methyl-5-ethylcarbamoyl)aminophenyl]-5-methylpyrrolo[2,1-<i>f</i>][1,2,4]triazine-6-carboxamide (<b>21g</b>). Representative Procedure for the Coupling of <b>24</b> with an Amine for the Preparation of <b>21g</b>–<b>i</b></h3><div class="NLM_p last">To a solution of acid <b>24</b> (25 mg, 0.07 mmol) in DMF was added HOBt (10.1 mg, 0.075 mmol) and EDC (14.3 mg, 0.075 mmol), and the mixture was stirred for 30 min. Ethyl amine hydrochloride (11.4 mg, 0.14 mmol) was added followed by DIPEA (24.4 <i>µ</i>L, 0.14 mmol), and the reaction mixture was stirred for 2 h. Water (1 mL) was added to precipitate the product, and the solids were stirred for 2 h, filtered, and dried under high vacuum to afford <b>21 g</b> (18.0 mg, 66% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.88 (br s, 1H), 7.65 (br m, 2H), 7.28 (m, 1H), 7.21 (m, 1H), 4.16 (app q, <i>J</i> = 7.0, 2H), 3.37 (app q, <i>J</i> = 7.5 Hz, 2H), 2.81 (s, 3H), 2.20 (s, 3H), 1.28 (t, <i>J</i> = 7.0 Hz, 3H), 1.22 (t, <i>J</i> = 7.6 Hz, 3H); Anal. RP-HPLC <i>t</i><sub>R</sub> = 2.89 min (column A, purity 96%); HRMS for C<sub>20</sub>H<sub>24</sub>N<sub>6</sub>O<sub>3</sub>, (M + H)<sup>+</sup> calcd 397.1988, found 397.1992.</div></div><div id="sec4_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> <i>N</i>-<i>iso</i>-Propyl-4-[(2-methyl-5-ethylcarbamoyl)aminophenyl]-5-methylpyrrolo[2,1-<i>f</i>][1,2,4]triazine-6-carboxamide (<b>21</b><b>h</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.92 (br s, 1H), 7.68 (m, 2H), 7.31 (m, 1H), 7.23 (m, 1H), 4.16 (m, 2H), 2.81 (s, 3H), 2.22 (s, 3H), 1.28 (t, <i>J</i> = 7.0 Hz, 3H), 1.25 (s, 3H), 1.24 (s, 3H); Anal. RP-HPLC <i>t</i><sub>R</sub> = 3.06 min (column A, purity 97.4%); HRMS for C<sub>21</sub>H<sub>26</sub>N<sub>6</sub>O<sub>3</sub>, (M + H)<sup>+</sup> calcd 411.2145, found 411.2146.</div></div><div id="sec4_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> <i>N</i>-(<i>S</i>)-<i>sec</i>-Buytl-4-[(2-methyl-5-ethylcarbamoyl)aminophenyl]-5-methylpyrrolo[2,1-<i>f</i>][1,2,4]triazine-6-carboxamide (<b>21i</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.92 (br s, 1H), 7.65 (m, 2H), 7.30 (m, 1H), 7.25 (m, 1H), 4.16 (q, <i>J</i> = 7.4 Hz, 2H), 4.00 (m, 1H), 2.98 (m, 2H), 2.81 (s, 3H), 2.22 (s, 3H), 1.58 (m, 2H), 1.29 (t, <i>J</i> = 7.0 Hz, 3H), 1.22 (d, <i>J</i> = 6.6 Hz, 3H), 0.97 (t, <i>J</i> = 7.5 Hz, 3H); Anal. RP-HPLC <i>t</i><sub>R</sub> = 3.25 min (column A, purity 94.1%); HRMS for C<sub>22</sub>H<sub>28</sub>N<sub>6</sub>O<sub>3</sub>, (M + H)<sup>+</sup> calcd 425.2301, found 425.2305.</div></div><div id="sec4_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> <i>N</i>-<i>n</i>-Propyl 4-(2-methyl-5-(methoxyacetamido)phenylamino)-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide (<b>21e</b>)</h3><div class="NLM_p last">This compound was prepared via the acylation of <b>20</b> with 2-methoxyacetyl chloride using the general procedure outlined for <b>21a</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.60 (s, 1H), 8.39 (s, 1H), 7.91 (m, 2H), 7.63 (m, 2H), 7.29 (m, 1H), 7.03 (m, 1H), 3.80 (s, 2H), 3.19 (s, 3H), 2.62 (s, 3H), 1.97 (s, 3H), 1.36 (m, 2H), 0.73 (m, 3H); Anal. RP-HPLC <i>t</i><sub>R</sub> = 2.84 min (column A, purity 95.9%); HRMS for C<sub>21</sub>H<sub>26</sub>N<sub>6</sub>O<sub>3</sub>, (M + H)<sup>+</sup> calcd 411.2145, found 411.2145.</div></div><div id="sec4_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> <i>N</i>-<i>n</i>-Propyl 4-(2-methyl-5-(acetamido)phenylamino)-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide (<b>21f</b>)</h3><div class="NLM_p last">This compound was prepared via the acylation of <b>20</b> with acetylchloride using the general procedure outlined for <b>21a</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.94 (s, 1H), 8.54 (s, 1H), 8.07 (m, 2H), 7.75 (m, 2H), 7.40 (m, 1H), 7.19 (m, 1H), 3.18 (m, 2H), 2.80 (s, 3H), 2.14 (s, 3H), 2.03 (s, 3H), 1.51 (m, 2H), 0.90 (t, <i>J</i> = 7.5 Hz, 3H); Anal. RP-HPLC <i>t</i><sub>R</sub> = 2.74 min (column A, purity 95%); LRMS for C<sub>2o</sub>H<sub>24</sub>N<sub>6</sub>O<sub>2</sub>, (M + H)<sup>+</sup> calcd 381.45, found 381.23.</div></div><div id="sec4_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> p38 Kinase Assay</h3><div class="NLM_p last">The assays were performed in V-bottomed 96-well plates. For both assays, the final assay volume was 60 <i>µ</i>L which was from three 20-<i>µ</i>L additions of enzyme, substrates (myelin basic protein (MBP) and ATP), and test compounds in assay buffer (50 mM Tris pH 7.5, 10 mM MgCl<sub>2</sub>, 50 mM NaCl, and 1 mM DTT). Bacterially expressed, activated p38α was preincubated with test compounds for 10 min prior to the initiation of reaction by adding substrates. The plates were incubated at room temperature for 45 min. The reaction was terminated by adding 5 <i>µ</i>L of 0.5 M EDTA to each well. The reaction mixture was aspirated onto a prewetted filtermat using a Skatron Micro96 cell harvester (Skatron) and then washed with PBS. The filtermat was dried in a microwave oven for 1 min, coated with a layer of MeltilLex A scintillation wax (PerkinElmer), and counted on a Microbeta scintillation counter (Model 1450, PerkinElmer). The data were analyzed using Prizm nonlinear least-squares regression (GraphPad Software). The final concentrations of reagents in the assays were [ATP], 1 <i>µ</i>M; [[γ-<sup>33</sup>P]ATP]], 3 nM; [MBP] (Sigma, M1891), 2 <i>µ</i>g/well; [p38], 15 ng/well; [DMSO], 0.3%.</div></div><div id="sec4_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> LPS-Induced TNFα Production in THP-1 Cells</h3><div class="NLM_p last">Human monocytic THP-1 cells, obtained from ATCC, were maintained in RPMI 1640 medium supplemented with 10% fetal bovine serum. Cells (40 000 cells in 80 <i>µ</i>L) were added to wells of 96-well flat-bottomed plates. Tested compounds (10 <i>µ</i>L) or vehicle (1% DMSO final) was added to cells. Subsequently, LPS (Sigma, No. L7261; 10 <i>µ</i>L /well) was added to the cells for a final concentration of 1 <i>µ</i>g/mL. Plates were incubated overnight at 37 °C and 5% CO<sub>2</sub>. Supernatant (50 <i>µ</i>L/well) was harvested for an ELISA assay. TNFα was captured by an antihuman TNFα antibody (R&D, No. MAB610) which was preabsorbed in high binding EIA plates (Costar, No. 3590). Captured TNF was recognized by a biotinylated antihuman TNF polyclonal antibody (R&D, No. BAF210). Streptavidin conjugated with peroxidase was added to each well, and the activity of peroxidase was quantitated by a peroxide substrate kit (Pierce, Nos. 34062 and 34006).</div></div><div id="sec4_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> LPS-Induced TNFα Production in Human PBMC</h3><div class="NLM_p last">Human PBMCs were isolated from whole blood collected from healthy donors. Blood was diluted into RPMI 1640 (Life Technologies) containing 2.5 mM EDTA (Life Technologies) and 10 <i>µ</i>g/mL polymyxin (Sigma) and, then, underlaid with ficoll (Accurate Scientific Co.) and centrifuged at 600<i>g</i> for 25 min. The interface was collected, and cells were washed twice and resuspended in RPMI, 10% FBS. Cells were then distributed (200 <i>µ</i>L/well) into 96-well tissue culture treated plates (Falcon) at 1 × 10<sup>6</sup> cells/mL in RPMI, 10% FBS. Test compounds were added to appropriate wells and incubated with cells for 30 min. Cells were then stimulated by the addition of lipopolysaccharide (LPS, BioWhittaker), with a final concentration of 25 ng/mL, and incubated for 6 h at 37 °C, 5% CO<sub>2</sub>. The cell supernatants were removed and assayed for TNFα by ELISA (R&D Systems).</div></div><div id="sec4_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> Inhibition of TNFα Release in Mice</h3><div class="NLM_p last">BALB\c female mice, 6–8 weeks of age, were obtained from Harlan Laboratories and maintained ad libitum on water and standard rodent chow (Harlan Teklad). Mice were acclimated to ambient conditions for at least 1 week prior to use. For oral dosing, the compounds were prepared in a solution of 100% polyethylene glycol (MW 300), and a dosing volume of 0.2 mL per mouse was administered by gavage 30 or 120 min prior to LPS injection (0.1 mL of LPS suspended at 10 µg/mL in PBS, administered ip). Blood samples were obtained 90 min after LPS injection. Serum was separated from clotted blood samples by centrifugation (5 min, 5000<i>g</i>, room temperature) and analyzed for levels of TNFα by ELISA assay (R&D Systems) according to the manufacturerʼs directions. Results are shown as mean percent inhibition of <i>n</i> = 6–8 mice per treatment group. All studies were performed using <b>11b</b> as a positive control and as a measure of model variability. All procedures involving animals were reviewed and approved by the Institutional Animal Care and Use Committee.</div></div><div id="sec4_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> Rat and Human Liver Microsome Stability</h3><div class="NLM_p last">Rat microsomes were purchased from XenoTech (Kansas City, KS). The human microsomes were purchased from In Vitro Technology (Baltimore, MD) and were pooled from 10 individual donors. The rates of oxidative metabolism were measured in triplicate under the following conditions: compound, 3 µM final concentration; final microsomal protein concentration approximately 1 mg/mL; NADPH 1 mM; pH 7.4 potassium phosphate buffer, 56 mM. Incubations were performed at 37 °C and were initiated by the addition of the substrate. Aliquots (100 µL) of the incubation were quenched at 0, 10, 20, 30, and 40 min by the addition of 1 volume of acetonitrile. Results from 10-min incubations were used for the rate calculations. Samples were analyzed by the LC/MS/MS assay for the amount of the drug remaining at any time point. The percent metabolized was calculated based on the disappearance of the parent compound.</div></div><div id="sec4_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> Rat Adjuvant Arthritis</h3><div class="NLM_p last">Male Lewis rats (Harlan, 175–200 g) were immunized sc at the base of the tail with 0.1 mL complete Freundʼs adjuvant containing 10 mg/mL <i>Mycobacterium butyricum</i>. Seven days later, baseline (predisease) measurements of hind paw volume were determined by volume displacement plethysmometry (Ugo Basile, Italy). Compound was administered orally in 1 mL PEG 300 bid beginning on day 11. Paw volume measurements were repeated 3 times/week for the remainder of the study. Data are presented as the summed increase in volume (expressed in mL) above baseline for each ratʼs two hind paws. Dexamethasone (1 mg/kg) was used as a positive control.</div></div><div id="sec4_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> Mouse Collagen Induced Arthritis</h3><div class="NLM_p">DBA/1LacJ male mice 6–8 weeks (The Jackson Laboratory, Bar Harbor, ME) were immunized subcutaneously on day 0 and day 21 with 200 µg bovine type II collagen in a 0.1 mL RIBI adjuvant system (RAS) with monophosphoryl lipid A (RIBI ImmunoChem Research, Hamilton, Montana). Following the day 21 booster, mice were monitored daily for the development paw inflammation. On day 26, the animals were randomly assigned to a treatment group and treatment (po, bid) was initiated immediately. Clinical paw scores for all four paws were summed for each mouse and mean ± SD was calculated for each treatment group. Dexamethasone (5 mg/kg) was used as a positive control.</div><div id="sec4_57_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> Clinical Scoring</h4><div class="NLM_p last">Each paw was visually scored by the following criteria: 0 = normal; 1 = one (or more) joints inflamed on digits; 2 = inflammation of plantar surface of paw and paw thickness increased; 3 = ankylosis of ankle joint (significantly reduced hock joint motion on flexion/extension).</div></div></div><div id="sec4_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> Crystal Structure of p38 MAP Kinase</h3><div class="NLM_p last">Recombinant p38α MAP Kinase with an N-terminal (His)<sub>5</sub>-affinity tag was expressed in <i>E. coli</i> and purified by sequential Q-Sepharose FF, His-Trap HP Ni<sup>2+</sup>-affinity, and Superdex 200 size exclusion chromatography. Purified (His)<sub>5</sub>-p38α, at 2 mg/mL in 25 mM Tris (pH 7.5), 50 mM NaCl, 5% glycerol, 0.5 mM EDTA, 2 mM DTT, was combined with a 5-fold molar excess of inhibitor from a 50 mM stock in DMSO, incubated at 20 °C for 1 h, and ultrafiltered (10 kDa cutoff) to a retentate protein concentration of 10 mg/mL. Cocrystals of (His)<sub>5</sub>-p38α <b>11j</b> inhibitor complexes grew spontaneously in hanging drop vapor-diffusion trials conducted at 4 °C with drops containing 1 µL of concentrated protein−inhibitor complex mixed with an equal volume of reservoir solution (50 mM Mes pH 6.0, 4% PEG 3350, 5 mM MgSO<sub>4</sub>). More perfect crystals of <b>11j</b> and <b>11b</b> were obtained using a cat whisker to streak clear drops with microseeds from crushed cocrystals of (His)<sub>5</sub>-p38α and <b>11j</b>. Prior to data collection, the crystals were slowly transferred to a stabilization solution (5% glycerol, 30% PEG 3350, 50 mM Mes pH 6.0, 50 mM NaCl) and then flash frozen in liquid nitrogen. Data were collected at the IMCA-CAT beamline ID-17 at the Advanced Photon Source, Argonne, IL, reduced with the programs DENZO and SCALEPACK,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> and refined by with the program autoBuster (Global Phasing, Ltd., Cambridge, U.K.). The final crystallographic refinement statistics are summarized in the <a class="ref internalNav" href="#si1" aria-label="Supporting Information">Supporting Information</a>. Details of the data collection, reduction, and refinement will be presented elsewhere.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i69"><a href="/doi/suppl/10.1021/jm7009414">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53205" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53205" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Table of HPLC purity analysis or combustion analysis of key compounds and final X-ray crystallographic refinement statistics. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm7009414/suppl_file/jm7009414-file002.pdf">jm7009414-file002.pdf (201.43 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm7009414" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70064" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70064" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Hynes</span> - <span class="hlFld-Affiliation affiliation">Departments of Immunology Chemistry, Immunology Biology, Metabolism and Pharmacokinetics, and Molecular Biosciences, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543-4000</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#157f7a7d7b3b7d6c7b7066557778663b767a78"><span class="__cf_email__" data-cfemail="bdd7d2d5d393d5c4d3d8cefddfd0ce93ded2d0">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alaric J. Dyckman</span> - <span class="hlFld-Affiliation affiliation">Departments of Immunology Chemistry, Immunology Biology, Metabolism and Pharmacokinetics, and Molecular Biosciences, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shuqun Lin</span> - <span class="hlFld-Affiliation affiliation">Departments of Immunology Chemistry, Immunology Biology, Metabolism and Pharmacokinetics, and Molecular Biosciences, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephen T. Wrobleski</span> - <span class="hlFld-Affiliation affiliation">Departments of Immunology Chemistry, Immunology Biology, Metabolism and Pharmacokinetics, and Molecular Biosciences, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hong Wu</span> - <span class="hlFld-Affiliation affiliation">Departments of Immunology Chemistry, Immunology Biology, Metabolism and Pharmacokinetics, and Molecular Biosciences, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kathleen M. Gillooly</span> - <span class="hlFld-Affiliation affiliation">Departments of Immunology Chemistry, Immunology Biology, Metabolism and Pharmacokinetics, and Molecular Biosciences, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steven B. Kanner</span> - <span class="hlFld-Affiliation affiliation">Departments of Immunology Chemistry, Immunology Biology, Metabolism and Pharmacokinetics, and Molecular Biosciences, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Herinder Lonial</span> - <span class="hlFld-Affiliation affiliation">Departments of Immunology Chemistry, Immunology Biology, Metabolism and Pharmacokinetics, and Molecular Biosciences, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Derek Loo</span> - <span class="hlFld-Affiliation affiliation">Departments of Immunology Chemistry, Immunology Biology, Metabolism and Pharmacokinetics, and Molecular Biosciences, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kim W. McIntyre</span> - <span class="hlFld-Affiliation affiliation">Departments of Immunology Chemistry, Immunology Biology, Metabolism and Pharmacokinetics, and Molecular Biosciences, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sidney Pitt</span> - <span class="hlFld-Affiliation affiliation">Departments of Immunology Chemistry, Immunology Biology, Metabolism and Pharmacokinetics, and Molecular Biosciences, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ding Ren Shen</span> - <span class="hlFld-Affiliation affiliation">Departments of Immunology Chemistry, Immunology Biology, Metabolism and Pharmacokinetics, and Molecular Biosciences, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David J. Shuster</span> - <span class="hlFld-Affiliation affiliation">Departments of Immunology Chemistry, Immunology Biology, Metabolism and Pharmacokinetics, and Molecular Biosciences, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">XiaoXia Yang</span> - <span class="hlFld-Affiliation affiliation">Departments of Immunology Chemistry, Immunology Biology, Metabolism and Pharmacokinetics, and Molecular Biosciences, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rosemary Zhang</span> - <span class="hlFld-Affiliation affiliation">Departments of Immunology Chemistry, Immunology Biology, Metabolism and Pharmacokinetics, and Molecular Biosciences, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kamelia Behnia</span> - <span class="hlFld-Affiliation affiliation">Departments of Immunology Chemistry, Immunology Biology, Metabolism and Pharmacokinetics, and Molecular Biosciences, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hongjian Zhang</span> - <span class="hlFld-Affiliation affiliation">Departments of Immunology Chemistry, Immunology Biology, Metabolism and Pharmacokinetics, and Molecular Biosciences, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Punit H. Marathe</span> - <span class="hlFld-Affiliation affiliation">Departments of Immunology Chemistry, Immunology Biology, Metabolism and Pharmacokinetics, and Molecular Biosciences, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Arthur M. Doweyko</span> - <span class="hlFld-Affiliation affiliation">Departments of Immunology Chemistry, Immunology Biology, Metabolism and Pharmacokinetics, and Molecular Biosciences, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John S. Tokarski</span> - <span class="hlFld-Affiliation affiliation">Departments of Immunology Chemistry, Immunology Biology, Metabolism and Pharmacokinetics, and Molecular Biosciences, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John S. Sack</span> - <span class="hlFld-Affiliation affiliation">Departments of Immunology Chemistry, Immunology Biology, Metabolism and Pharmacokinetics, and Molecular Biosciences, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew Pokross</span> - <span class="hlFld-Affiliation affiliation">Departments of Immunology Chemistry, Immunology Biology, Metabolism and Pharmacokinetics, and Molecular Biosciences, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Susan E. Kiefer</span> - <span class="hlFld-Affiliation affiliation">Departments of Immunology Chemistry, Immunology Biology, Metabolism and Pharmacokinetics, and Molecular Biosciences, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John A. Newitt</span> - <span class="hlFld-Affiliation affiliation">Departments of Immunology Chemistry, Immunology Biology, Metabolism and Pharmacokinetics, and Molecular Biosciences, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joel C. Barrish</span> - <span class="hlFld-Affiliation affiliation">Departments of Immunology Chemistry, Immunology Biology, Metabolism and Pharmacokinetics, and Molecular Biosciences, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Dodd</span> - <span class="hlFld-Affiliation affiliation">Departments of Immunology Chemistry, Immunology Biology, Metabolism and Pharmacokinetics, and Molecular Biosciences, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gary L. Schieven</span> - <span class="hlFld-Affiliation affiliation">Departments of Immunology Chemistry, Immunology Biology, Metabolism and Pharmacokinetics, and Molecular Biosciences, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Katerina Leftheris</span> - <span class="hlFld-Affiliation affiliation">Departments of Immunology Chemistry, Immunology Biology, Metabolism and Pharmacokinetics, and Molecular Biosciences, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543-4000</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i68">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07582" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07582" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors would like to thank Robert Borzilleri and Brian Fink for helpful discussions and useful intermediates at the outset of this effort, the Discovery Analytical Sciences Department for obtaining high-resolution MS analysis, and the staff of the IMCA-CAT beamline 17- ID at the Advanced Photon Source, Argonne, IL. The use of the beamline was supported by the companies of the Industrial Macromolecular Crystallography Association through a contract with the Center for Advanced Radiation Sources at the University of Chicago.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i70">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63612" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63612" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 20 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Choy, E. H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panayi, G. S.</span><span> </span><span class="NLM_article-title">Cyokine Pathways and Joint Inflammation in Rheumatoid Arthritis</span> <span class="citation_source-journal">N. Eng. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">344</span><span class="NLM_x">, </span> <span class="NLM_fpage">907</span><span class="NLM_x">–</span> <span class="NLM_lpage">916</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm7009414&amp;key=10.1056%2FNEJM200103223441207" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm7009414&amp;key=11259725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm7009414&amp;key=1%3ACAS%3A528%3ADC%252BD3MXisFyrur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=344&publication_year=2001&pages=907-916&author=E.+H.+S.+Choyauthor=G.+S.+Panayi&title=Cyokine+Pathways+and+Joint+Inflammation+in+Rheumatoid+Arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Cytokine pathways and joint inflammation in rheumatoid arthritis</span></div><div class="casAuthors">Choy, Ernest H. S.; Panayi, Gabriel S.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">344</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">907-916</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review with 79 refs.  Although the cause of rheumatoid arthritis is still unclear, the improved understanding of the pathogenesis of the disease has opened the door to innovative therapies.  By targeting mols. that are directly involved in the pathogenesis of rheumatoid arthritis, these therapies may be more efficacious and specific and less toxic in the short and long term than std. therapies.  Radiol. evidence suggests that these new therapies, such as anticytokine therapy, may slow disease progression.  Finally, the success of anticytokine therapy will also provide valuable insights into the initiation and progression of rheumatoid arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8KnAs8wt9tbVg90H21EOLACvtfcHk0lgiGLZvoB3siw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXisFyrur8%253D&md5=407ee2bc06a307c241e60f048e5f4a95</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1056%2FNEJM200103223441207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM200103223441207%26sid%3Dliteratum%253Aachs%26aulast%3DChoy%26aufirst%3DE.%2BH.%2BS.%26aulast%3DPanayi%26aufirst%3DG.%2BS.%26atitle%3DCyokine%2520Pathways%2520and%2520Joint%2520Inflammation%2520in%2520Rheumatoid%2520Arthritis%26jtitle%3DN.%2520Eng.%2520J.%2520Med.%26date%3D2001%26volume%3D344%26spage%3D907%26epage%3D916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Dinarello, C. A.</span><span> </span><span class="NLM_article-title">Inflammatory cytokines: Interleukin-1 and Tumor Necrosis Factor as Effector Molecules in Autoimmune Diseases</span> <span class="citation_source-journal">Curr. Opin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">941</span><span class="NLM_x">–</span> <span class="NLM_lpage">948</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Fjm7009414&amp;key=10.1016%2FS0952-7915%2805%2980018-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Fjm7009414&amp;key=1665333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Fjm7009414&amp;key=1%3ACAS%3A528%3ADyaK38Xkt1ChtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1991&pages=941-948&author=C.+A.+Dinarello&title=Inflammatory+cytokines%3A+Interleukin-1+and+Tumor+Necrosis+Factor+as+Effector+Molecules+in+Autoimmune+Diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammatory cytokines:  interleukin-1 and tumor necrosis factor as effector molecules in autoimmune diseases</span></div><div class="casAuthors">Dinarello, Charles A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Immunology</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">941-8</span>CODEN:
                <span class="NLM_cas:coden">COPIEL</span>;
        ISSN:<span class="NLM_cas:issn">0952-7915</span>.
    </div><div class="casAbstract">The nature of the events that ppt. autoimmune diseases varies.  Interleukin-1 and tumor necrosis factor do not ppt. autoimmune diseases but rather act as effector mols.  They induce eicosanoid and NO synthesis, stimulate collagenases and collagen synthesis, and trigger the genes for other cytokines, namely interleukin-2, interleukin-6 and interleukin-8.  The ability to block interleukin-1 with the receptor antagonist, and tumor necrosis factor with sol. receptors, has given investigators specific tools to test the role of these two cytokines in the pathol. processes of autoimmune disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhF6Z-Gd_1RrVg90H21EOLACvtfcHk0lgPEqEqieC2iA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xkt1ChtLs%253D&md5=9124ac01336892ed242ed4583f14b4c6</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1016%2FS0952-7915%2805%2980018-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0952-7915%252805%252980018-4%26sid%3Dliteratum%253Aachs%26aulast%3DDinarello%26aufirst%3DC.%2BA.%26atitle%3DInflammatory%2520cytokines%253A%2520Interleukin-1%2520and%2520Tumor%2520Necrosis%2520Factor%2520as%2520Effector%2520Molecules%2520in%2520Autoimmune%2520Diseases%26jtitle%3DCurr.%2520Opin.%2520Immunol.%26date%3D1991%26volume%3D3%26spage%3D941%26epage%3D948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Palladino, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahjat, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theodorakis, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moldawer, L. L.</span><span> </span><span class="NLM_article-title">Anti-TNF-α Therapies: The Next Generation</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">736</span><span class="NLM_x">–</span> <span class="NLM_lpage">746</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Fjm7009414&amp;key=10.1038%2Fnrd1175" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Fjm7009414&amp;key=12951580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Fjm7009414&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvVWlsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=736-746&author=M.+A.+Palladinoauthor=F.+R.+Bahjatauthor=E.+A.+Theodorakisauthor=L.+L.+Moldawer&title=Anti-TNF-%CE%B1+Therapies%3A+The+Next+Generation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-TNF-α therapies: the next generation</span></div><div class="casAuthors">Palladino, Michael A.; Bahjat, Frances Rena; Theodorakis, Emmanuel A.; Moldawer, Lyle L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">736-746</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The functioning of the immune system is finely balanced by the activities of pro-inflammatory and anti-inflammatory mediators or cytokines.  Unregulated activities of these mediators can lead to the development of serious inflammatory diseases.  In particular, enhanced tumor-necrosis factor-α (TNF-α) synthesis is assocd. with the development of rheumatoid arthritis, psoriatic arthritis, and inflammatory bowel disease.  Inhibiting TNF-α activities in these diseases has been remarkably successful.  However, the current injectable protein therapies have assocd. risks and limitations.  An oral, small mol. that regulates TNF-α biol. could either replace the injectables or provide better disease control when used alone or in conjunction with existing therapies.  Here, the authors discuss the present understanding of TNF-α-mediated biol. and the current injectable therapies in clin. use, and focus on some of the new therapeutic approaches with oral, small-mol. inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmD8W7lUANYrVg90H21EOLACvtfcHk0lgPEqEqieC2iA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvVWlsLc%253D&md5=700fdae848391fbc910b5538217be0f8</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1038%2Fnrd1175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1175%26sid%3Dliteratum%253Aachs%26aulast%3DPalladino%26aufirst%3DM.%2BA.%26aulast%3DBahjat%26aufirst%3DF.%2BR.%26aulast%3DTheodorakis%26aufirst%3DE.%2BA.%26aulast%3DMoldawer%26aufirst%3DL.%2BL.%26atitle%3DAnti-TNF-%25CE%25B1%2520Therapies%253A%2520The%2520Next%2520Generation%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2003%26volume%3D2%26spage%3D736%26epage%3D746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Braddock, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, A.</span><span> </span><span class="NLM_article-title">Targeting IL-1 in Inflammatory Disease: New Opportunities for Therapeutic Intervention</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">10</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=1-10&author=M.+Braddockauthor=A.+Quinn&title=Targeting+IL-1+in+Inflammatory+Disease%3A+New+Opportunities+for+Therapeutic+Intervention"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBraddock%26aufirst%3DM.%26aulast%3DQuinn%26aufirst%3DA.%26atitle%3DTargeting%2520IL-1%2520in%2520Inflammatory%2520Disease%253A%2520New%2520Opportunities%2520for%2520Therapeutic%2520Intervention%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D1%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Westra, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Limburg, P. C.</span><span> </span><span class="NLM_article-title">p38 Mitogen-Activated Protein Kinase (MAPK) in Rheumatoid Arthritis</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">867</span><span class="NLM_x">–</span> <span class="NLM_lpage">874</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=867-874&author=J.+Westraauthor=P.+C.+Limburg&title=p38+Mitogen-Activated+Protein+Kinase+%28MAPK%29+in+Rheumatoid+Arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWestra%26aufirst%3DJ.%26aulast%3DLimburg%26aufirst%3DP.%2BC.%26atitle%3Dp38%2520Mitogen-Activated%2520Protein%2520Kinase%2520%2528MAPK%2529%2520in%2520Rheumatoid%2520Arthritis%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D867%26epage%3D874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Salituro, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Germann, U. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bemis, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, M. S.</span><span> </span><span class="NLM_article-title">Inhibitors of p38 MAP Kinase: Therapeutic Intervention in Cytokine-Mediated Diseases</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">807</span><span class="NLM_x">–</span> <span class="NLM_lpage">823</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Fjm7009414&amp;key=10495353" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Fjm7009414&amp;key=1%3ACAS%3A528%3ADyaK1MXlvFWqtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1999&pages=807-823&author=F.+G.+Salituroauthor=U.+A.+Germannauthor=K.+P.+Wilsonauthor=G.+W.+Bemisauthor=T.+Foxauthor=M.+S.+Su&title=Inhibitors+of+p38+MAP+Kinase%3A+Therapeutic+Intervention+in+Cytokine-Mediated+Diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of p38 MAP kinase: therapeutic intervention in cytokine-mediated diseases</span></div><div class="casAuthors">Salituro, Francesco G.; Germann, Ursula A.; Wilson, Keith P.; Bemis, Guy W.; Fox, Ted; Su, Michael S.-S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">807-823</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review with 91 refs.  P38 MAP kinase is a member of the family of kinases which mediate intracellular transduction pathways.  The activation of this particular MAP kinase pathway is in response to a broad variety of extracellular stimuli.  Subsequent downstream events triggered by p38 activation result in the prodn. of IL-1 and TNF-α, suggesting that inhibition of this enzyme may provide a useful therapeutic target for intervention in various diseases mediated by these cytokines.  Understanding the biol. consequences of p38 activation and inhibition has been the subject of intensive research over the past several years and there is now ample evidence to suggest that inhibition of this enzyme represents a valid approach for target intervention in various cytokine-mediated diseases.  Crystal structures of both apo enzyme and enzyme bound to various ligands in conjunction with site specific mutagenesis studies have provided a wealth of information regarding the interactions necessary to result in potent inhibition and selectivity from other kinases.  This information has proven useful towards the anal. of previously reported compds. and will provide addnl. insight towards the design of new compds. and building upon existing SAR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSaK3z0Hlrx7Vg90H21EOLACvtfcHk0lg9X1DHQHK0SQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlvFWqtLs%253D&md5=fe744a5cb2b84f70e147be1a6e9e0a5a</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSalituro%26aufirst%3DF.%2BG.%26aulast%3DGermann%26aufirst%3DU.%2BA.%26aulast%3DWilson%26aufirst%3DK.%2BP.%26aulast%3DBemis%26aufirst%3DG.%2BW.%26aulast%3DFox%26aufirst%3DT.%26aulast%3DSu%26aufirst%3DM.%2BS.%26atitle%3DInhibitors%2520of%2520p38%2520MAP%2520Kinase%253A%2520Therapeutic%2520Intervention%2520in%2520Cytokine-Mediated%2520Diseases%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D1999%26volume%3D6%26spage%3D807%26epage%3D823" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Foster, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halley, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Souness, J. E.</span><span> </span><span class="NLM_article-title">Potential of p38 Inhibitors in the Treatment of Rheumatoid Arthritis</span> <span class="citation_source-journal">Drug News Perspect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">488</span><span class="NLM_x">–</span> <span class="NLM_lpage">497</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Fjm7009414&amp;key=12937622" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Fjm7009414&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmsFKktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2000&pages=488-497&author=M.+L.+Fosterauthor=F.+Halleyauthor=J.+E.+Souness&title=Potential+of+p38+Inhibitors+in+the+Treatment+of+Rheumatoid+Arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Potential of p38 inhibitors in the treatment of rheumatoid arthritis</span></div><div class="casAuthors">Foster, Martyn L.; Halley, Frank; Souness, John E.</div><div class="citationInfo"><span class="NLM_cas:title">Drug News & Perspectives</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">488-497</span>CODEN:
                <span class="NLM_cas:coden">DNPEED</span>;
        ISSN:<span class="NLM_cas:issn">0214-0934</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review, with 64 refs.  Rheumatoid arthritis (RA) is a chronic debilitating disease estd. to afflict 1-3% of the world population.  Although palliative treatments (nonsteroidal anti-inflammatory drugs or NSAIDs) are widely prescribed, there are currently only a few treatments that can modify the insidious progression of the disease (disease-modifying antirheumatic drugs or DMARDs), which frequently leads to phys. incapacitation and, on occasion, death.  Proinflammatory cytokines such as tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) are implicated in the disease onset and in the progression of bone and joint destruction that characterizes chronic RA.  P38 is an intracellular mitogen/stress-activated protein kinase (MAPK/SAPK) that regulates both the release and the actions of TNF-α and IL-1β.  Inhibition of p38 kinase is thus an important potential target for novel DMARDs.  Following the pioneering work conducted at SmithKline Beecham and elucidation of the roles of p38 with potent and selective inhibitors such as SB-203580, many pharmaceutical companies have embarked upon p38 synthetic programs, as indicated by the ever-increasing no. of patents in this domain.  At Aventis, a rapid parallel synthesis project led to the identification of RPR-200765A, a potent and selective p38 inhibitor of the lipopolysaccharide-induced release of TNF-α in vitro in mononuclear phagocytes and in vivo in the rat.  It also reduces disease incidence and progression in the rat streptococcal cell wall arthritis model when administered orally in either a prophylactic or a therapeutic dosing regimen.  Development of p38 inhibitors has been slow, probably because of toxicol. problems, which might explain why only two oral p38 inhibitors, SB-242235 and VX-745, have advanced into clin. development.  In the present article, the preclin. data exemplified in studies on RPR-200765A indicating why p38 inhibitors are attracting so much attention as potential novel anti-RA drugs are reviewed.  Current information on the different structural classes of p38 inhibitors is presented and possible reasons for the delays in their development are critically discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPsDRV9bCN37Vg90H21EOLACvtfcHk0lg9X1DHQHK0SQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmsFKktg%253D%253D&md5=b634b7ab2f3e8fd6747c4889e324f3a3</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFoster%26aufirst%3DM.%2BL.%26aulast%3DHalley%26aufirst%3DF.%26aulast%3DSouness%26aufirst%3DJ.%2BE.%26atitle%3DPotential%2520of%2520p38%2520Inhibitors%2520in%2520the%2520Treatment%2520of%2520Rheumatoid%2520Arthritis%26jtitle%3DDrug%2520News%2520Perspect.%26date%3D2000%26volume%3D13%26spage%3D488%26epage%3D497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Kumar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, J</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. C.</span><span> </span><span class="NLM_article-title">P38 MAP Kinases: Key Signaling Molecules as Therapeutic Targets for Inflammatory Diseases</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">717</span><span class="NLM_x">–</span> <span class="NLM_lpage">726</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=717-726&author=S.+Kumarauthor=J+Boehmauthor=J.+C.+Lee&title=P38+MAP+Kinases%3A+Key+Signaling+Molecules+as+Therapeutic+Targets+for+Inflammatory+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DBoehm%26aufirst%3DJ%26aulast%3DLee%26aufirst%3DJ.%2BC.%26atitle%3DP38%2520MAP%2520Kinases%253A%2520Key%2520Signaling%2520Molecules%2520as%2520Therapeutic%2520Targets%2520for%2520Inflammatory%2520Diseases%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2003%26volume%3D2%26spage%3D717%26epage%3D726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Saklatvala, J.</span><span> </span><span class="NLM_article-title">The p38 MAP kinase pathway as a therapeutic target in inflammatory disease</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">372</span><span class="NLM_x">–</span> <span class="NLM_lpage">377</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=16&amp;doi=10.1021%2Fjm7009414&amp;key=10.1016%2Fj.coph.2004.03.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=8&amp;doi=10.1021%2Fjm7009414&amp;key=15251131" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=32&amp;doi=10.1021%2Fjm7009414&amp;key=1%3ACAS%3A528%3ADC%252BD2cXls1Wgu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=372-377&author=J.+Saklatvala&title=The+p38+MAP+kinase+pathway+as+a+therapeutic+target+in+inflammatory+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4dR"><div class="casContent"><span class="casTitleNuber">4d</span><div class="casTitle"><span class="NLM_cas:atitle">The p38 MAP kinase pathway as a therapeutic target in inflammatory disease</span></div><div class="casAuthors">Saklatvala, Jeremy</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">372-377</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with refs.  The p38 MAPK signalling pathway plays an important role in inflammation and other physiol. processes.  Specific inhibitors of p38 α and β MAPK block prodn. of the major inflammatory cytokines (i.e. tumor necrosis factor-α and interleukin-1) and other proteins (e.g. cyclooxygenase-2), and are anti-inflammatory in animal models of disease.  A major function of the pathway is post-transcriptional control of inflammatory gene expression.  Many of the mRNAs are unstable (or untranslatable) because of AU-rich elements in the 3'untranslated region.  Signalling in the p38 pathway counteracts these and stabilizes the mRNAs by preventing their otherwise rapid de-adenylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpglO4EVBhJ-LVg90H21EOLACvtfcHk0lg9X1DHQHK0SQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXls1Wgu7s%253D&md5=5678936250f1dbc9c27707bd7edf6108</span></div><a href="/servlet/linkout?suffix=cit4d&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2004.03.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2004.03.009%26sid%3Dliteratum%253Aachs%26aulast%3DSaklatvala%26aufirst%3DJ.%26atitle%3DThe%2520p38%2520MAP%2520kinase%2520pathway%2520as%2520a%2520therapeutic%2520target%2520in%2520inflammatory%2520disease%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2004%26volume%3D4%26spage%3D372%26epage%3D377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Kumar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blake, S. M.</span><span> </span><span class="NLM_article-title">Pharmacological Potential of p38 MAPK Inhibitors</span> <span class="citation_source-journal">Handbook Exp. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">167</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">83</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4e&amp;dbid=16&amp;doi=10.1021%2Fjm7009414&amp;key=10.1007%2F3-540-26670-4_4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4e&amp;dbid=32&amp;doi=10.1021%2Fjm7009414&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFCn" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2005&pages=65-83&author=S.+Kumarauthor=S.+M.+Blake&title=Pharmacological+Potential+of+p38+MAPK+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4eR"><div class="casContent"><span class="casTitleNuber">4e</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological potential of p38 MAPK inhibitors</span></div><div class="casAuthors">Kumar, S.; Blake, S. M.</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue">Inhibitors of Protein Kinases and Protein Phosphates</span>),
    <span class="NLM_cas:pages">65-83</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">0171-2004</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  A key component of the intracellular signaling pathways involved in cellular response to environmental stress and inflammatory cytokines is the p38 family of mitogen-activated protein kinases (MAPKs).  Of the four isoforms of the p38 family of MAPKs identified thus far, p38α is the most characterized enzyme.  Since the discovery of p38α MAPK as a target of a series of compds. that inhibited the prodn. of inflammatory cytokines, an intense effort has been applied to further identify, develop, and refine highly potent and selective inhibitors of this enzyme.  In addn., availability of p38α MAPK inhibitors has allowed the investigators to dissect this signaling pathway and to examine its role in various pathologies.  A large body of biochem. as well as genetic evidence indicates a crit. role of p38α MAPK in both the prodn. of inflammatory cytokines such as interleukin (IL)-1 and tumor necrosis factor (TNF) and subsequent signaling initiated in response to these cytokines.  This suggests that inhibition of p38α MAPK pathway will have utility in pathol. settings where tissue inflammation and pro-inflammatory cytokines have been implicated.  Indeed, several p38α MAPK inhibitors have been shown to be efficacious in preclin. animal models of a variety of diseases, including rheumatoid arthritis, pulmonary diseases, neuronal protection, and cancer.  In the past few years, several groups have advanced inhibitors into early clin. studies for rheumatoid arthritis, but none thus far has reached the crit. phase III efficacy stage.  In this chapter, we review.  The p38 MAPK pathway and pharmacol. potential of p38α MAPK inhibitors in various pathologies with particular emphasis on inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3KHIOOv2-uLVg90H21EOLACvtfcHk0lg3mCyUVlrPkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFCn&md5=ee807b0804df8944e482514b34d3461b</span></div><a href="/servlet/linkout?suffix=cit4e&amp;dbid=16384&amp;doi=10.1007%2F3-540-26670-4_4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F3-540-26670-4_4%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DBlake%26aufirst%3DS.%2BM.%26atitle%3DPharmacological%2520Potential%2520of%2520p38%2520MAPK%2520Inhibitors%26jtitle%3DHandbook%2520Exp.%2520Pharmacol.%26date%3D2005%26volume%3D167%26spage%3D65%26epage%3D83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Fijen, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zijlstra, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Boer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spanjersberg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, Tervaert, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Werf, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lightenberg, J. J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tulleken, J. E.</span><span> </span><span class="NLM_article-title">Suppression of the Clinical and Cytokine Response to Endotoxin by RWJ-67657, a p38 Mitogen-Activated Protein-Kinase Inhibitor, in Healthy Human Volunteers</span> <span class="citation_source-journal">Clin. Exp. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Fjm7009414&amp;key=10.1046%2Fj.1365-2249.2001.01485.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Fjm7009414&amp;key=11359438" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Fjm7009414&amp;key=1%3ACAS%3A528%3ADC%252BD3MXktl2kt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2001&pages=16-20&author=J.+W.+Fijenauthor=J.+G.+Zijlstraauthor=P.+De+Boerauthor=R.+Spanjersbergauthor=J.+W.+Cohen%2C+Tervaertauthor=T.+S.+van+der+Werfauthor=J.+J.+M.+Lightenbergauthor=J.+E.+Tulleken&title=Suppression+of+the+Clinical+and+Cytokine+Response+to+Endotoxin+by+RWJ-67657%2C+a+p38+Mitogen-Activated+Protein-Kinase+Inhibitor%2C+in+Healthy+Human+Volunteers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Suppression of the clinical and cytokine response to endotoxin by RWJ-67657, a p38 mitogen-activated protein-kinase inhibitor, in healthy human volunteers</span></div><div class="casAuthors">Fijen, J. W.; Zijlstra, J. G.; De Boer, P.; Spanjersberg, R.; Tervaert, J. W. Cohen; Van Der Werf, T. S.; Ligtenberg, J. J. M.; Tulleken, J. E.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and Experimental Immunology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">16-20</span>CODEN:
                <span class="NLM_cas:coden">CEXIAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-9104</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">Sepsis resulting in multiorgan failure and death is still a major problem in intensive care medicine, despite extensive attempts to interfere in the supposed underlying mechanism of a deranged immune system.  This is not only due to the persistent lacunae in knowledge about the immune system in sepsis but also due to the lack of sufficient instruments for intervention.  Inhibitors of the p38 mitogen-activated protein kinase (p38MAPK) have been used to study the signalling pathway of the immune response.  In vitro and animal studies have demonstrated that blocking p38MAPK could mitigate the pro-inflammatory response and improve survival after endotoxemia.  Using an endotoxemia model in healthy human volunteers, the authors evaluated the attenuation of clin. and cytokine response to endotoxin after inhibition of p38MAPK by an oral dose of RWJ-67657, a pyrindinyl imidazole.  They measured the clin. parameters temp., blood pressure, and heart rate.  The proinflammatory cytokines tumor necrosis factor α, interleukin 6, and interleukin 8 were measured by ELISA at various points during a 24-h period.  Drug toxicity was evaluated by routine clin. and lab. examns.  After a single dose of RWJ-67657, the temp. and blood pressure response remained at the basal level.  The inhibition of TNF α, IL 6, and IL 8 response was dose-dependent.  With the max. dosage, redn. in peak serum levels of the proinflammatory cytokines was >90%.  There was no drug-related toxicity.  Interpretation: Inhibition of p38MAPK by RWJ-67657 might be a tool to intervene in the deranged immune response in sepsis and other inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYVGs4rg1_z7Vg90H21EOLACvtfcHk0lg3mCyUVlrPkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXktl2kt74%253D&md5=3ced1727cb4676ae20a794c8c02946cb</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2249.2001.01485.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2249.2001.01485.x%26sid%3Dliteratum%253Aachs%26aulast%3DFijen%26aufirst%3DJ.%2BW.%26aulast%3DZijlstra%26aufirst%3DJ.%2BG.%26aulast%3DDe%2BBoer%26aufirst%3DP.%26aulast%3DSpanjersberg%26aufirst%3DR.%26aulast%3DCohen%252C%2BTervaert%26aufirst%3DJ.%2BW.%26aulast%3Dvan%2Bder%2BWerf%26aufirst%3DT.%2BS.%26aulast%3DLightenberg%26aufirst%3DJ.%2BJ.%2BM.%26aulast%3DTulleken%26aufirst%3DJ.%2BE.%26atitle%3DSuppression%2520of%2520the%2520Clinical%2520and%2520Cytokine%2520Response%2520to%2520Endotoxin%2520by%2520RWJ-67657%252C%2520a%2520p38%2520Mitogen-Activated%2520Protein-Kinase%2520Inhibitor%252C%2520in%2520Healthy%2520Human%2520Volunteers%26jtitle%3DClin.%2520Exp.%2520Immunol.%26date%3D2001%26volume%3D124%26spage%3D16%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Branger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van den Blink, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weijer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madwed, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bos, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yong, C.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polmar, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olszyna, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hack, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Deventer, S. J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peppelenbosch, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Poll, T.</span><span> </span><span class="NLM_article-title">Anti-Inflammatory Effects of a p38 Mitogen-Activated Protein Kinase Inhibitor During Human Endotoxemia</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">168</span><span class="NLM_x">, </span> <span class="NLM_fpage">4070</span><span class="NLM_x">–</span> <span class="NLM_lpage">4077</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2002&pages=4070-4077&author=J.+Brangerauthor=B.+van+den+Blinkauthor=S.+Weijerauthor=J.+Madwedauthor=C.+L.+Bosauthor=A.+Guptaauthor=C.-L.+Yongauthor=S.+H.+Polmarauthor=D.+P.+Olszynaauthor=E.+C.+Hackauthor=S.+J.+H.+van+Deventerauthor=M.+P.+Peppelenboschauthor=T.+van+der+Poll&title=Anti-Inflammatory+Effects+of+a+p38+Mitogen-Activated+Protein+Kinase+Inhibitor+During+Human+Endotoxemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBranger%26aufirst%3DJ.%26aulast%3Dvan%2Bden%2BBlink%26aufirst%3DB.%26aulast%3DWeijer%26aufirst%3DS.%26aulast%3DMadwed%26aufirst%3DJ.%26aulast%3DBos%26aufirst%3DC.%2BL.%26aulast%3DGupta%26aufirst%3DA.%26aulast%3DYong%26aufirst%3DC.-L.%26aulast%3DPolmar%26aufirst%3DS.%2BH.%26aulast%3DOlszyna%26aufirst%3DD.%2BP.%26aulast%3DHack%26aufirst%3DE.%2BC.%26aulast%3Dvan%2BDeventer%26aufirst%3DS.%2BJ.%2BH.%26aulast%3DPeppelenbosch%26aufirst%3DM.%2BP.%26aulast%3Dvan%2Bder%2BPoll%26aufirst%3DT.%26atitle%3DAnti-Inflammatory%2520Effects%2520of%2520a%2520p38%2520Mitogen-Activated%2520Protein%2520Kinase%2520Inhibitor%2520During%2520Human%2520Endotoxemia%26jtitle%3DJ.%2520Immunol.%26date%3D2002%26volume%3D168%26spage%3D4070%26epage%3D4077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hale, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trollinger, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rihanek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manthey, C. L.</span><span> </span><span class="NLM_article-title">Differential Expression and Activation fo p38 Mitogen-Activated Protein Kinase α, β, γ, and δ in Inflammatory Cell Lineages</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">162</span><span class="NLM_x">, </span> <span class="NLM_fpage">4246</span><span class="NLM_x">–</span> <span class="NLM_lpage">4252</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=162&publication_year=1999&pages=4246-4252&author=K.+K.+Haleauthor=D.+Trollingerauthor=M.+Rihanekauthor=C.+L.+Manthey&title=Differential+Expression+and+Activation+fo+p38+Mitogen-Activated+Protein+Kinase+%CE%B1%2C+%CE%B2%2C+%CE%B3%2C+and+%CE%B4+in+Inflammatory+Cell+Lineages"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHale%26aufirst%3DK.%2BK.%26aulast%3DTrollinger%26aufirst%3DD.%26aulast%3DRihanek%26aufirst%3DM.%26aulast%3DManthey%26aufirst%3DC.%2BL.%26atitle%3DDifferential%2520Expression%2520and%2520Activation%2520fo%2520p38%2520Mitogen-Activated%2520Protein%2520Kinase%2520%25CE%25B1%252C%2520%25CE%25B2%252C%2520%25CE%25B3%252C%2520and%2520%25CE%25B4%2520in%2520Inflammatory%2520Cell%2520Lineages%26jtitle%3DJ.%2520Immunol.%26date%3D1999%26volume%3D162%26spage%3D4246%26epage%3D4252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Allen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hambor, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNeish, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabel, C. A.</span><span> </span><span class="NLM_article-title">Deficiency of the Stress Kinase p38α Results in Embryonic Lethality: Characterization of the Kinase Dependence of Stress Responses of Enzyme-deficient Embryonic Stem Cells</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">191</span><span class="NLM_x">, </span> <span class="NLM_fpage">859</span><span class="NLM_x">–</span> <span class="NLM_lpage">869</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=191&publication_year=2000&pages=859-869&author=M.+Allenauthor=L.+Svenssonauthor=M.+Roachauthor=J.+Hamborauthor=J.+McNeishauthor=C.+A.+Gabel&title=Deficiency+of+the+Stress+Kinase+p38%CE%B1+Results+in+Embryonic+Lethality%3A+Characterization+of+the+Kinase+Dependence+of+Stress+Responses+of+Enzyme-deficient+Embryonic+Stem+Cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DM.%26aulast%3DSvensson%26aufirst%3DL.%26aulast%3DRoach%26aufirst%3DM.%26aulast%3DHambor%26aufirst%3DJ.%26aulast%3DMcNeish%26aufirst%3DJ.%26aulast%3DGabel%26aufirst%3DC.%2BA.%26atitle%3DDeficiency%2520of%2520the%2520Stress%2520Kinase%2520p38%25CE%25B1%2520Results%2520in%2520Embryonic%2520Lethality%253A%2520Characterization%2520of%2520the%2520Kinase%2520Dependence%2520of%2520Stress%2520Responses%2520of%2520Enzyme-deficient%2520Embryonic%2520Stem%2520Cells%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2000%26volume%3D191%26spage%3D859%26epage%3D869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Fearns, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kline, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gram, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Padova, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zurini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulevitch, R. J.</span><span> </span><span class="NLM_article-title">Coordinate Activation of Endogenous p38α, β, γ, and δ by Inflammatory Stimuli</span> <span class="citation_source-journal">J. Leukocyte Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">705</span><span class="NLM_x">–</span> <span class="NLM_lpage">711</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=8&amp;doi=10.1021%2Fjm7009414&amp;key=10811012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=32&amp;doi=10.1021%2Fjm7009414&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjsVKnt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2000&pages=705-711&author=C.+Fearnsauthor=L.+Klineauthor=H.+Gramauthor=F.+Di+Padovaauthor=M.+Zuriniauthor=J.+Hanauthor=R.+J.+Ulevitch&title=Coordinate+Activation+of+Endogenous+p38%CE%B1%2C+%CE%B2%2C+%CE%B3%2C+and+%CE%B4+by+Inflammatory+Stimuli"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6cR"><div class="casContent"><span class="casTitleNuber">6c</span><div class="casTitle"><span class="NLM_cas:atitle">Coordinate activation of endogenous p38α, β, γ, and δ by inflammatory stimuli</span></div><div class="casAuthors">Fearns, C.; Kline, L.; Gram, H.; Di Padova, F.; Zurini, M.; Han, J.; Ulevitch, R. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Leukocyte Biology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">705-711</span>CODEN:
                <span class="NLM_cas:coden">JLBIE7</span>;
        ISSN:<span class="NLM_cas:issn">0741-5400</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">The p38 family of mitogen-activated protein kinases is believed to mediate a variety of leukocyte responses to pro-inflammatory stimuli.  There are four members of the p38 family, and although activation of the different members has been studied in transiently transfected cells much less is known about activation of the endogenous p38s, particularly in myeloid lineage cells.  To investigate activation of endogenous p38s, we have made monoclonal antibodies specific for each p38 and have used these antibodies to study p38 activation by pro-inflammatory stimuli in several human monocytic cell lines.  Without stimulation endogenous p38α kinase activity was readily detectable, whereas that of p38β, γ, and δ was barely measurable.  In response to inflammatory stimuli, we obsd. a time- and dose-dependent activation of all four p38s.  The kinetics of activation of each of the p38s were similar for each stimulus used, suggesting a common upstream activation pathway.  Simultaneous activation of the p38s suggests that all four may be important in inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpo-y1kpHdw8bVg90H21EOLACvtfcHk0li6xzbx1-Wr5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjsVKnt7s%253D&md5=3a5eafdd8d239bff6252fe43f8e4d48a</span></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFearns%26aufirst%3DC.%26aulast%3DKline%26aufirst%3DL.%26aulast%3DGram%26aufirst%3DH.%26aulast%3DDi%2BPadova%26aufirst%3DF.%26aulast%3DZurini%26aufirst%3DM.%26aulast%3DHan%26aufirst%3DJ.%26aulast%3DUlevitch%26aufirst%3DR.%2BJ.%26atitle%3DCoordinate%2520Activation%2520of%2520Endogenous%2520p38%25CE%25B1%252C%2520%25CE%25B2%252C%2520%25CE%25B3%252C%2520and%2520%25CE%25B4%2520by%2520Inflammatory%2520Stimuli%26jtitle%3DJ.%2520Leukocyte%2520Biol.%26date%3D2000%26volume%3D67%26spage%3D705%26epage%3D711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="note"><p class="first last">For reviews detailing the current small molecule p38 kinase inhibitor field see</p></div><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hynes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leftheris, K.</span><span> </span><span class="NLM_article-title">Small Molecule p38 Inhibitors: Novel Structural Features and Advances from 2002–2005</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">967</span><span class="NLM_x">–</span> <span class="NLM_lpage">985</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Fjm7009414&amp;key=10.2174%2F1568026054985920" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Fjm7009414&amp;key=16178741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Fjm7009414&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFeitrbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=967-985&author=J.+Hynesauthor=K.+Leftheris&title=Small+Molecule+p38+Inhibitors%3A+Novel+Structural+Features+and+Advances+from+2002%E2%80%932005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule p38 inhibitors: Novel structural features and advances from 2002-2005</span></div><div class="casAuthors">Hynes, John, Jr.; Leftheris, Katerina</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">967-985</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The discovery and development of selective, efficacious, and safe small mol. p38 mitogen-activated protein kinase inhibitors for the treatment of inflammatory diseases remains the focus of many pharmaceutical research programs.  Advances in small mol. p38 inhibitor design in potency and oral efficacy have been accelerated with the large no. of available inhibitor-enzyme x-ray structures.  These advances have allowed for the discovery of diverse sets of inhibitors with the opportunity to map inhibitor interactions and design selective inhibitors.  This review covers recent compd. disclosures in the patent and published literature over the last three years.  Many disclosures represent new chemotypes as well as creative modifications of known structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXWto2uZjwJrVg90H21EOLACvtfcHk0li6xzbx1-Wr5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFeitrbP&md5=e8a3966e7f270b6171b95f306d3fc341</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.2174%2F1568026054985920&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026054985920%26sid%3Dliteratum%253Aachs%26aulast%3DHynes%26aufirst%3DJ.%26aulast%3DLeftheris%26aufirst%3DK.%26atitle%3DSmall%2520Molecule%2520p38%2520Inhibitors%253A%2520Novel%2520Structural%2520Features%2520and%2520Advances%2520from%25202002%25E2%2580%25932005%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D967%26epage%3D985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wagner, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufer, S.</span><span> </span><span class="NLM_article-title">Small Molecular Anti-Cytokine Agents</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">62</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Fjm7009414&amp;key=10.1002%2Fmed.20042" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=1-62&author=G.+Wagnerauthor=S.+Laufer&title=Small+Molecular+Anti-Cytokine+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1002%2Fmed.20042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20042%26sid%3Dliteratum%253Aachs%26aulast%3DWagner%26aufirst%3DG.%26aulast%3DLaufer%26aufirst%3DS.%26atitle%3DSmall%2520Molecular%2520Anti-Cytokine%2520Agents%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2006%26volume%3D1%26spage%3D1%26epage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Lee, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominguez, C.</span><span> </span><span class="NLM_article-title">MAP Kinase p38 Inhibitors: Clinical Results and an Intimate Look at Their Interactions with p38α Protein</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2979</span><span class="NLM_x">–</span> <span class="NLM_lpage">2994</span><div class="note"><p class="first last">. Additional references for the compounds in Figure 1.</p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=16&amp;doi=10.1021%2Fjm7009414&amp;key=10.2174%2F092986705774462914" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=8&amp;doi=10.1021%2Fjm7009414&amp;key=16378500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=32&amp;doi=10.1021%2Fjm7009414&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Grt7jF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=2979-2994&author=M.+R.+Leeauthor=C.+Dominguez&title=MAP+Kinase+p38+Inhibitors%3A+Clinical+Results+and+an+Intimate+Look+at+Their+Interactions+with+p38%CE%B1+Protein"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7cR"><div class="casContent"><span class="casTitleNuber">7c</span><div class="casTitle"><span class="NLM_cas:atitle">MAP kinase p38 inhibitors: Clinical results and an intimate look at their interactions with p38α protein</span></div><div class="casAuthors">Lee, Matthew R.; Dominguez, Celia</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">2979-2994</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Mitogen-activated protein kinase p38 is a serine/threonine kinase originally isolated from lipopolysaccharide (LPS) stimulated monocytes.  There are four isoforms p38α, p38β, p38γ, and p38δ.  The most thoroughly studied isoform is p38α, whose activation has been obsd. in many hematopoietic and non-hematopoietic cell types upon appropriate stimuli.  Subsequently, p38α kinase has been shown to be involved in the biosynthesis of TNFα and IL-1β at the translational and transcriptional level.  MAP kinase p38α represents a point of convergence for multiple signaling processes that are activated in inflammation and thus a key potential target for the modulation of cytokine prodn.  The discovery and publication of p38α and the pyridinyl-imidazole inhibitor initiated a huge effort by many companies to develop p38α inhibitors as potential treatment for inflammatory diseases.  Herein we provide a brief overview of recent reported clin. results for AMG 548, BIRB 796, VX 702, SCIO 469, and SCIO 323.  However, our focus will be on the binding modes of these inhibitors and other p38 inhibitors in the recent literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZSldsfUAO6bVg90H21EOLACvtfcHk0li6xzbx1-Wr5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Grt7jF&md5=eb21253fcc2df76280cd9a1812ed1015</span></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=10.2174%2F092986705774462914&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986705774462914%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DM.%2BR.%26aulast%3DDominguez%26aufirst%3DC.%26atitle%3DMAP%2520Kinase%2520p38%2520Inhibitors%253A%2520Clinical%2520Results%2520and%2520an%2520Intimate%2520Look%2520at%2520Their%2520Interactions%2520with%2520p38%25CE%25B1%2520Protein%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2005%26volume%3D12%26spage%3D2979%26epage%3D2994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7d"><span><span class="NLM_label">(d) </span>Compound-006 <span class="NLM_contrib-group">Devraj, R. V.</span><span> </span><span class="NLM_article-title">Discovery and Development of Orally Active p38 Kinase Inhibitors as Anti-TNF Agents</span>. Absracts of Papers, 229th National Meeting of the American Chemical Society, San Diego, CA,<span class="NLM_x"> </span><span class="NLM_year">2004</span><span class="NLM_x">; </span>MEDI 296.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=R.+V.+Devraj&title=Discovery+and+Development+of+Orally+Active+p38+Kinase+Inhibitors+as+Anti-TNF+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DDevraj%26aufirst%3DR.%2BV.%26atitle%3DDiscovery%2520and%2520Development%2520of%2520Orally%2520Active%2520p38%2520Kinase%2520Inhibitors%2520as%2520Anti-TNF%2520Agents%26jtitle%3DAbsracts%2520of%2520Papers%252C%2520229th%2520National%2520Meeting%2520of%2520the%2520American%2520Chemical%2520Society%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Miwatashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arikawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotani, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naruo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asahi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohkawa, S.</span><span> </span><span class="NLM_article-title">Novel Inhibitor of p38 MAP Kinase as an Anti-TNFα Drug: Discovery of <i>N</i>-[4-[2-ethyl-4-(3-methylphenyl)-1,3-thiazol-5-yl]-2-pyridyl]benzamide (TAK-715) as a Potent and Orally Active Anti-rheumatoid Arthritis Agent</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">5966</span><span class="NLM_x">–</span> <span class="NLM_lpage">5979</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050165o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=5966-5979&author=S.+Miwatashiauthor=Y.+Arikawaauthor=E.+Kotaniauthor=M.+Miyamotoauthor=K.+Naruoauthor=H.+Kimuraauthor=T.+Tanakaauthor=S.+Asahiauthor=S.+Ohkawa&title=Novel+Inhibitor+of+p38+MAP+Kinase+as+an+Anti-TNF%CE%B1+Drug%3A+Discovery+of+N-%5B4-%5B2-ethyl-4-%283-methylphenyl%29-1%2C3-thiazol-5-yl%5D-2-pyridyl%5Dbenzamide+%28TAK-715%29+as+a+Potent+and+Orally+Active+Anti-rheumatoid+Arthritis+Agent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7e&amp;dbid=16384&amp;doi=10.1021%2Fjm050165o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050165o%26sid%3Dliteratum%253Aachs%26aulast%3DMiwatashi%26aufirst%3DS.%26aulast%3DArikawa%26aufirst%3DY.%26aulast%3DKotani%26aufirst%3DE.%26aulast%3DMiyamoto%26aufirst%3DM.%26aulast%3DNaruo%26aufirst%3DK.%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DAsahi%26aufirst%3DS.%26aulast%3DOhkawa%26aufirst%3DS.%26atitle%3DNovel%2520Inhibitor%2520of%2520p38%2520MAP%2520Kinase%2520as%2520an%2520Anti-TNF%25CE%25B1%2520Drug%253A%2520Discovery%2520of%2520N-%255B4-%255B2-ethyl-4-%25283-methylphenyl%2529-1%252C3-thiazol-5-yl%255D-2-pyridyl%255Dbenzamide%2520%2528TAK-715%2529%2520as%2520a%2520Potent%2520and%2520Orally%2520Active%2520Anti-rheumatoid%2520Arthritis%2520Agent%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D5966%26epage%3D5979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Dugar, S.</span><span> </span><span class="NLM_article-title">Discovery of p38-alpha MAP Kinase Inhibitor SCIO-469</span>.  <span class="citation_source-journal">Inflammation Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_issue">(Suppl 2)</span><span class="NLM_elocation-id">Abs 1027</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2005&issue=%28Suppl+2%29&author=S.+Dugar&title=Discovery+of+p38-alpha+MAP+Kinase+Inhibitor+SCIO-469"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDugar%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520p38-alpha%2520MAP%2520Kinase%2520Inhibitor%2520SCIO-469%26jtitle%3DInflammation%2520Res.%26date%3D2005%26volume%3D54%26issue%3D%2528Suppl%25202%2529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Leftheris, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyckman, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussain, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hynes, J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letourneau, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metzger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriarty, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riviello, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimshock, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wityak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrobleski, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillooly, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuster, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diller, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doweyko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sack, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldwin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henderson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schieven, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, M.</span><span> </span><span class="NLM_article-title">The Discovery of Orally Active Triaminotriazine Aniline Amides as Inhibitors of p38 MAP Kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">6283</span><span class="NLM_x">–</span> <span class="NLM_lpage">6291</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049521d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6283-6291&author=K.+Leftherisauthor=G.+Ahmedauthor=R.+Chanauthor=A.+J.+Dyckmanauthor=Z.+Hussainauthor=K.+Hoauthor=J.+Hynesauthor=J.+Letourneauauthor=W.+Liauthor=S.+Linauthor=A.+Metzgerauthor=K.+J.+Moriartyauthor=C.+Rivielloauthor=Y.+Shimshockauthor=J.+Wenauthor=J.+Wityakauthor=S.+T.+Wrobleskiauthor=H.+Wuauthor=J.+Wuauthor=M.+Desaiauthor=K.+M.+Gilloolyauthor=T.+H.+Linauthor=D.+Looauthor=K.+W.+McIntyreauthor=S.+Pittauthor=D.+R.+Shenauthor=D.+J.+Shusterauthor=R.+Zhangauthor=D.+Dillerauthor=A.+Doweykoauthor=J.+Sackauthor=J.+Baldwinauthor=J.+Barrishauthor=J.+Doddauthor=I.+Hendersonauthor=S.+Kannerauthor=G.+L.+Schievenauthor=M.+Webb&title=The+Discovery+of+Orally+Active+Triaminotriazine+Aniline+Amides+as+Inhibitors+of+p38+MAP+Kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm049521d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049521d%26sid%3Dliteratum%253Aachs%26aulast%3DLeftheris%26aufirst%3DK.%26aulast%3DAhmed%26aufirst%3DG.%26aulast%3DChan%26aufirst%3DR.%26aulast%3DDyckman%26aufirst%3DA.%2BJ.%26aulast%3DHussain%26aufirst%3DZ.%26aulast%3DHo%26aufirst%3DK.%26aulast%3DHynes%26aufirst%3DJ.%26aulast%3DLetourneau%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DMetzger%26aufirst%3DA.%26aulast%3DMoriarty%26aufirst%3DK.%2BJ.%26aulast%3DRiviello%26aufirst%3DC.%26aulast%3DShimshock%26aufirst%3DY.%26aulast%3DWen%26aufirst%3DJ.%26aulast%3DWityak%26aufirst%3DJ.%26aulast%3DWrobleski%26aufirst%3DS.%2BT.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DDesai%26aufirst%3DM.%26aulast%3DGillooly%26aufirst%3DK.%2BM.%26aulast%3DLin%26aufirst%3DT.%2BH.%26aulast%3DLoo%26aufirst%3DD.%26aulast%3DMcIntyre%26aufirst%3DK.%2BW.%26aulast%3DPitt%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DD.%2BR.%26aulast%3DShuster%26aufirst%3DD.%2BJ.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DDiller%26aufirst%3DD.%26aulast%3DDoweyko%26aufirst%3DA.%26aulast%3DSack%26aufirst%3DJ.%26aulast%3DBaldwin%26aufirst%3DJ.%26aulast%3DBarrish%26aufirst%3DJ.%26aulast%3DDodd%26aufirst%3DJ.%26aulast%3DHenderson%26aufirst%3DI.%26aulast%3DKanner%26aufirst%3DS.%26aulast%3DSchieven%26aufirst%3DG.%2BL.%26aulast%3DWebb%26aufirst%3DM.%26atitle%3DThe%2520Discovery%2520of%2520Orally%2520Active%2520Triaminotriazine%2520Aniline%2520Amides%2520as%2520Inhibitors%2520of%2520p38%2520MAP%2520Kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D6283%26epage%3D6291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Hunt, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitt, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borzilleri, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gullo-Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fargnoli, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fink, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, W.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortillo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vite, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wautlet, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhide, R.</span><span> </span><span class="NLM_article-title">Discovery of the Pyrrolo[2,1-f][1,2,4]triazine Nucleus as a New Kinase Inhibitor Template</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">4054</span><span class="NLM_x">–</span> <span class="NLM_lpage">4059</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049892u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=4054-4059&author=J.+T.+Huntauthor=T.+Mittauthor=R.+Borzilleriauthor=J.+Gullo-Brownauthor=J.+Fargnoliauthor=B.+Finkauthor=W.-C.+Hanauthor=S.+Mortilloauthor=G.+Viteauthor=B.+Wautletauthor=T.+Wongauthor=C.+Yuauthor=Z.+Zhengauthor=R.+Bhide&title=Discovery+of+the+Pyrrolo%5B2%2C1-f%5D%5B1%2C2%2C4%5Dtriazine+Nucleus+as+a+New+Kinase+Inhibitor+Template"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm049892u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049892u%26sid%3Dliteratum%253Aachs%26aulast%3DHunt%26aufirst%3DJ.%2BT.%26aulast%3DMitt%26aufirst%3DT.%26aulast%3DBorzilleri%26aufirst%3DR.%26aulast%3DGullo-Brown%26aufirst%3DJ.%26aulast%3DFargnoli%26aufirst%3DJ.%26aulast%3DFink%26aufirst%3DB.%26aulast%3DHan%26aufirst%3DW.-C.%26aulast%3DMortillo%26aufirst%3DS.%26aulast%3DVite%26aufirst%3DG.%26aulast%3DWautlet%26aufirst%3DB.%26aulast%3DWong%26aufirst%3DT.%26aulast%3DYu%26aufirst%3DC.%26aulast%3DZheng%26aufirst%3DZ.%26aulast%3DBhide%26aufirst%3DR.%26atitle%3DDiscovery%2520of%2520the%2520Pyrrolo%255B2%252C1-f%255D%255B1%252C2%252C4%255Dtriazine%2520Nucleus%2520as%2520a%2520New%2520Kinase%2520Inhibitor%2520Template%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D4054%26epage%3D4059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><div class="note"><p class="first last">30% of the parent drug was remaining after 30 min of incubation in mouse liver microsomes</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=30%25+of+the+parent+drug+was+remaining+after+30+min+of+incubation+in+mouse+liver+microsomes."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dunpublished%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><div class="note"><p class="first last">See ref <a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">9</a></p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=See+ref+9."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dunpublished%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Hynes, J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doubleday, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyckman, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godfrey, J. D.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosso, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiau, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leftheris, K.</span><span> </span><span class="NLM_article-title">N-Amination of Pyrrole and Indole Heterocycles with Monochloramine (NH<sub>2</sub>Cl)</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">1368</span><span class="NLM_x">–</span> <span class="NLM_lpage">1371</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo035587p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm7009414&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkt1Gktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2004&pages=1368-1371&author=J.+Hynesauthor=W.+W.+Doubledayauthor=A.+J.+Dyckmanauthor=J.+D.+Godfreyauthor=J.+A.+Grossoauthor=S.+Kiauauthor=K.+Leftheris&title=N-Amination+of+Pyrrole+and+Indole+Heterocycles+with+Monochloramine+%28NH2Cl%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">N-Amination of pyrrole and indole heterocycles with monochloramine (NH2Cl)</span></div><div class="casAuthors">Hynes, John, Jr.; Doubleday, Wendel W.; Dyckman, Alaric J.; Godfrey, Jollie D., Jr.; Grosso, John A.; Kiau, Susanne; Leftheris, Katerina</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1368-1371</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A survey of several electrophilic ammonia reagents for the N-amination of indole- and pyrrole-contg. heterocycles revealed that monochloramine was an excellent reagent for this transformation.  Pyrroles and indoles, contg. a variety of substitution, were aminated on the nitrogen to give N-aminopyrroles, e.g., I, and N-aminoindoles, e.g., II.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYnh0gDOLFm7Vg90H21EOLACvtfcHk0ljcLYrjcsjUPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkt1Gktg%253D%253D&md5=1af624e88095b0c4571861e7bfbc0a1b</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjo035587p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo035587p%26sid%3Dliteratum%253Aachs%26aulast%3DHynes%26aufirst%3DJ.%26aulast%3DDoubleday%26aufirst%3DW.%2BW.%26aulast%3DDyckman%26aufirst%3DA.%2BJ.%26aulast%3DGodfrey%26aufirst%3DJ.%2BD.%26aulast%3DGrosso%26aufirst%3DJ.%2BA.%26aulast%3DKiau%26aufirst%3DS.%26aulast%3DLeftheris%26aufirst%3DK.%26atitle%3DN-Amination%2520of%2520Pyrrole%2520and%2520Indole%2520Heterocycles%2520with%2520Monochloramine%2520%2528NH2Cl%2529%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2004%26volume%3D69%26spage%3D1368%26epage%3D1371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><div class="note"><p class="first last">Consistent with our previous observations (e.g., <b>3b</b> to <b>3a</b>), conversion of the C5′ methyl hydroxamate of <b>11b</b> to an alkyl amide (methyl, ethyl) resulted in a >80-fold decrease in p38α kinase inhibition (data not shown).</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Consistent+with+our+previous+observations+%28e.g.%2C+3b+to+3a%29%2C+conversion+of+the+C5%E2%80%B2+methyl+hydroxamate+of+11b+to+an+alkyl+amide+%28methyl%2C+ethyl%29+resulted+in+a+%3E80-fold+decrease+in+p38%CE%B1+kinase+inhibition+%28data+not+shown%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dunpublished%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Liverton, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butcher, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claiborne, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claremon, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Libby, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitzenberger, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selnick, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tebben, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varga, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agarwal, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dancheck, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forsyth, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frantz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanlon, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harper, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofsess, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">; Kostura, Ma.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OʼNeill, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orevillo, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolando, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahly, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visco, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OʼKeefe, S. J.</span><span> </span><span class="NLM_article-title">Design and synthesis of potent, selective and orally bioavailable tetrasubstituted imidazole inhibitors of p38 mitogen-activated kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">2190</span><span class="NLM_x">–</span> <span class="NLM_lpage">2180</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=2190-2180&author=N.+J.+Livertonauthor=J.+W.+Butcherauthor=C.+F.+Claiborneauthor=D.+A.+Claremonauthor=B.+E.+Libbyauthor=K.+T.+Nguyenauthor=S.+M.+Pitzenbergerauthor=H.+G.+Selnickauthor=G.+R.+Smithauthor=A.+Tebbenauthor=J.+P.+Vaccaauthor=S.+L.+Vargaauthor=L.+Agarwalauthor=K.+Dancheckauthor=A.+J.+Forsythauthor=D.+S.+Fletcherauthor=B.+Frantzauthor=W.+A.+Hanlonauthor=C.+F.+Harperauthor=S.+J.+Hofsessauthor=Ma.+%3B+Kosturaauthor=J.+Linauthor=S.+Luellauthor=E.+A.+O%CA%BCNeillauthor=C.+J.+Orevilloauthor=M.+Pangauthor=J.+Parsonsauthor=A.+Rolandoauthor=Y.+Sahlyauthor=D.+M.+Viscoauthor=S.+J.+O%CA%BCKeefe&title=Design+and+synthesis+of+potent%2C+selective+and+orally+bioavailable+tetrasubstituted+imidazole+inhibitors+of+p38+mitogen-activated+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26aulast%3DButcher%26aufirst%3DJ.%2BW.%26aulast%3DClaiborne%26aufirst%3DC.%2BF.%26aulast%3DClaremon%26aufirst%3DD.%2BA.%26aulast%3DLibby%26aufirst%3DB.%2BE.%26aulast%3DNguyen%26aufirst%3DK.%2BT.%26aulast%3DPitzenberger%26aufirst%3DS.%2BM.%26aulast%3DSelnick%26aufirst%3DH.%2BG.%26aulast%3DSmith%26aufirst%3DG.%2BR.%26aulast%3DTebben%26aufirst%3DA.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DVarga%26aufirst%3DS.%2BL.%26aulast%3DAgarwal%26aufirst%3DL.%26aulast%3DDancheck%26aufirst%3DK.%26aulast%3DForsyth%26aufirst%3DA.%2BJ.%26aulast%3DFletcher%26aufirst%3DD.%2BS.%26aulast%3DFrantz%26aufirst%3DB.%26aulast%3DHanlon%26aufirst%3DW.%2BA.%26aulast%3DHarper%26aufirst%3DC.%2BF.%26aulast%3DHofsess%26aufirst%3DS.%2BJ.%26aulast%3D%253B%2BKostura%26aufirst%3DMa.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DLuell%26aufirst%3DS.%26aulast%3DO%25CA%25BCNeill%26aufirst%3DE.%2BA.%26aulast%3DOrevillo%26aufirst%3DC.%2BJ.%26aulast%3DPang%26aufirst%3DM.%26aulast%3DParsons%26aufirst%3DJ.%26aulast%3DRolando%26aufirst%3DA.%26aulast%3DSahly%26aufirst%3DY.%26aulast%3DVisco%26aufirst%3DD.%2BM.%26aulast%3DO%25CA%25BCKeefe%26aufirst%3DS.%2BJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520potent%252C%2520selective%2520and%2520orally%2520bioavailable%2520tetrasubstituted%2520imidazole%2520inhibitors%2520of%2520p38%2520mitogen-activated%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D2190%26epage%3D2180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Fitzgerald, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaller, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pikounis, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OʼKeefe, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scapin, G.</span> <span class="citation_source-journal">Nat. Struc. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">764</span><span class="NLM_x">–</span> <span class="NLM_lpage">769</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=16&amp;doi=10.1021%2Fjm7009414&amp;key=10.1038%2Fnsb949" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=8&amp;doi=10.1021%2Fjm7009414&amp;key=12897767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=32&amp;doi=10.1021%2Fjm7009414&amp;key=1%3ACAS%3A528%3ADC%252BD3sXms1GktrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Fitzgerald%2C+C.+E.%3B+Patel%2C+S.+B.%3B+Becker%2C+J.+W.%3B+Cameron%2C+P.+M.%3B+Zaller%2C+D.%3B+Pikounis%2C+V.+B.%3B+O%CA%BCKeefe%2C+S.+J.%3B+Scapin%2C+G.Nat.+Struc.+Biol.+2003%2C+10%2C+764%E2%80%93769"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14bR"><div class="casContent"><span class="casTitleNuber">14b</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for p38α MAP kinase quinazolinone and pyridol-pyrimidine inhibitor specificity</span></div><div class="casAuthors">Fitzgerald, Catherine E.; Patel, Sangita B.; Becker, Joseph W.; Cameron, Patricia M.; Zaller, Dennis; Pikounis, Vasilis Bill; O'Keefe, Stephen J.; Scapin, Giovanna</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">764-769</span>CODEN:
                <span class="NLM_cas:coden">NSBIEW</span>;
        ISSN:<span class="NLM_cas:issn">1072-8368</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The quinazolinone and pyridol-pyrimidine classes of p38 MAP kinase inhibitors have a previously unseen degree of specificity for p38 over other MAP kinases.  Comparison of the crystal structures of p38 bound to four different compds. shows that binding of the more specific mols. is characterized by a peptide flip between Met109 and Gly110.  Gly110 is a residue specific to the α, β and γ isoforms of p38.  The δ isoform and the other MAP kinases have bulkier residues in this position.  These residues would likely make the peptide flip energetically unfavorable, thus explaining the selectivity of binding.  To test this hypothesis, we constructed G110A and G110D mutants of p38 and measured the potency of several compds. against them.  The results confirm that the selectivity of quinazolinones and pyridol-pyrimidines results from the presence of a glycine in position 110.  This unique mode of binding may be exploited in the design of new p38 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpb5LnKf2_OqbVg90H21EOLACvtfcHk0lhrzMML3zaG7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXms1GktrY%253D&md5=85e063241af29ee0461a42e6d90514ba</span></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1038%2Fnsb949&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsb949%26sid%3Dliteratum%253Aachs%26aulast%3DFitzgerald%26aufirst%3DC.%2BE.%26aulast%3DPatel%26aufirst%3DS.%2BB.%26aulast%3DBecker%26aufirst%3DJ.%2BW.%26aulast%3DCameron%26aufirst%3DP.%2BM.%26aulast%3DZaller%26aufirst%3DD.%26aulast%3DPikounis%26aufirst%3DV.%2BB.%26aulast%3DO%25CA%25BCKeefe%26aufirst%3DS.%2BJ.%26aulast%3DScapin%26aufirst%3DG.%26jtitle%3DNat.%2520Struc.%2520Biol.%26date%3D2003%26volume%3D10%26spage%3D764%26epage%3D769" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14c"><span><span class="NLM_label">(c) </span><div class="note"><p class="first last">For a review of p38 inhibitor-protein kinase complexes see:</p></div><span class="NLM_contrib-group">Wrobleski, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doweyko, A. M.</span><span> </span><span class="NLM_article-title">Structural Comparison of p38 Inhibitor-Protein Complexes: A Review of Recent p38 Inhibitors Having Unique Binding Interactions</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1005</span><span class="NLM_x">–</span> <span class="NLM_lpage">1016</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14c&amp;dbid=16&amp;doi=10.1021%2Fjm7009414&amp;key=10.2174%2F1568026054985894" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14c&amp;dbid=8&amp;doi=10.1021%2Fjm7009414&amp;key=16178743" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14c&amp;dbid=32&amp;doi=10.1021%2Fjm7009414&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFeitrbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=1005-1016&author=S.+T.+Wrobleskiauthor=A.+M.+Doweyko&title=Structural+Comparison+of+p38+Inhibitor-Protein+Complexes%3A+A+Review+of+Recent+p38+Inhibitors+Having+Unique+Binding+Interactions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14cR"><div class="casContent"><span class="casTitleNuber">14c</span><div class="casTitle"><span class="NLM_cas:atitle">Structural comparison of p38 inhibitor-protein complexes: A review of recent p38 inhibitors having unique binding interactions</span></div><div class="casAuthors">Wrobleski, Stephen T.; Doweyko, Arthur M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1005-1016</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Small mol. inhibition of protein kinases in the treatment of significant diseases such as cancer, Alzheimer's disease, diabetes, and rheumatoid arthritis has attracted significant attention over the past two decades and has clearly become one of the most significant challenges for drug discovery in the 21st century.  While the recent identification of 518 different kinases in the human genome has offered a wealth of opportunities for drug intervention in the treatment of these diseases, it has also created a daunting challenge with respect to selective kinase inhibition as a viable strategy in target-based drug design.  Over the past decade, the design and development of a small mol. that selectively inhibits the p38 mitogen activated protein (MAP) kinase has clearly emerged as one.  This review will focus on the comparison of the x-ray crystal structures and binding models of the most recent p38 inhibitor-enzyme complexes and the identification of the structural elements and interactions that may be important in providing inhibitor potency and selectivity toward the p38 MAP kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTUmGGtEwCPbVg90H21EOLACvtfcHk0lhrzMML3zaG7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFeitrbJ&md5=5add0d628abece6a2e15675e575cd97e</span></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=10.2174%2F1568026054985894&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026054985894%26sid%3Dliteratum%253Aachs%26aulast%3DWrobleski%26aufirst%3DS.%2BT.%26aulast%3DDoweyko%26aufirst%3DA.%2BM.%26atitle%3DStructural%2520Comparison%2520of%2520p38%2520Inhibitor-Protein%2520Complexes%253A%2520A%2520Review%2520of%2520Recent%2520p38%2520Inhibitors%2520Having%2520Unique%2520Binding%2520Interactions%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D1005%26epage%3D1016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Leftheris, K.;</span> et al. <div class="note"><p class="first last">unpublished results</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Leftheris%2C+K.%3B+et+al.+unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dunpublished%26sid%3Dliteratum%253Aachs%26aulast%3DLeftheris%26aufirst%3DK." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Cambanis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobre, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niculescu-Duvaz, I.</span><span> </span><span class="NLM_article-title">Potential anticancer agents. V. Aromatic nitrogen mustards related to 3-[N,N-bis(2-chloroethyl)amino]-4-methylbenzoic acid</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1969</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">4</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00301a043" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1969&pages=161-4&author=A.+Cambanisauthor=V.+Dobreauthor=I.+Niculescu-Duvaz&title=Potential+anticancer+agents.+V.+Aromatic+nitrogen+mustards+related+to+3-%5BN%2CN-bis%282-chloroethyl%29amino%5D-4-methylbenzoic+acid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm00301a043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00301a043%26sid%3Dliteratum%253Aachs%26aulast%3DCambanis%26aufirst%3DA.%26aulast%3DDobre%26aufirst%3DV.%26aulast%3DNiculescu-Duvaz%26aufirst%3DI.%26atitle%3DPotential%2520anticancer%2520agents.%2520V.%2520Aromatic%2520nitrogen%2520mustards%2520related%2520to%25203-%255BN%252CN-bis%25282-chloroethyl%2529amino%255D-4-methylbenzoic%2520acid%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1969%26volume%3D12%26spage%3D161%26epage%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Fink, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vite, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mastalerz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadow, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leavitt, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crews, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitt, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vyas, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokarski, J. S.</span><span> </span><span class="NLM_article-title">New dual inhibitors of EGFR and HER2 protein tyrosine kinases</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">4774</span><span class="NLM_x">–</span> <span class="NLM_lpage">4779</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=4774-4779&author=B.+E.+Finkauthor=G.+D.+Viteauthor=H.+Mastalerzauthor=J.+F.+Kadowauthor=S.+Kimauthor=K.+J.+Leavittauthor=K.+Duauthor=D.+Crewsauthor=T.+Mittauthor=T.+W.+Wongauthor=J.+T.+Huntauthor=D.+M.+Vyasauthor=J.+S.+Tokarski&title=New+dual+inhibitors+of+EGFR+and+HER2+protein+tyrosine+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFink%26aufirst%3DB.%2BE.%26aulast%3DVite%26aufirst%3DG.%2BD.%26aulast%3DMastalerz%26aufirst%3DH.%26aulast%3DKadow%26aufirst%3DJ.%2BF.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DLeavitt%26aufirst%3DK.%2BJ.%26aulast%3DDu%26aufirst%3DK.%26aulast%3DCrews%26aufirst%3DD.%26aulast%3DMitt%26aufirst%3DT.%26aulast%3DWong%26aufirst%3DT.%2BW.%26aulast%3DHunt%26aufirst%3DJ.%2BT.%26aulast%3DVyas%26aufirst%3DD.%2BM.%26aulast%3DTokarski%26aufirst%3DJ.%2BS.%26atitle%3DNew%2520dual%2520inhibitors%2520of%2520EGFR%2520and%2520HER2%2520protein%2520tyrosine%2520kinases%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D4774%26epage%3D4779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Borzilleri, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, Z.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wautlet, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortillo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeyaseelan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukral, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamath, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vyas, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokarski, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fargnoli, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhide, R. S.</span><span> </span><span class="NLM_article-title">Design, Synthesis, and Evaluation of Orally Active 4-(2,4-Difluoro-5-(methoxycarbamoyl)phenylamino)pyrrolo[2,1-f][1,2,4]triazines as Dual Vascular Endothelial Growth Factor Receptor-2 and Fibroblast Growth Factor Receptor-1 Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">3991</span><span class="NLM_x">–</span> <span class="NLM_lpage">4008</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0501275" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=3991-4008&author=R.+M.+Borzilleriauthor=X.+Zhengauthor=L.+Qianauthor=C.+Ellisauthor=Z.-W.+Caiauthor=B.+S.+Wautletauthor=S.+Mortilloauthor=R.+Jeyaseelanauthor=D.+W.+Kukralauthor=A.+Furaauthor=A.+Kamathauthor=V.+Vyasauthor=J.+S.+Tokarskiauthor=J.+C.+Barrishauthor=J.+T.+Huntauthor=L.+J.+Lombardoauthor=J.+Fargnoliauthor=R.+S.+Bhide&title=Design%2C+Synthesis%2C+and+Evaluation+of+Orally+Active+4-%282%2C4-Difluoro-5-%28methoxycarbamoyl%29phenylamino%29pyrrolo%5B2%2C1-f%5D%5B1%2C2%2C4%5Dtriazines+as+Dual+Vascular+Endothelial+Growth+Factor+Receptor-2+and+Fibroblast+Growth+Factor+Receptor-1+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm0501275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0501275%26sid%3Dliteratum%253Aachs%26aulast%3DBorzilleri%26aufirst%3DR.%2BM.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DQian%26aufirst%3DL.%26aulast%3DEllis%26aufirst%3DC.%26aulast%3DCai%26aufirst%3DZ.-W.%26aulast%3DWautlet%26aufirst%3DB.%2BS.%26aulast%3DMortillo%26aufirst%3DS.%26aulast%3DJeyaseelan%26aufirst%3DR.%26aulast%3DKukral%26aufirst%3DD.%2BW.%26aulast%3DFura%26aufirst%3DA.%26aulast%3DKamath%26aufirst%3DA.%26aulast%3DVyas%26aufirst%3DV.%26aulast%3DTokarski%26aufirst%3DJ.%2BS.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DHunt%26aufirst%3DJ.%2BT.%26aulast%3DLombardo%26aufirst%3DL.%2BJ.%26aulast%3DFargnoli%26aufirst%3DJ.%26aulast%3DBhide%26aufirst%3DR.%2BS.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Evaluation%2520of%2520Orally%2520Active%25204-%25282%252C4-Difluoro-5-%2528methoxycarbamoyl%2529phenylamino%2529pyrrolo%255B2%252C1-f%255D%255B1%252C2%252C4%255Dtriazines%2520as%2520Dual%2520Vascular%2520Endothelial%2520Growth%2520Factor%2520Receptor-2%2520and%2520Fibroblast%2520Growth%2520Factor%2520Receptor-1%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D3991%26epage%3D4008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Otwinowski, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minor, W.</span><span> </span><span class="NLM_article-title">Processing X-ray data collected in oscillation mode</span> <span class="citation_source-journal">Methods Enzymol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">326</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=1996&pages=307-326&author=Z.+Otwinowskiauthor=W.+Minor&title=Processing+X-ray+data+collected+in+oscillation+mode"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOtwinowski%26aufirst%3DZ.%26aulast%3DMinor%26aufirst%3DW.%26atitle%3DProcessing%2520X-ray%2520data%2520collected%2520in%2520oscillation%2520mode%26jtitle%3DMethods%2520Enzymol.%26date%3D1996%26volume%3D276%26spage%3D307%26epage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Sack, J. S.; Kish, K. F.; Pokross, M.; Duke, G. J.; Xie, D.; Tredup, J. A.; Kiefer, S. E.; Newitt, J.</span><div class="note"><p class="first last">unpublished results</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Sack%2C+J.+S.%3B+Kish%2C+K.+F.%3B+Pokross%2C+M.%3B+Duke%2C+G.+J.%3B+Xie%2C+D.%3B+Tredup%2C+J.+A.%3B+Kiefer%2C+S.+E.%3B+Newitt%2C+J.unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dunpublished%26sid%3Dliteratum%253Aachs%26aulast%3DSack%26aufirst%3DJ.%2BS." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b'],'ref2':['cit2a','cit2b'],'ref3':['cit3'],'ref4':['cit4a','cit4b','cit4c','cit4d','cit4e'],'ref5':['cit5a','cit5b'],'ref6':['cit6a','cit6b','cit6c'],'ref7':['cit7a','cit7b','cit7c','cit7d','cit7e','cit7f'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14a','cit14b','cit14c'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 52 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrea  Unzue</span>, <span class="hlFld-ContribAuthor ">Jing  Dong</span>, <span class="hlFld-ContribAuthor ">Karine  Lafleur</span>, <span class="hlFld-ContribAuthor ">Hongtao  Zhao</span>, <span class="hlFld-ContribAuthor ">Emilie  Frugier</span>, <span class="hlFld-ContribAuthor ">Amedeo  Caflisch</span>, and <span class="hlFld-ContribAuthor ">Cristina  Nevado</span>  . </span><span class="cited-content_cbyCitation_article-title">Pyrrolo[3,2-b]quinoxaline Derivatives as Types I1/2 and II Eph Tyrosine Kinase Inhibitors: Structure-Based Design, Synthesis, and in Vivo Validation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (15)
                                     , 6834-6844. <a href="https://doi.org/10.1021/jm5009242" title="DOI URL">https://doi.org/10.1021/jm5009242</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5009242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5009242%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPyrrolo%25255B3%25252C2-b%25255Dquinoxaline%252BDerivatives%252Bas%252BTypes%252BI1%25252F2%252Band%252BII%252BEph%252BTyrosine%252BKinase%252BInhibitors%25253A%252BStructure-Based%252BDesign%25252C%252BSynthesis%25252C%252Band%252Bin%252BVivo%252BValidation%26aulast%3DUnzue%26aufirst%3DAndrea%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D18062014%26date%3D30072014%26date%3D14082014%26volume%3D57%26issue%3D15%26spage%3D6834%26epage%3D6844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bin  Zheng</span>, <span class="hlFld-ContribAuthor ">David A.  Conlon</span>, <span class="hlFld-ContribAuthor ">R. Michael  Corbett</span>, <span class="hlFld-ContribAuthor ">Melissa  Chau</span>, <span class="hlFld-ContribAuthor ">Dau-Ming  Hsieh</span>, <span class="hlFld-ContribAuthor ">Agnes  Yeboah</span>, <span class="hlFld-ContribAuthor ">Daniel  Hsieh</span>, <span class="hlFld-ContribAuthor ">Jale  Müslehiddinoğlu</span>, <span class="hlFld-ContribAuthor ">William P.  Gallagher</span>, <span class="hlFld-ContribAuthor ">Jeffrey N.  Simon</span>, and <span class="hlFld-ContribAuthor ">Justin  Burt</span>  . </span><span class="cited-content_cbyCitation_article-title">Development of a Practical Synthesis of a Functionalized Pyrrolo[2,1-f][1,2,4]triazine Nucleus. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2012,</strong> <em>16 </em>
                                    (11)
                                     , 1846-1853. <a href="https://doi.org/10.1021/op300252n" title="DOI URL">https://doi.org/10.1021/op300252n</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/op300252n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fop300252n%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DDevelopment%252Bof%252Ba%252BPractical%252BSynthesis%252Bof%252Ba%252BFunctionalized%252BPyrrolo%25255B2%25252C1-f%25255D%25255B1%25252C2%25252C4%25255Dtriazine%252BNucleus%26aulast%3DZheng%26aufirst%3DBin%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D10092012%26date%3D06112012%26date%3D16112012%26date%3D15102012%26volume%3D16%26issue%3D11%26spage%3D1846%26epage%3D1853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhongping  Shi</span>, <span class="hlFld-ContribAuthor ">Susanne  Kiau</span>, <span class="hlFld-ContribAuthor ">Paul  Lobben</span>, <span class="hlFld-ContribAuthor ">John  Hynes, Jr.</span>, <span class="hlFld-ContribAuthor ">Hong  Wu</span>, <span class="hlFld-ContribAuthor ">Luca  Parlanti</span>, <span class="hlFld-ContribAuthor ">Robert  Discordia</span>, <span class="hlFld-ContribAuthor ">Wendel W.  Doubleday</span>, <span class="hlFld-ContribAuthor ">Katerina  Leftheris</span>, <span class="hlFld-ContribAuthor ">Alaric J.  Dyckman</span>, <span class="hlFld-ContribAuthor ">Stephen T.  Wrobleski</span>, <span class="hlFld-ContribAuthor ">Konstantinos  Dambalas</span>, <span class="hlFld-ContribAuthor ">Srinivas  Tummala</span>, <span class="hlFld-ContribAuthor ">Simon  Leung</span>, and <span class="hlFld-ContribAuthor ">Ehrlic  Lo</span>  . </span><span class="cited-content_cbyCitation_article-title">Development of a Practical Synthesis of a p38 Kinase Inhibitor via a Safe and Robust Amination. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2012,</strong> <em>16 </em>
                                    (10)
                                     , 1618-1625. <a href="https://doi.org/10.1021/op300181r" title="DOI URL">https://doi.org/10.1021/op300181r</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/op300181r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fop300181r%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DDevelopment%252Bof%252Ba%252BPractical%252BSynthesis%252Bof%252Ba%252Bp38%252BKinase%252BInhibitor%252Bvia%252Ba%252BSafe%252Band%252BRobust%252BAmination%26aulast%3DShi%26aufirst%3DZhongping%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D06072012%26date%3D21092012%26date%3D19102012%26date%3D31082012%26volume%3D16%26issue%3D10%26spage%3D1618%26epage%3D1625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew  Segall</span>, <span class="hlFld-ContribAuthor ">Ed  Champness</span>, <span class="hlFld-ContribAuthor ">Chris  Leeding</span>, <span class="hlFld-ContribAuthor ">Ryan  Lilien</span>, <span class="hlFld-ContribAuthor ">Ramgopal  Mettu</span>, and <span class="hlFld-ContribAuthor ">Brian  Stevens</span>  . </span><span class="cited-content_cbyCitation_article-title">Applying Medicinal Chemistry Transformations and Multiparameter Optimization to Guide the Search for High-Quality Leads and Candidates. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2011,</strong> <em>51 </em>
                                    (11)
                                     , 2967-2976. <a href="https://doi.org/10.1021/ci2003208" title="DOI URL">https://doi.org/10.1021/ci2003208</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci2003208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci2003208%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DApplying%252BMedicinal%252BChemistry%252BTransformations%252Band%252BMultiparameter%252BOptimization%252Bto%252BGuide%252Bthe%252BSearch%252Bfor%252BHigh-Quality%252BLeads%252Band%252BCandidates%26aulast%3DSegall%26aufirst%3DMatthew%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D13072011%26date%3D18102011%26date%3D28112011%26date%3D07102011%26volume%3D51%26issue%3D11%26spage%3D2967%26epage%3D2976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chunjian  Liu</span>, <span class="hlFld-ContribAuthor ">James  Lin</span>, <span class="hlFld-ContribAuthor ">Stephen T.  Wrobleski</span>, <span class="hlFld-ContribAuthor ">Shuqun  Lin</span>, <span class="hlFld-ContribAuthor ">John  Hynes, Jr.</span>, <span class="hlFld-ContribAuthor ">Hong  Wu</span>, <span class="hlFld-ContribAuthor ">Alaric J.  Dyckman</span>, <span class="hlFld-ContribAuthor ">Tianle  Li</span>, <span class="hlFld-ContribAuthor ">John  Wityak</span>, <span class="hlFld-ContribAuthor ">Kathleen M.  Gillooly</span>, <span class="hlFld-ContribAuthor ">Sidney  Pitt</span>, <span class="hlFld-ContribAuthor ">Ding Ren  Shen</span>, <span class="hlFld-ContribAuthor ">Rosemary F.  Zhang</span>, <span class="hlFld-ContribAuthor ">Kim W.  McIntyre</span>, <span class="hlFld-ContribAuthor ">Luisa  Salter-Cid</span>, <span class="hlFld-ContribAuthor ">David J.  Shuster</span>, <span class="hlFld-ContribAuthor ">Hongjian  Zhang</span>, <span class="hlFld-ContribAuthor ">Punit H.  Marathe</span>, <span class="hlFld-ContribAuthor ">Arthur M.  Doweyko</span>, <span class="hlFld-ContribAuthor ">John S.  Sack</span>, <span class="hlFld-ContribAuthor ">Susan E.  Kiefer</span>, <span class="hlFld-ContribAuthor ">Kevin F.  Kish</span>, <span class="hlFld-ContribAuthor ">John A.  Newitt</span>, <span class="hlFld-ContribAuthor ">Murray  McKinnon</span>, <span class="hlFld-ContribAuthor ">John H.  Dodd</span>, <span class="hlFld-ContribAuthor ">Joel C.  Barrish</span>, <span class="hlFld-ContribAuthor ">Gary L.  Schieven</span>, and <span class="hlFld-ContribAuthor ">Katerina  Leftheris</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 4-(5-(Cyclopropylcarbamoyl)-2-methylphenylamino)-5-methyl-N-propylpyrrolo[1,2-f][1,2,4]triazine-6-carboxamide (BMS-582949), a Clinical p38α MAP Kinase Inhibitor for the Treatment of Inflammatory Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (18)
                                     , 6629-6639. <a href="https://doi.org/10.1021/jm100540x" title="DOI URL">https://doi.org/10.1021/jm100540x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm100540x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm100540x%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B4-%2525285-%252528Cyclopropylcarbamoyl%252529-2-methylphenylamino%252529-5-methyl-N-propylpyrrolo%25255B1%25252C2-f%25255D%25255B1%25252C2%25252C4%25255Dtriazine-6-carboxamide%252B%252528BMS-582949%252529%25252C%252Ba%252BClinical%252Bp38%2525CE%2525B1%252BMAP%252BKinase%252BInhibitor%252Bfor%252Bthe%252BTreatment%252Bof%252BInflammatory%252BDiseases%26aulast%3DLiu%26aufirst%3DChunjian%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D04052010%26date%3D30082010%26date%3D23092010%26volume%3D53%26issue%3D18%26spage%3D6629%26epage%3D6639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Caterina  Bissantz</span>, <span class="hlFld-ContribAuthor ">Bernd  Kuhn</span> and <span class="hlFld-ContribAuthor ">Martin  Stahl</span>. </span><span class="cited-content_cbyCitation_article-title">A Medicinal Chemist’s Guide to Molecular Interactions. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (14)
                                     , 5061-5084. <a href="https://doi.org/10.1021/jm100112j" title="DOI URL">https://doi.org/10.1021/jm100112j</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm100112j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm100112j%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252BMedicinal%252BChemist%2525E2%252580%252599s%252BGuide%252Bto%252BMolecular%252BInteractions%26aulast%3DBissantz%26aufirst%3DCaterina%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D27012010%26date%3D26032010%26date%3D22072010%26volume%3D53%26issue%3D14%26spage%3D5061%26epage%3D5084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fabio  Zuccotto</span>, <span class="hlFld-ContribAuthor ">Elena  Ardini</span>, <span class="hlFld-ContribAuthor ">Elena  Casale</span> and <span class="hlFld-ContribAuthor ">Mauro  Angiolini</span>  . </span><span class="cited-content_cbyCitation_article-title">Through the “Gatekeeper Door”: Exploiting the Active Kinase Conformation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (7)
                                     , 2681-2694. <a href="https://doi.org/10.1021/jm901443h" title="DOI URL">https://doi.org/10.1021/jm901443h</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm901443h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm901443h%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThrough%252Bthe%252B%2525E2%252580%25259CGatekeeper%252BDoor%2525E2%252580%25259D%25253A%252BExploiting%252Bthe%252BActive%252BKinase%252BConformation%26aulast%3DZuccotto%26aufirst%3DFabio%26date%3D2010%26date%3D2009%26date%3D2009%26date%3D29092009%26date%3D14122009%26date%3D08042010%26volume%3D53%26issue%3D7%26spage%3D2681%26epage%3D2694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiangwei  Du</span>, <span class="hlFld-ContribAuthor ">Xin  Xie</span> and <span class="hlFld-ContribAuthor ">Yuanhong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Gold-Catalyzed Cyclization of Alkynylaziridines as an Efficient Approach toward Functionalized N-Phth Pyrroles. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2010,</strong> <em>75 </em>
                                    (2)
                                     , 510-513. <a href="https://doi.org/10.1021/jo902357x" title="DOI URL">https://doi.org/10.1021/jo902357x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo902357x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo902357x%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DGold-Catalyzed%252BCyclization%252Bof%252BAlkynylaziridines%252Bas%252Ban%252BEfficient%252BApproach%252Btoward%252BFunctionalized%252BN-Phth%252BPyrroles%26aulast%3DDu%26aufirst%3DXiangwei%26date%3D2010%26date%3D2009%26date%3D2009%26date%3D03112009%26date%3D14122009%26date%3D15012010%26volume%3D75%26issue%3D2%26spage%3D510%26epage%3D513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">F.  Marandi</span>, <span class="hlFld-ContribAuthor ">K.  Moeini</span>, <span class="hlFld-ContribAuthor ">H.  Krautscheid</span>. </span><span class="cited-content_cbyCitation_article-title">A PYRIDYL-TRIAZINE COMPLEX OF Co(II): 
SPECTROSCOPIC, STRUCTURAL, AND DOCKING STUDIES. </span><span class="cited-content_cbyCitation_journal-name">Journal of Structural Chemistry</span><span> <strong>2021,</strong> <em>62 </em>
                                    (4)
                                     , 590-597. <a href="https://doi.org/10.1134/S0022476621040119" title="DOI URL">https://doi.org/10.1134/S0022476621040119</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S0022476621040119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS0022476621040119%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Structural%2520Chemistry%26atitle%3DA%252BPYRIDYL-TRIAZINE%252BCOMPLEX%252BOF%252BCo%252528II%252529%25253A%252BSPECTROSCOPIC%25252C%252BSTRUCTURAL%25252C%252BAND%252BDOCKING%252BSTUDIES%26aulast%3DMarandi%26aufirst%3DF.%26date%3D2021%26date%3D2021%26volume%3D62%26issue%3D4%26spage%3D590%26epage%3D597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maryam  Tahmasby</span>, <span class="hlFld-ContribAuthor ">Ali  Darehkordi</span>, <span class="hlFld-ContribAuthor ">Marziyeh  Mohammadi</span>, <span class="hlFld-ContribAuthor ">Farzaneh  Nejadkhorasani</span>. </span><span class="cited-content_cbyCitation_article-title">Pyrido triazin-nucleus synthesis and theoretical studies: 2,3,6-trioxo-8-aryl-1,3,4,6-tetrahydro-]2H[pyrido]1,2-b] [1,2,4[triazin-7,9-dicarbonitryl derivatives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2021,</strong> <em>1224 </em>, 129032. <a href="https://doi.org/10.1016/j.molstruc.2020.129032" title="DOI URL">https://doi.org/10.1016/j.molstruc.2020.129032</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2020.129032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2020.129032%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DPyrido%252Btriazin-nucleus%252Bsynthesis%252Band%252Btheoretical%252Bstudies%25253A%252B2%25252C3%25252C6-trioxo-8-aryl-1%25252C3%25252C4%25252C6-tetrahydro-%25255D2H%25255Bpyrido%25255D1%25252C2-b%25255D%252B%25255B1%25252C2%25252C4%25255Btriazin-7%25252C9-dicarbonitryl%252Bderivatives%26aulast%3DTahmasby%26aufirst%3DMaryam%26date%3D2021%26volume%3D1224%26spage%3D129032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S.M.  Ivanov</span>. </span><span class="cited-content_cbyCitation_article-title">1,2,4-Triazines and Their Benzo Derivatives. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,<a href="https://doi.org/10.1016/B978-0-12-818655-8.00062-7" title="DOI URL">https://doi.org/10.1016/B978-0-12-818655-8.00062-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-818655-8.00062-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-818655-8.00062-7%26sid%3Dliteratum%253Aachs%26atitle%3D1%25252C2%25252C4-Triazines%252Band%252BTheir%252BBenzo%252BDerivatives%26aulast%3DIvanov%26aufirst%3DS.M.%26date%3D2021%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2021%26volume%3Dvol.%252010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anne  Westermeyer</span>, <span class="hlFld-ContribAuthor ">Gérard  Guillamot</span>, <span class="hlFld-ContribAuthor ">Phannarath  Phansavath</span>, <span class="hlFld-ContribAuthor ">Virginie  Ratovelomanana-Vidal</span>. </span><span class="cited-content_cbyCitation_article-title">Copper-catalyzed cycloisomerization of alkynylaziridines to access functionalized 2-substituted-4-formylpyrroles. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2020,</strong> <em>76 </em>
                                    (51)
                                     , 131221. <a href="https://doi.org/10.1016/j.tet.2020.131221" title="DOI URL">https://doi.org/10.1016/j.tet.2020.131221</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2020.131221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2020.131221%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DCopper-catalyzed%252Bcycloisomerization%252Bof%252Balkynylaziridines%252Bto%252Baccess%252Bfunctionalized%252B2-substituted-4-formylpyrroles%26aulast%3DWestermeyer%26aufirst%3DAnne%26date%3D2020%26volume%3D76%26issue%3D51%26spage%3D131221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nadia Y.  Megally Abdo</span>, <span class="hlFld-ContribAuthor ">Rafat  Milad Mohareb</span>, <span class="hlFld-ContribAuthor ">Peter A.  Halim</span>. </span><span class="cited-content_cbyCitation_article-title">Uses of cyclohexane-1,3-dione for the synthesis of 1,2,4-triazine derivatives as anti-proliferative agents and tyrosine kinases inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>97 </em>, 103667. <a href="https://doi.org/10.1016/j.bioorg.2020.103667" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.103667</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.103667&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.103667%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DUses%252Bof%252Bcyclohexane-1%25252C3-dione%252Bfor%252Bthe%252Bsynthesis%252Bof%252B1%25252C2%25252C4-triazine%252Bderivatives%252Bas%252Banti-proliferative%252Bagents%252Band%252Btyrosine%252Bkinases%252Binhibitors%26aulast%3DMegally%2BAbdo%26aufirst%3DNadia%2BY.%26date%3D2020%26volume%3D97%26spage%3D103667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Claudia  Lalli</span>. </span><span class="cited-content_cbyCitation_article-title">Bicyclic 5-6 Systems With One Bridgehead (Ring Junction) Nitrogen Atom: Two Extra Heteroatoms 0:2. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,<a href="https://doi.org/10.1016/B978-0-12-409547-2.14939-X" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.14939-X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.14939-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.14939-X%26sid%3Dliteratum%253Aachs%26atitle%3DBicyclic%252B5-6%252BSystems%252BWith%252BOne%252BBridgehead%252B%252528Ring%252BJunction%252529%252BNitrogen%252BAtom%25253A%252BTwo%252BExtra%252BHeteroatoms%252B0%25253A2%26aulast%3DLalli%26aufirst%3DClaudia%26date%3D2020%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hao  Liu</span>, <span class="hlFld-ContribAuthor ">Sihui  Long</span>, <span class="hlFld-ContribAuthor ">K.P.  Rakesh</span>, <span class="hlFld-ContribAuthor ">Gao-Feng  Zha</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-activity relationships (SAR) of triazine derivatives: Promising antimicrobial agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>185 </em>, 111804. <a href="https://doi.org/10.1016/j.ejmech.2019.111804" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111804</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111804&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111804%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-activity%252Brelationships%252B%252528SAR%252529%252Bof%252Btriazine%252Bderivatives%25253A%252BPromising%252Bantimicrobial%252Bagents%26aulast%3DLiu%26aufirst%3DHao%26date%3D2020%26volume%3D185%26spage%3D111804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laura  Marín-Ocampo</span>, <span class="hlFld-ContribAuthor ">Luz Angela  Veloza</span>, <span class="hlFld-ContribAuthor ">Rodrigo  Abonia</span>, <span class="hlFld-ContribAuthor ">Juan C.  Sepúlveda-Arias</span>. </span><span class="cited-content_cbyCitation_article-title">Anti-inflammatory activity of triazine derivatives: A systematic review. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>162 </em>, 435-447. <a href="https://doi.org/10.1016/j.ejmech.2018.11.027" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.11.027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.11.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.11.027%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAnti-inflammatory%252Bactivity%252Bof%252Btriazine%252Bderivatives%25253A%252BA%252Bsystematic%252Breview%26aulast%3DMar%25C3%25ADn-Ocampo%26aufirst%3DLaura%26date%3D2019%26volume%3D162%26spage%3D435%26epage%3D447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Farzin  Marandi</span>, <span class="hlFld-ContribAuthor ">Keyvan  Moeini</span>, <span class="hlFld-ContribAuthor ">Akbar  Arkak</span>, <span class="hlFld-ContribAuthor ">Zahra  Mardani</span>, <span class="hlFld-ContribAuthor ">Harald  Krautscheid</span>. </span><span class="cited-content_cbyCitation_article-title">Docking studies to evaluate the biological activities of the Co(II) and Ni(II) complexes containing the triazine unit: supported by structural, spectral, and theoretical studies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Coordination Chemistry</span><span> <strong>2018,</strong> <em>71 </em>
                                    (23)
                                     , 3893-3911. <a href="https://doi.org/10.1080/00958972.2018.1543871" title="DOI URL">https://doi.org/10.1080/00958972.2018.1543871</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00958972.2018.1543871&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00958972.2018.1543871%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Coordination%2520Chemistry%26atitle%3DDocking%252Bstudies%252Bto%252Bevaluate%252Bthe%252Bbiological%252Bactivities%252Bof%252Bthe%252BCo%252528II%252529%252Band%252BNi%252528II%252529%252Bcomplexes%252Bcontaining%252Bthe%252Btriazine%252Bunit%25253A%252Bsupported%252Bby%252Bstructural%25252C%252Bspectral%25252C%252Band%252Btheoretical%252Bstudies%26aulast%3DMarandi%26aufirst%3DFarzin%26date%3D2018%26date%3D2019%26volume%3D71%26issue%3D23%26spage%3D3893%26epage%3D3911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stella  Cascioferro</span>, <span class="hlFld-ContribAuthor ">Barbara  Parrino</span>, <span class="hlFld-ContribAuthor ">Virginia  Spanò</span>, <span class="hlFld-ContribAuthor ">Anna  Carbone</span>, <span class="hlFld-ContribAuthor ">Alessandra  Montalbano</span>, <span class="hlFld-ContribAuthor ">Paola  Barraja</span>, <span class="hlFld-ContribAuthor ">Patrizia  Diana</span>, <span class="hlFld-ContribAuthor ">Girolamo  Cirrincione</span>. </span><span class="cited-content_cbyCitation_article-title">An overview on the recent developments of 1,2,4-triazine derivatives as anticancer compounds. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>142 </em>, 328-375. <a href="https://doi.org/10.1016/j.ejmech.2017.08.009" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.08.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.08.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.08.009%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAn%252Boverview%252Bon%252Bthe%252Brecent%252Bdevelopments%252Bof%252B1%25252C2%25252C4-triazine%252Bderivatives%252Bas%252Banticancer%252Bcompounds%26aulast%3DCascioferro%26aufirst%3DStella%26date%3D2017%26volume%3D142%26spage%3D328%26epage%3D375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gregory R.  Ott</span>, <span class="hlFld-ContribAuthor ">David A.  Favor</span>. </span><span class="cited-content_cbyCitation_article-title">Pyrrolo[2,1-f][1,2,4]triazines: From C-nucleosides to kinases and back again, the remarkable journey of a versatile nitrogen heterocycle. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (18)
                                     , 4238-4246. <a href="https://doi.org/10.1016/j.bmcl.2017.07.073" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.07.073</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.07.073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.07.073%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DPyrrolo%25255B2%25252C1-f%25255D%25255B1%25252C2%25252C4%25255Dtriazines%25253A%252BFrom%252BC-nucleosides%252Bto%252Bkinases%252Band%252Bback%252Bagain%25252C%252Bthe%252Bremarkable%252Bjourney%252Bof%252Ba%252Bversatile%252Bnitrogen%252Bheterocycle%26aulast%3DOtt%26aufirst%3DGregory%2BR.%26date%3D2017%26volume%3D27%26issue%3D18%26spage%3D4238%26epage%3D4246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">E. Prabhu  Raman</span>, <span class="hlFld-ContribAuthor ">Sirish Kaushik  Lakkaraju</span>, <span class="hlFld-ContribAuthor ">Rajiah Aldrin  Denny</span>, <span class="hlFld-ContribAuthor ">Alexander D.  MacKerell</span>. </span><span class="cited-content_cbyCitation_article-title">Estimation of relative free energies of binding using pre-computed ensembles based on the single-step free energy perturbation and the site-identification by Ligand competitive saturation approaches. </span><span class="cited-content_cbyCitation_journal-name">Journal of Computational Chemistry</span><span> <strong>2017,</strong> <em>38 </em>
                                    (15)
                                     , 1238-1251. <a href="https://doi.org/10.1002/jcc.24522" title="DOI URL">https://doi.org/10.1002/jcc.24522</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jcc.24522&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjcc.24522%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Computational%2520Chemistry%26atitle%3DEstimation%252Bof%252Brelative%252Bfree%252Benergies%252Bof%252Bbinding%252Busing%252Bpre-computed%252Bensembles%252Bbased%252Bon%252Bthe%252Bsingle-step%252Bfree%252Benergy%252Bperturbation%252Band%252Bthe%252Bsite-identification%252Bby%252BLigand%252Bcompetitive%252Bsaturation%252Bapproaches%26aulast%3DRaman%26aufirst%3DE.%2BPrabhu%26date%3D2017%26date%3D2016%26volume%3D38%26issue%3D15%26spage%3D1238%26epage%3D1251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">N.C.  Desai</span>, <span class="hlFld-ContribAuthor ">Atul H.  Makwana</span>, <span class="hlFld-ContribAuthor ">R.D.  Senta</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, characterization and antimicrobial activity of some novel 4-(4-(arylamino)-6-(piperidin-1-yl)-1,3,5-triazine-2-ylamino)-N-(pyrimidin-2-yl)benzenesulfonamides. </span><span class="cited-content_cbyCitation_journal-name">Journal of Saudi Chemical Society</span><span> <strong>2016,</strong> <em>20 </em>
                                    (6)
                                     , 686-694. <a href="https://doi.org/10.1016/j.jscs.2015.01.004" title="DOI URL">https://doi.org/10.1016/j.jscs.2015.01.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jscs.2015.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jscs.2015.01.004%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Saudi%2520Chemical%2520Society%26atitle%3DSynthesis%25252C%252Bcharacterization%252Band%252Bantimicrobial%252Bactivity%252Bof%252Bsome%252Bnovel%252B4-%2525284-%252528arylamino%252529-6-%252528piperidin-1-yl%252529-1%25252C3%25252C5-triazine-2-ylamino%252529-N-%252528pyrimidin-2-yl%252529benzenesulfonamides%26aulast%3DDesai%26aufirst%3DN.C.%26date%3D2016%26volume%3D20%26issue%3D6%26spage%3D686%26epage%3D694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">Process Optimization. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 35-191. <a href="https://doi.org/10.1201/9781315367316-3" title="DOI URL">https://doi.org/10.1201/9781315367316-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1201/9781315367316-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1201%2F9781315367316-3%26sid%3Dliteratum%253Aachs%26atitle%3DProcess%252BOptimization%26date%3D2016%26date%3D2016%26spage%3D35%26epage%3D191%26pub%3DCRC%2520Press%26atitle%3DHandbook%252Bfor%252BChemical%252BProcess%252BResearch%252Band%252BDevelopment%26aulast%3DZhao%26aufirst%3DWenyi%26date%3D2016%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrea  Unzue</span>, <span class="hlFld-ContribAuthor ">Karine  Lafleur</span>, <span class="hlFld-ContribAuthor ">Hongtao  Zhao</span>, <span class="hlFld-ContribAuthor ">Ting  Zhou</span>, <span class="hlFld-ContribAuthor ">Jing  Dong</span>, <span class="hlFld-ContribAuthor ">Peter  Kolb</span>, <span class="hlFld-ContribAuthor ">Johanna  Liebl</span>, <span class="hlFld-ContribAuthor ">Stefan  Zahler</span>, <span class="hlFld-ContribAuthor ">Amedeo  Caflisch</span>, <span class="hlFld-ContribAuthor ">Cristina  Nevado</span>. </span><span class="cited-content_cbyCitation_article-title">Three stories on Eph kinase inhibitors: From in silico discovery to in vivo validation. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>112 </em>, 347-366. <a href="https://doi.org/10.1016/j.ejmech.2016.01.057" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.01.057</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.01.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.01.057%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThree%252Bstories%252Bon%252BEph%252Bkinase%252Binhibitors%25253A%252BFrom%252Bin%252Bsilico%252Bdiscovery%252Bto%252Bin%2525C2%2525A0vivo%252Bvalidation%26aulast%3DUnzue%26aufirst%3DAndrea%26date%3D2016%26volume%3D112%26spage%3D347%26epage%3D366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M. R. E.  Aly</span>, <span class="hlFld-ContribAuthor ">A. A.  Gobouri</span>, <span class="hlFld-ContribAuthor ">S. H.  Abdel Hafez</span>, <span class="hlFld-ContribAuthor ">H. A.  Saad</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, reactions, and biological activity of some triazine derivatives containing sulfa drug moieties. </span><span class="cited-content_cbyCitation_journal-name">Russian Journal of Bioorganic Chemistry</span><span> <strong>2015,</strong> <em>41 </em>
                                    (4)
                                     , 437-450. <a href="https://doi.org/10.1134/S1068162015040032" title="DOI URL">https://doi.org/10.1134/S1068162015040032</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S1068162015040032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS1068162015040032%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Journal%2520of%2520Bioorganic%2520Chemistry%26atitle%3DSynthesis%25252C%252Breactions%25252C%252Band%252Bbiological%252Bactivity%252Bof%252Bsome%252Btriazine%252Bderivatives%252Bcontaining%252Bsulfa%252Bdrug%252Bmoieties%26aulast%3DAly%26aufirst%3DM.%2BR.%2BE.%26date%3D2015%26date%3D2015%26volume%3D41%26issue%3D4%26spage%3D437%26epage%3D450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anand R.  Saundane</span>, <span class="hlFld-ContribAuthor ">R.  Kalpana</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of novel indolo[2,3-c]isoquinoline derivatives. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2015,</strong> <em>24 </em>
                                    (4)
                                     , 1681-1695. <a href="https://doi.org/10.1007/s00044-014-1243-2" title="DOI URL">https://doi.org/10.1007/s00044-014-1243-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-014-1243-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-014-1243-2%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bindolo%25255B2%25252C3-c%25255Disoquinoline%252Bderivatives%26aulast%3DSaundane%26aufirst%3DAnand%2BR.%26date%3D2015%26date%3D2014%26volume%3D24%26issue%3D4%26spage%3D1681%26epage%3D1695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Preethi  Badrinarayan</span>, <span class="hlFld-ContribAuthor ">G. Narahari  Sastry</span>, . </span><span class="cited-content_cbyCitation_article-title">Specificity Rendering ‘Hot-Spots’ for Aurora Kinase Inhibitor Design: The Role of Non-Covalent Interactions and Conformational Transitions. </span><span class="cited-content_cbyCitation_journal-name">PLoS ONE</span><span> <strong>2014,</strong> <em>9 </em>
                                    (12)
                                     , e113773. <a href="https://doi.org/10.1371/journal.pone.0113773" title="DOI URL">https://doi.org/10.1371/journal.pone.0113773</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0113773&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0113773%26sid%3Dliteratum%253Aachs%26jtitle%3DPLoS%2520ONE%26atitle%3DSpecificity%252BRendering%252B%2525E2%252580%252598Hot-Spots%2525E2%252580%252599%252Bfor%252BAurora%252BKinase%252BInhibitor%252BDesign%25253A%252BThe%252BRole%252Bof%252BNon-Covalent%252BInteractions%252Band%252BConformational%252BTransitions%26aulast%3DBadrinarayan%26aufirst%3DPreethi%26date%3D2014%26date%3D2014%26volume%3D9%26issue%3D12%26spage%3De113773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lan  Wang</span>, <span class="hlFld-ContribAuthor ">Mark  Stanley</span>, <span class="hlFld-ContribAuthor ">Jason W.  Boggs</span>, <span class="hlFld-ContribAuthor ">Terry D.  Crawford</span>, <span class="hlFld-ContribAuthor ">Brandon J.  Bravo</span>, <span class="hlFld-ContribAuthor ">Anthony M.  Giannetti</span>, <span class="hlFld-ContribAuthor ">Seth F.  Harris</span>, <span class="hlFld-ContribAuthor ">Steven R.  Magnuson</span>, <span class="hlFld-ContribAuthor ">Jim  Nonomiya</span>, <span class="hlFld-ContribAuthor ">Stephen  Schmidt</span>, <span class="hlFld-ContribAuthor ">Ping  Wu</span>, <span class="hlFld-ContribAuthor ">Weilan  Ye</span>, <span class="hlFld-ContribAuthor ">Stephen E.  Gould</span>, <span class="hlFld-ContribAuthor ">Lesley J.  Murray</span>, <span class="hlFld-ContribAuthor ">Chudi O.  Ndubaku</span>, <span class="hlFld-ContribAuthor ">Huifen  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment-based identification and optimization of a class of potent pyrrolo[2,1-f][1,2,4]triazine MAP4K4 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (18)
                                     , 4546-4552. <a href="https://doi.org/10.1016/j.bmcl.2014.07.071" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.07.071</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.07.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.07.071%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DFragment-based%252Bidentification%252Band%252Boptimization%252Bof%252Ba%252Bclass%252Bof%252Bpotent%252Bpyrrolo%25255B2%25252C1-f%25255D%25255B1%25252C2%25252C4%25255Dtriazine%252BMAP4K4%252Binhibitors%26aulast%3DWang%26aufirst%3DLan%26date%3D2014%26volume%3D24%26issue%3D18%26spage%3D4546%26epage%3D4552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Min  Wang</span>, <span class="hlFld-ContribAuthor ">Mingzhang  Gao</span>, <span class="hlFld-ContribAuthor ">Qi-Huang  Zheng</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of carbon-11-labeled 4-(phenylamino)-pyrrolo[2,1-f][1,2,4]triazine derivatives as new potential PET tracers for imaging of p38α mitogen-activated protein kinase. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (16)
                                     , 3700-3705. <a href="https://doi.org/10.1016/j.bmcl.2014.07.017" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.07.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.07.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.07.017%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Bof%252Bcarbon-11-labeled%252B4-%252528phenylamino%252529-pyrrolo%25255B2%25252C1-f%25255D%25255B1%25252C2%25252C4%25255Dtriazine%252Bderivatives%252Bas%252Bnew%252Bpotential%252BPET%252Btracers%252Bfor%252Bimaging%252Bof%252Bp38%2525CE%2525B1%252Bmitogen-activated%252Bprotein%252Bkinase%26aulast%3DWang%26aufirst%3DMin%26date%3D2014%26volume%3D24%26issue%3D16%26spage%3D3700%26epage%3D3705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianyang  Chen</span>, <span class="hlFld-ContribAuthor ">Bo  Liu</span>, <span class="hlFld-ContribAuthor ">Yanhong  Chen</span>, <span class="hlFld-ContribAuthor ">Qian  He</span>, <span class="hlFld-ContribAuthor ">Chunhao  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Copper(ii)-catalyzed cascade approach for the synthesis of pyrrolo[2,1-f][1,2,4]triazine-fused isoquinolines. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2014,</strong> <em>4 </em>
                                    (22)
                                     , 11168. <a href="https://doi.org/10.1039/c3ra47324d" title="DOI URL">https://doi.org/10.1039/c3ra47324d</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c3ra47324d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc3ra47324d%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DCopper%252528ii%252529-catalyzed%252Bcascade%252Bapproach%252Bfor%252Bthe%252Bsynthesis%252Bof%252Bpyrrolo%25255B2%25252C1-f%25255D%25255B1%25252C2%25252C4%25255Dtriazine-fused%252Bisoquinolines%26aulast%3DChen%26aufirst%3DJianyang%26date%3D2014%26volume%3D4%26issue%3D22%26spage%3D11168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chunjian  Liu</span>, <span class="hlFld-ContribAuthor ">James  Lin</span>, <span class="hlFld-ContribAuthor ">Gerry  Everlof</span>, <span class="hlFld-ContribAuthor ">Christoph  Gesenberg</span>, <span class="hlFld-ContribAuthor ">Hongjian  Zhang</span>, <span class="hlFld-ContribAuthor ">Punit H.  Marathe</span>, <span class="hlFld-ContribAuthor ">Mary  Malley</span>, <span class="hlFld-ContribAuthor ">Michael A.  Galella</span>, <span class="hlFld-ContribAuthor ">Murray  Mckinnon</span>, <span class="hlFld-ContribAuthor ">John H.  Dodd</span>, <span class="hlFld-ContribAuthor ">Joel C.  Barrish</span>, <span class="hlFld-ContribAuthor ">Gary L.  Schieven</span>, <span class="hlFld-ContribAuthor ">Katerina  Leftheris</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of carbamoylmethylene linked prodrugs of BMS-582949, a clinical p38α inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (10)
                                     , 3028-3033. <a href="https://doi.org/10.1016/j.bmcl.2013.03.022" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.03.022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.03.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.03.022%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Bcarbamoylmethylene%252Blinked%252Bprodrugs%252Bof%252BBMS-582949%25252C%252Ba%252Bclinical%252Bp38%2525CE%2525B1%252Binhibitor%26aulast%3DLiu%26aufirst%3DChunjian%26date%3D2013%26volume%3D23%26issue%3D10%26spage%3D3028%26epage%3D3033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haoyue  Xiang</span>, <span class="hlFld-ContribAuthor ">Yanhong  Chen</span>, <span class="hlFld-ContribAuthor ">Qian  He</span>, <span class="hlFld-ContribAuthor ">Yuyuan  Xie</span>, <span class="hlFld-ContribAuthor ">Chunhao  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Pot, atom and step economic synthesis: a diversity-oriented approach to construct 2-substituted pyrrolo[2,1-f][1,2,4]triazin-4(3H)-ones. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2013,</strong> <em>3 </em>
                                    (17)
                                     , 5807. <a href="https://doi.org/10.1039/c3ra22909b" title="DOI URL">https://doi.org/10.1039/c3ra22909b</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c3ra22909b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc3ra22909b%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DPot%25252C%252Batom%252Band%252Bstep%252Beconomic%252Bsynthesis%25253A%252Ba%252Bdiversity-oriented%252Bapproach%252Bto%252Bconstruct%252B2-substituted%252Bpyrrolo%25255B2%25252C1-f%25255D%25255B1%25252C2%25252C4%25255Dtriazin-4%2525283H%252529-ones%26aulast%3DXiang%26aufirst%3DHaoyue%26date%3D2013%26volume%3D3%26issue%3D17%26spage%3D5807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Agnieszka  Szuster-Ciesielska</span>, <span class="hlFld-ContribAuthor ">Krzysztof  Sztanke</span>, <span class="hlFld-ContribAuthor ">Martyna  Kandefer-Szerszeń</span>. </span><span class="cited-content_cbyCitation_article-title">A novel fused 1,2,4-triazine aryl derivative as antioxidant and nonselective antagonist of adenosine A2A receptors in ethanol-activated liver stellate cells. </span><span class="cited-content_cbyCitation_journal-name">Chemico-Biological Interactions</span><span> <strong>2012,</strong> <em>195 </em>
                                    (1)
                                     , 18-24. <a href="https://doi.org/10.1016/j.cbi.2011.10.004" title="DOI URL">https://doi.org/10.1016/j.cbi.2011.10.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cbi.2011.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cbi.2011.10.004%26sid%3Dliteratum%253Aachs%26jtitle%3DChemico-Biological%2520Interactions%26atitle%3DA%252Bnovel%252Bfused%252B1%25252C2%25252C4-triazine%252Baryl%252Bderivative%252Bas%252Bantioxidant%252Band%252Bnonselective%252Bantagonist%252Bof%252Badenosine%252BA2A%252Breceptors%252Bin%252Bethanol-activated%252Bliver%252Bstellate%252Bcells%26aulast%3DSzuster-Ciesielska%26aufirst%3DAgnieszka%26date%3D2012%26volume%3D195%26issue%3D1%26spage%3D18%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stefan  Fischer</span>, <span class="hlFld-ContribAuthor ">Solveigh C  Koeberle</span>, <span class="hlFld-ContribAuthor ">Stefan A  Laufer</span>. </span><span class="cited-content_cbyCitation_article-title">p38α mitogen-activated protein kinase inhibitors, a patent review (2005 – 2011). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2011,</strong> <em>21 </em>
                                    (12)
                                     , 1843-1866. <a href="https://doi.org/10.1517/13543776.2011.636737" title="DOI URL">https://doi.org/10.1517/13543776.2011.636737</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2011.636737&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2011.636737%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3Dp38%2525CE%2525B1%252Bmitogen-activated%252Bprotein%252Bkinase%252Binhibitors%25252C%252Ba%252Bpatent%252Breview%252B%2525282005%252B%2525E2%252580%252593%252B2011%252529%26aulast%3DFischer%26aufirst%3DStefan%26date%3D2011%26date%3D2011%26volume%3D21%26issue%3D12%26spage%3D1843%26epage%3D1866" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rishikesh V.  Antre</span>, <span class="hlFld-ContribAuthor ">A.  Cendilkumar</span>, <span class="hlFld-ContribAuthor ">Divakar  Goli</span>, <span class="hlFld-ContribAuthor ">Ganesh S.  Andhale</span>, <span class="hlFld-ContribAuthor ">Rajesh J.  Oswal</span>. </span><span class="cited-content_cbyCitation_article-title">Microwave assisted synthesis of novel pyrazolone derivatives attached to a pyrimidine moiety and evaluation of their anti-inflammatory, analgesic and antipyretic activities. </span><span class="cited-content_cbyCitation_journal-name">Saudi Pharmaceutical Journal</span><span> <strong>2011,</strong> <em>19 </em>
                                    (4)
                                     , 233-243. <a href="https://doi.org/10.1016/j.jsps.2011.05.006" title="DOI URL">https://doi.org/10.1016/j.jsps.2011.05.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jsps.2011.05.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jsps.2011.05.006%26sid%3Dliteratum%253Aachs%26jtitle%3DSaudi%2520Pharmaceutical%2520Journal%26atitle%3DMicrowave%252Bassisted%252Bsynthesis%252Bof%252Bnovel%252Bpyrazolone%252Bderivatives%252Battached%252Bto%252Ba%252Bpyrimidine%252Bmoiety%252Band%252Bevaluation%252Bof%252Btheir%252Banti-inflammatory%25252C%252Banalgesic%252Band%252Bantipyretic%252Bactivities%26aulast%3DAntre%26aufirst%3DRishikesh%2BV.%26date%3D2011%26volume%3D19%26issue%3D4%26spage%3D233%26epage%3D243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alaric J.  Dyckman</span>, <span class="hlFld-ContribAuthor ">Tianle  Li</span>, <span class="hlFld-ContribAuthor ">Sidney  Pitt</span>, <span class="hlFld-ContribAuthor ">Rosemary  Zhang</span>, <span class="hlFld-ContribAuthor ">Ding Ren  Shen</span>, <span class="hlFld-ContribAuthor ">Kim W.  McIntyre</span>, <span class="hlFld-ContribAuthor ">Kathleen M.  Gillooly</span>, <span class="hlFld-ContribAuthor ">David J.  Shuster</span>, <span class="hlFld-ContribAuthor ">Arthur M.  Doweyko</span>, <span class="hlFld-ContribAuthor ">John S.  Sack</span>, <span class="hlFld-ContribAuthor ">Kevin  Kish</span>, <span class="hlFld-ContribAuthor ">Susan E.  Kiefer</span>, <span class="hlFld-ContribAuthor ">John A.  Newitt</span>, <span class="hlFld-ContribAuthor ">Hongjian  Zhang</span>, <span class="hlFld-ContribAuthor ">Punit H.  Marathe</span>, <span class="hlFld-ContribAuthor ">Murray  McKinnon</span>, <span class="hlFld-ContribAuthor ">Joel C.  Barrish</span>, <span class="hlFld-ContribAuthor ">John H.  Dodd</span>, <span class="hlFld-ContribAuthor ">Gary L.  Schieven</span>, <span class="hlFld-ContribAuthor ">Katerina  Leftheris</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of pyrrolo[2,1-f][1,2,4]triazine C6-ketones as potent, orally active p38α MAP kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>21 </em>
                                    (15)
                                     , 4633-4637. <a href="https://doi.org/10.1016/j.bmcl.2011.05.091" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.05.091</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.05.091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.05.091%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bpyrrolo%25255B2%25252C1-f%25255D%25255B1%25252C2%25252C4%25255Dtriazine%252BC6-ketones%252Bas%252Bpotent%25252C%252Borally%252Bactive%252Bp38%2525CE%2525B1%252BMAP%252Bkinase%252Binhibitors%26aulast%3DDyckman%26aufirst%3DAlaric%2BJ.%26date%3D2011%26volume%3D21%26issue%3D15%26spage%3D4633%26epage%3D4637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul  Eastwood</span>, <span class="hlFld-ContribAuthor ">Jacob  González</span>, <span class="hlFld-ContribAuthor ">Elena  Gómez</span>, <span class="hlFld-ContribAuthor ">Bernat  Vidal</span>, <span class="hlFld-ContribAuthor ">Francisco  Caturla</span>, <span class="hlFld-ContribAuthor ">Ramón  Roca</span>, <span class="hlFld-ContribAuthor ">Cristina  Balagué</span>, <span class="hlFld-ContribAuthor ">Adelina  Orellana</span>, <span class="hlFld-ContribAuthor ">María  Domínguez</span>. </span><span class="cited-content_cbyCitation_article-title">Indolin-2-one p38α inhibitors I: Design, profiling and crystallographic binding mode. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>21 </em>
                                    (14)
                                     , 4130-4133. <a href="https://doi.org/10.1016/j.bmcl.2011.05.114" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.05.114</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.05.114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.05.114%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIndolin-2-one%252Bp38%2525CE%2525B1%252Binhibitors%252BI%25253A%252BDesign%25252C%252Bprofiling%252Band%252Bcrystallographic%252Bbinding%252Bmode%26aulast%3DEastwood%26aufirst%3DPaul%26date%3D2011%26volume%3D21%26issue%3D14%26spage%3D4130%26epage%3D4133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hosam  Saad</span>, <span class="hlFld-ContribAuthor ">Ahmed  Moustafa</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Anticancer Activity of Some New S-Glycosyl and S-Alkyl 1,2,4-Triazinone Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2011,</strong> <em>16 </em>
                                    (7)
                                     , 5682-5700. <a href="https://doi.org/10.3390/molecules16075682" title="DOI URL">https://doi.org/10.3390/molecules16075682</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules16075682&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules16075682%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%252Band%252BAnticancer%252BActivity%252Bof%252BSome%252BNew%252BS-Glycosyl%252Band%252BS-Alkyl%252B1%25252C2%25252C4-Triazinone%252BDerivatives%26aulast%3DSaad%26aufirst%3DHosam%26date%3D2011%26date%3D2011%26volume%3D16%26issue%3D7%26spage%3D5682%26epage%3D5700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hosam A.  Saad</span>, <span class="hlFld-ContribAuthor ">Mohamed M.  Youssef</span>, <span class="hlFld-ContribAuthor ">Mosselhi A.  Mosselhi</span>. </span><span class="cited-content_cbyCitation_article-title">Microwave Assisted Synthesis of Some New Fused 1,2,4-Triazines Bearing Thiophene Moieties With Expected Pharmacological Activity. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2011,</strong> <em>16 </em>
                                    (6)
                                     , 4937-4957. <a href="https://doi.org/10.3390/molecules16064937" title="DOI URL">https://doi.org/10.3390/molecules16064937</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules16064937&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules16064937%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DMicrowave%252BAssisted%252BSynthesis%252Bof%252BSome%252BNew%252BFused%252B1%25252C2%25252C4-Triazines%252BBearing%252BThiophene%252BMoieties%252BWith%252BExpected%252BPharmacological%252BActivity%26aulast%3DSaad%26aufirst%3DHosam%2BA.%26date%3D2011%26date%3D2011%26volume%3D16%26issue%3D6%26spage%3D4937%26epage%3D4957" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mauro  Angiolini</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting the DFG-in kinase conformation: a new trend emerging from a patent analysis. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2011,</strong> <em>3 </em>
                                    (3)
                                     , 309-337. <a href="https://doi.org/10.4155/fmc.10.294" title="DOI URL">https://doi.org/10.4155/fmc.10.294</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.10.294&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.10.294%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252Bthe%252BDFG-in%252Bkinase%252Bconformation%25253A%252Ba%252Bnew%252Btrend%252Bemerging%252Bfrom%252Ba%252Bpatent%252Banalysis%26aulast%3DAngiolini%26aufirst%3DMauro%26date%3D2011%26volume%3D3%26issue%3D3%26spage%3D309%26epage%3D337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jagabandhu  Das</span>, <span class="hlFld-ContribAuthor ">Robert V.  Moquin</span>, <span class="hlFld-ContribAuthor ">Alaric J.  Dyckman</span>, <span class="hlFld-ContribAuthor ">Tianle  Li</span>, <span class="hlFld-ContribAuthor ">Sidney  Pitt</span>, <span class="hlFld-ContribAuthor ">Rosemary  Zhang</span>, <span class="hlFld-ContribAuthor ">Ding Ren  Shen</span>, <span class="hlFld-ContribAuthor ">Kim W.  McIntyre</span>, <span class="hlFld-ContribAuthor ">Kathleen  Gillooly</span>, <span class="hlFld-ContribAuthor ">Arthur M.  Doweyko</span>, <span class="hlFld-ContribAuthor ">John A.  Newitt</span>, <span class="hlFld-ContribAuthor ">John S.  Sack</span>, <span class="hlFld-ContribAuthor ">Hongjian  Zhang</span>, <span class="hlFld-ContribAuthor ">Susan E.  Kiefer</span>, <span class="hlFld-ContribAuthor ">Kevin  Kish</span>, <span class="hlFld-ContribAuthor ">Murray  McKinnon</span>, <span class="hlFld-ContribAuthor ">Joel C.  Barrish</span>, <span class="hlFld-ContribAuthor ">John H.  Dodd</span>, <span class="hlFld-ContribAuthor ">Gary L.  Schieven</span>, <span class="hlFld-ContribAuthor ">Katerina  Leftheris</span>. </span><span class="cited-content_cbyCitation_article-title">5-Amino-pyrazoles as potent and selective p38α inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (23)
                                     , 6886-6889. <a href="https://doi.org/10.1016/j.bmcl.2010.10.034" title="DOI URL">https://doi.org/10.1016/j.bmcl.2010.10.034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2010.10.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2010.10.034%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D5-Amino-pyrazoles%252Bas%252Bpotent%252Band%252Bselective%252Bp38%2525CE%2525B1%252Binhibitors%26aulast%3DDas%26aufirst%3DJagabandhu%26date%3D2010%26volume%3D20%26issue%3D23%26spage%3D6886%26epage%3D6889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ping  Lan</span>, <span class="hlFld-ContribAuthor ">Zhi-Jian  Huang</span>, <span class="hlFld-ContribAuthor ">Jun-Rong  Sun</span>, <span class="hlFld-ContribAuthor ">Wei-Min  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">3D-QSAR and Molecular Docking Studies on Fused Pyrazoles as p38α Mitogen-Activated Protein Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2010,</strong> <em>11 </em>
                                    (9)
                                     , 3357-3374. <a href="https://doi.org/10.3390/ijms11093357" title="DOI URL">https://doi.org/10.3390/ijms11093357</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms11093357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms11093357%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3D3D-QSAR%252Band%252BMolecular%252BDocking%252BStudies%252Bon%252BFused%252BPyrazoles%252Bas%252Bp38%2525CE%2525B1%252BMitogen-Activated%252BProtein%252BKinase%252BInhibitors%26aulast%3DLan%26aufirst%3DPing%26date%3D2010%26date%3D2010%26volume%3D11%26issue%3D9%26spage%3D3357%26epage%3D3374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roland E.  Dolle</span>, <span class="hlFld-ContribAuthor ">Karin  Worm</span>. </span><span class="cited-content_cbyCitation_article-title">Role of Chemistry in Lead Discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2010,</strong>,, 259-290. <a href="https://doi.org/10.1002/9780470584170.ch9" title="DOI URL">https://doi.org/10.1002/9780470584170.ch9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9780470584170.ch9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9780470584170.ch9%26sid%3Dliteratum%253Aachs%26atitle%3DRole%252Bof%252BChemistry%252Bin%252BLead%252BDiscovery%26aulast%3DDolle%26aufirst%3DRoland%2BE.%26date%3D2010%26date%3D2010%26spage%3D259%26epage%3D290%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DLead%252BGeneration%252BApproaches%252Bin%252BDrug%252BDiscovery%26aulast%3DRankovic%26aufirst%3DZoran%26date%3D2010%26date%3D2010%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lenka  Munoz</span>, <span class="hlFld-ContribAuthor ">Roland  Selig</span>, <span class="hlFld-ContribAuthor ">Yiu To  Yeung</span>, <span class="hlFld-ContribAuthor ">Christian  Peifer</span>, <span class="hlFld-ContribAuthor ">Dominik  Hauser</span>, <span class="hlFld-ContribAuthor ">Stefan  Laufer</span>. </span><span class="cited-content_cbyCitation_article-title">Fluorescence polarization binding assay to develop inhibitors of inactive p38α mitogen-activated protein kinase. </span><span class="cited-content_cbyCitation_journal-name">Analytical Biochemistry</span><span> <strong>2010,</strong> <em>401 </em>
                                    (1)
                                     , 125-133. <a href="https://doi.org/10.1016/j.ab.2010.02.016" title="DOI URL">https://doi.org/10.1016/j.ab.2010.02.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ab.2010.02.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ab.2010.02.016%26sid%3Dliteratum%253Aachs%26jtitle%3DAnalytical%2520Biochemistry%26atitle%3DFluorescence%252Bpolarization%252Bbinding%252Bassay%252Bto%252Bdevelop%252Binhibitors%252Bof%252Binactive%252Bp38%2525CE%2525B1%252Bmitogen-activated%252Bprotein%252Bkinase%26aulast%3DMunoz%26aufirst%3DLenka%26date%3D2010%26volume%3D401%26issue%3D1%26spage%3D125%26epage%3D133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Quan  Chen</span>, <span class="hlFld-ContribAuthor ">Wei  Cui</span>, <span class="hlFld-ContribAuthor ">Mingjuan  Ji</span>. </span><span class="cited-content_cbyCitation_article-title">Studies of chirality effect of 4-(phenylamino)-pyrrolo[2,1-f][1,2,4]triazine on p38α by molecular dynamics simulations and free energy calculations. </span><span class="cited-content_cbyCitation_journal-name">Journal of Computer-Aided Molecular Design</span><span> <strong>2009,</strong> <em>23 </em>
                                    (10)
                                     , 737-745. <a href="https://doi.org/10.1007/s10822-009-9298-8" title="DOI URL">https://doi.org/10.1007/s10822-009-9298-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10822-009-9298-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10822-009-9298-8%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Computer-Aided%2520Molecular%2520Design%26atitle%3DStudies%252Bof%252Bchirality%252Beffect%252Bof%252B4-%252528phenylamino%252529-pyrrolo%25255B2%25252C1-f%25255D%25255B1%25252C2%25252C4%25255Dtriazine%252Bon%252Bp38%2525CE%2525B1%252Bby%252Bmolecular%252Bdynamics%252Bsimulations%252Band%252Bfree%252Benergy%252Bcalculations%26aulast%3DChen%26aufirst%3DQuan%26date%3D2009%26date%3D2009%26volume%3D23%26issue%3D10%26spage%3D737%26epage%3D745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ryan P.  Wurz</span>, <span class="hlFld-ContribAuthor ">Liping H.  Pettus</span>, <span class="hlFld-ContribAuthor ">Shimin  Xu</span>, <span class="hlFld-ContribAuthor ">Bradley  Henkle</span>, <span class="hlFld-ContribAuthor ">Lisa  Sherman</span>, <span class="hlFld-ContribAuthor ">Matthew  Plant</span>, <span class="hlFld-ContribAuthor ">Kent  Miner</span>, <span class="hlFld-ContribAuthor ">Helen  McBride</span>, <span class="hlFld-ContribAuthor ">Lu Min  Wong</span>, <span class="hlFld-ContribAuthor ">Christiaan J.M.  Saris</span>, <span class="hlFld-ContribAuthor ">Matthew R.  Lee</span>, <span class="hlFld-ContribAuthor ">Samer  Chmait</span>, <span class="hlFld-ContribAuthor ">Christopher  Mohr</span>, <span class="hlFld-ContribAuthor ">Faye  Hsieh</span>, <span class="hlFld-ContribAuthor ">Andrew S.  Tasker</span>. </span><span class="cited-content_cbyCitation_article-title">Part 1: Structure–Activity Relationship (SAR) investigations of fused pyrazoles as potent, selective and orally available inhibitors of p38α mitogen-activated protein kinase. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2009,</strong> <em>19 </em>
                                    (16)
                                     , 4724-4728. <a href="https://doi.org/10.1016/j.bmcl.2009.06.058" title="DOI URL">https://doi.org/10.1016/j.bmcl.2009.06.058</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2009.06.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2009.06.058%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DPart%252B1%25253A%252BStructure%2525E2%252580%252593Activity%252BRelationship%252B%252528SAR%252529%252Binvestigations%252Bof%252Bfused%252Bpyrazoles%252Bas%252Bpotent%25252C%252Bselective%252Band%252Borally%252Bavailable%252Binhibitors%252Bof%252Bp38%2525CE%2525B1%252Bmitogen-activated%252Bprotein%252Bkinase%26aulast%3DWurz%26aufirst%3DRyan%2BP.%26date%3D2009%26volume%3D19%26issue%3D16%26spage%3D4724%26epage%3D4728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter  Norman</span>. </span><span class="cited-content_cbyCitation_article-title">BMS-582949: crystalline form of a p38α inhibitor? WO2008079857. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2009,</strong> <em>19 </em>
                                    (8)
                                     , 1165-1168. <a href="https://doi.org/10.1517/13543770902816160" title="DOI URL">https://doi.org/10.1517/13543770902816160</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543770902816160&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543770902816160%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DBMS-582949%25253A%252Bcrystalline%252Bform%252Bof%252Ba%252Bp38%2525CE%2525B1%252Binhibitor%25253F%252BWO2008079857%26aulast%3DNorman%26aufirst%3DPeter%26date%3D2009%26date%3D2009%26volume%3D19%26issue%3D8%26spage%3D1165%26epage%3D1168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhao  Yang</span>, <span class="hlFld-ContribAuthor ">Zhi-Xiang  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Phenyl
              N
              -(4-fluorophenyl)carbamate. </span><span class="cited-content_cbyCitation_journal-name">Acta Crystallographica Section E Structure Reports Online</span><span> <strong>2009,</strong> <em>65 </em>
                                    (5)
                                     , o1036-o1036. <a href="https://doi.org/10.1107/S1600536809013312" title="DOI URL">https://doi.org/10.1107/S1600536809013312</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1107/S1600536809013312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1107%2FS1600536809013312%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Crystallographica%2520Section%2520E%2520Structure%2520Reports%2520Online%26atitle%3DPhenyl%252BN%252B-%2525284-fluorophenyl%252529carbamate%26aulast%3DYang%26aufirst%3DZhao%26date%3D2009%26date%3D2009%26volume%3D65%26issue%3D5%26spage%3Do1036%26epage%3Do1036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dae-Kee  Kim</span>, <span class="hlFld-ContribAuthor ">Jin-Hwi  Lim</span>, <span class="hlFld-ContribAuthor ">Jung A.  Lee</span>, <span class="hlFld-ContribAuthor ">Purushottam M.  Dewang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of trisubstituted imidazole derivatives as inhibitors of p38α mitogen-activated protein kinase. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2008,</strong> <em>18 </em>
                                    (14)
                                     , 4006-4010. <a href="https://doi.org/10.1016/j.bmcl.2008.06.007" title="DOI URL">https://doi.org/10.1016/j.bmcl.2008.06.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2008.06.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2008.06.007%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Btrisubstituted%252Bimidazole%252Bderivatives%252Bas%252Binhibitors%252Bof%252Bp38%2525CE%2525B1%252Bmitogen-activated%252Bprotein%252Bkinase%26aulast%3DKim%26aufirst%3DDae-Kee%26date%3D2008%26volume%3D18%26issue%3D14%26spage%3D4006%26epage%3D4010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephen T.  Wrobleski</span>, <span class="hlFld-ContribAuthor ">Shuqun  Lin</span>, <span class="hlFld-ContribAuthor ">John  Hynes</span>, <span class="hlFld-ContribAuthor ">Hong  Wu</span>, <span class="hlFld-ContribAuthor ">Sidney  Pitt</span>, <span class="hlFld-ContribAuthor ">Ding Ren  Shen</span>, <span class="hlFld-ContribAuthor ">Rosemary  Zhang</span>, <span class="hlFld-ContribAuthor ">Kathleen M.  Gillooly</span>, <span class="hlFld-ContribAuthor ">David J.  Shuster</span>, <span class="hlFld-ContribAuthor ">Kim W.  McIntyre</span>, <span class="hlFld-ContribAuthor ">Arthur M.  Doweyko</span>, <span class="hlFld-ContribAuthor ">Kevin F.  Kish</span>, <span class="hlFld-ContribAuthor ">Jeffrey A.  Tredup</span>, <span class="hlFld-ContribAuthor ">Gerald J.  Duke</span>, <span class="hlFld-ContribAuthor ">John S.  Sack</span>, <span class="hlFld-ContribAuthor ">Murray  McKinnon</span>, <span class="hlFld-ContribAuthor ">John  Dodd</span>, <span class="hlFld-ContribAuthor ">Joel C.  Barrish</span>, <span class="hlFld-ContribAuthor ">Gary L.  Schieven</span>, <span class="hlFld-ContribAuthor ">Katerina  Leftheris</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and SAR of new pyrrolo[2,1-f][1,2,4]triazines as potent p38α MAP kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2008,</strong> <em>18 </em>
                                    (8)
                                     , 2739-2744. <a href="https://doi.org/10.1016/j.bmcl.2008.02.067" title="DOI URL">https://doi.org/10.1016/j.bmcl.2008.02.067</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2008.02.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2008.02.067%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252BSAR%252Bof%252Bnew%252Bpyrrolo%25255B2%25252C1-f%25255D%25255B1%25252C2%25252C4%25255Dtriazines%252Bas%252Bpotent%252Bp38%2525CE%2525B1%252BMAP%252Bkinase%252Binhibitors%26aulast%3DWrobleski%26aufirst%3DStephen%2BT.%26date%3D2008%26volume%3D18%26issue%3D8%26spage%3D2739%26epage%3D2744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jagabandhu  Das</span>, <span class="hlFld-ContribAuthor ">Robert V.  Moquin</span>, <span class="hlFld-ContribAuthor ">Sidney  Pitt</span>, <span class="hlFld-ContribAuthor ">Rosemary  Zhang</span>, <span class="hlFld-ContribAuthor ">Ding Ren  Shen</span>, <span class="hlFld-ContribAuthor ">Kim W.  McIntyre</span>, <span class="hlFld-ContribAuthor ">Kathleen  Gillooly</span>, <span class="hlFld-ContribAuthor ">Arthur M.  Doweyko</span>, <span class="hlFld-ContribAuthor ">John S.  Sack</span>, <span class="hlFld-ContribAuthor ">Hongjian  Zhang</span>, <span class="hlFld-ContribAuthor ">Susan E.  Kiefer</span>, <span class="hlFld-ContribAuthor ">Kevin  Kish</span>, <span class="hlFld-ContribAuthor ">Murray  McKinnon</span>, <span class="hlFld-ContribAuthor ">Joel C.  Barrish</span>, <span class="hlFld-ContribAuthor ">John H.  Dodd</span>, <span class="hlFld-ContribAuthor ">Gary L.  Schieven</span>, <span class="hlFld-ContribAuthor ">Katerina  Leftheris</span>. </span><span class="cited-content_cbyCitation_article-title">Pyrazolo-pyrimidines: A novel heterocyclic scaffold for potent and selective p38α inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2008,</strong> <em>18 </em>
                                    (8)
                                     , 2652-2657. <a href="https://doi.org/10.1016/j.bmcl.2008.03.019" title="DOI URL">https://doi.org/10.1016/j.bmcl.2008.03.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2008.03.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2008.03.019%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DPyrazolo-pyrimidines%25253A%252BA%252Bnovel%252Bheterocyclic%252Bscaffold%252Bfor%252Bpotent%252Band%252Bselective%252Bp38%2525CE%2525B1%252Binhibitors%26aulast%3DDas%26aufirst%3DJagabandhu%26date%3D2008%26volume%3D18%26issue%3D8%26spage%3D2652%26epage%3D2657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chunjian  Liu</span>, <span class="hlFld-ContribAuthor ">James  Lin</span>, <span class="hlFld-ContribAuthor ">Sidney  Pitt</span>, <span class="hlFld-ContribAuthor ">Rosemary F.  Zhang</span>, <span class="hlFld-ContribAuthor ">John S.  Sack</span>, <span class="hlFld-ContribAuthor ">Susan E.  Kiefer</span>, <span class="hlFld-ContribAuthor ">Kevin  Kish</span>, <span class="hlFld-ContribAuthor ">Arthur M.  Doweyko</span>, <span class="hlFld-ContribAuthor ">Hongjian  Zhang</span>, <span class="hlFld-ContribAuthor ">Punit H.  Marathe</span>, <span class="hlFld-ContribAuthor ">James  Trzaskos</span>, <span class="hlFld-ContribAuthor ">Murray  Mckinnon</span>, <span class="hlFld-ContribAuthor ">John H.  Dodd</span>, <span class="hlFld-ContribAuthor ">Joel C.  Barrish</span>, <span class="hlFld-ContribAuthor ">Gary L.  Schieven</span>, <span class="hlFld-ContribAuthor ">Katerina  Leftheris</span>. </span><span class="cited-content_cbyCitation_article-title">Benzothiazole based inhibitors of p38α MAP kinase. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2008,</strong> <em>18 </em>
                                    (6)
                                     , 1874-1879. <a href="https://doi.org/10.1016/j.bmcl.2008.02.011" title="DOI URL">https://doi.org/10.1016/j.bmcl.2008.02.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2008.02.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2008.02.011%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DBenzothiazole%252Bbased%252Binhibitors%252Bof%252Bp38%2525CE%2525B1%252BMAP%252Bkinase%26aulast%3DLiu%26aufirst%3DChunjian%26date%3D2008%26volume%3D18%26issue%3D6%26spage%3D1874%26epage%3D1879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John  Hynes</span>, <span class="hlFld-ContribAuthor ">Hong  Wu</span>, <span class="hlFld-ContribAuthor ">Sidney  Pitt</span>, <span class="hlFld-ContribAuthor ">Ding Ren  Shen</span>, <span class="hlFld-ContribAuthor ">Rosemary  Zhang</span>, <span class="hlFld-ContribAuthor ">Gary L.  Schieven</span>, <span class="hlFld-ContribAuthor ">Kathleen M.  Gillooly</span>, <span class="hlFld-ContribAuthor ">David J.  Shuster</span>, <span class="hlFld-ContribAuthor ">Tracy L.  Taylor</span>, <span class="hlFld-ContribAuthor ">XiaoXia  Yang</span>, <span class="hlFld-ContribAuthor ">Kim W.  McIntyre</span>, <span class="hlFld-ContribAuthor ">Murray  McKinnon</span>, <span class="hlFld-ContribAuthor ">Hongjian  Zhang</span>, <span class="hlFld-ContribAuthor ">Punit H.  Marathe</span>, <span class="hlFld-ContribAuthor ">Arthur M.  Doweyko</span>, <span class="hlFld-ContribAuthor ">Kevin  Kish</span>, <span class="hlFld-ContribAuthor ">Susan E.  Kiefer</span>, <span class="hlFld-ContribAuthor ">John S.  Sack</span>, <span class="hlFld-ContribAuthor ">John A.  Newitt</span>, <span class="hlFld-ContribAuthor ">Joel C.  Barrish</span>, <span class="hlFld-ContribAuthor ">John  Dodd</span>, <span class="hlFld-ContribAuthor ">Katerina  Leftheris</span>. </span><span class="cited-content_cbyCitation_article-title">The discovery of (R)-2-(sec-butylamino)-N-(2-methyl-5-(methylcarbamoyl)phenyl) thiazole-5-carboxamide (BMS-640994)—A potent and efficacious p38α MAP kinase inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2008,</strong> <em>18 </em>
                                    (6)
                                     , 1762-1767. <a href="https://doi.org/10.1016/j.bmcl.2008.02.031" title="DOI URL">https://doi.org/10.1016/j.bmcl.2008.02.031</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2008.02.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2008.02.031%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DThe%252Bdiscovery%252Bof%252B%252528R%252529-2-%252528sec-butylamino%252529-N-%2525282-methyl-5-%252528methylcarbamoyl%252529phenyl%252529%252Bthiazole-5-carboxamide%252B%252528BMS-640994%252529%2525E2%252580%252594A%252Bpotent%252Band%252Befficacious%252Bp38%2525CE%2525B1%252BMAP%252Bkinase%252Binhibitor%26aulast%3DHynes%26aufirst%3DJohn%26date%3D2008%26volume%3D18%26issue%3D6%26spage%3D1762%26epage%3D1767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/medium/jm-2007-009414_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/large/jm-2007-009414_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009414&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/medium/jm-2007-009414_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/large/jm-2007-009414_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Examples of p38 MAPK inhibitors that have reached in-human studies.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/large/jm-2007-009414_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009414&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/medium/jm-2007-009414_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/large/jm-2007-009414_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Discovery of the pyrrolo[2,1-<i>f</i>][1,2,4]triazine p38 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/large/jm-2007-009414_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009414&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/medium/jm-2007-009414_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/large/jm-2007-009414_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Proposed binding modes of <b>3b</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/large/jm-2007-009414_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009414&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/medium/jm-2007-009414_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/large/jm-2007-009414_0004.jpeg" id="rightTab-gs1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/large/jm-2007-009414_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009414&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) DnpONH<sub>2</sub> or NH<sub>2</sub>Cl, NaH, DMF, 85%; (b) formamide, 165 °C, 89%; (c) POCl<sub>3</sub>, 110 °C, 3 h, 94%; (d) DMF, DIPEA, 55 °C, 12−18 h; (e) 1 N NaOH, THF, 55 °C; (f) R-NH<sub>2</sub> or R-NH<sub>3</sub>Cl, EDC, HOBt, DMF, DIPEA, rt.</p></p></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/medium/jm-2007-009414_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/large/jm-2007-009414_0005.jpeg" id="rightTab-gs2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/large/jm-2007-009414_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009414&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) DPPA, TEA, dioxane, 60 °C (ii) ROH, 80 °C; (b) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 93%; (c) (RCO)<sub>2</sub>O, CH<sub>2</sub>Cl<sub>2</sub>, TEA; (d) R—N═C═O, CH<sub>2</sub>Cl<sub>2</sub>, TEA.</p></p></figure><figure data-id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/medium/jm-2007-009414_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/large/jm-2007-009414_0006.jpeg" id="rightTab-gs3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/large/jm-2007-009414_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009414&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 3-nitro-6-methyl aniline, DIPEA, DMF, 55 °C, 86%; (b) (i) 1 N NaOH, THF, MeOH (ii) propyl amine, DMF, EDC, HOBt, 93%; (c) H<sub>2</sub>, 10% Pd/C, MeOH, 95%; (d) ROC(O)Cl, CH<sub>2</sub>Cl<sub>2</sub>, DIPEA; (e) DMF, DIPEA, 55 °C, 81%; (f) 1 N NaOH, THF, MeOH, 65 °C; (g) RNH<sub>2</sub> or RNH<sub>3</sub>Cl, EDC, HOBt, DMF DIPEA, rt.</p></p></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/medium/jm-2007-009414_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/large/jm-2007-009414_0012.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. X-ray cocrystal structure of <b>11b</b> and <b>11j</b> with p38α.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/large/jm-2007-009414_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009414&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/medium/jm-2007-009414_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/large/jm-2007-009414_0013.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Efficacy in the rat adjuvant arthritis model (6–8 mice per group). Terminal paw measurements (mean ± SEM) were as follows: <b>11b</b>, 0.78 ± 0.15 mL; <b>11c</b>, 0.85 ± 0.0.15 mL; <b>11d</b>, 0.83 ± 0.20 mL; <b>11j</b>, 0.86 ± 0.16 mL; vehicle, 1.5 ± 0.17 mL.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/large/jm-2007-009414_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009414&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/medium/jm-2007-009414_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/large/jm-2007-009414_0014.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Efficacy in mouse collagen induced arthritis (6–8 mice per group). Compounds <b>11b</b> and <b>11j</b> achieved statistically significant reduction in clinical score (<i>p</i> < 0.05, Kruskall-Wallis test) vs vehicle (PEG300 or Tween80/EtOH/water 90/5/5). Compound <b>11b</b> was dosed as the monomethanesulfonic acid salt; <b>11c</b> was dosed as the monobisulfate salt; <b>11j</b> was dosed as the monohydrochloride salt. All doses were adjusted to the free base equivalent. The study is inclusive of two separate experiments in which the vehicle and dexamethazone controls were nearly identical. </p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-1/jm7009414/production/images/large/jm-2007-009414_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009414&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i70">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65032" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65032" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 20 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Choy, E. H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panayi, G. S.</span><span> </span><span class="NLM_article-title">Cyokine Pathways and Joint Inflammation in Rheumatoid Arthritis</span> <span class="citation_source-journal">N. Eng. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">344</span><span class="NLM_x">, </span> <span class="NLM_fpage">907</span><span class="NLM_x">–</span> <span class="NLM_lpage">916</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm7009414&amp;key=10.1056%2FNEJM200103223441207" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm7009414&amp;key=11259725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm7009414&amp;key=1%3ACAS%3A528%3ADC%252BD3MXisFyrur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=344&publication_year=2001&pages=907-916&author=E.+H.+S.+Choyauthor=G.+S.+Panayi&title=Cyokine+Pathways+and+Joint+Inflammation+in+Rheumatoid+Arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Cytokine pathways and joint inflammation in rheumatoid arthritis</span></div><div class="casAuthors">Choy, Ernest H. S.; Panayi, Gabriel S.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">344</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">907-916</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review with 79 refs.  Although the cause of rheumatoid arthritis is still unclear, the improved understanding of the pathogenesis of the disease has opened the door to innovative therapies.  By targeting mols. that are directly involved in the pathogenesis of rheumatoid arthritis, these therapies may be more efficacious and specific and less toxic in the short and long term than std. therapies.  Radiol. evidence suggests that these new therapies, such as anticytokine therapy, may slow disease progression.  Finally, the success of anticytokine therapy will also provide valuable insights into the initiation and progression of rheumatoid arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8KnAs8wt9tbVg90H21EOLACvtfcHk0ljzYHLj7ZC2UQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXisFyrur8%253D&md5=407ee2bc06a307c241e60f048e5f4a95</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1056%2FNEJM200103223441207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM200103223441207%26sid%3Dliteratum%253Aachs%26aulast%3DChoy%26aufirst%3DE.%2BH.%2BS.%26aulast%3DPanayi%26aufirst%3DG.%2BS.%26atitle%3DCyokine%2520Pathways%2520and%2520Joint%2520Inflammation%2520in%2520Rheumatoid%2520Arthritis%26jtitle%3DN.%2520Eng.%2520J.%2520Med.%26date%3D2001%26volume%3D344%26spage%3D907%26epage%3D916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Dinarello, C. A.</span><span> </span><span class="NLM_article-title">Inflammatory cytokines: Interleukin-1 and Tumor Necrosis Factor as Effector Molecules in Autoimmune Diseases</span> <span class="citation_source-journal">Curr. Opin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">941</span><span class="NLM_x">–</span> <span class="NLM_lpage">948</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Fjm7009414&amp;key=10.1016%2FS0952-7915%2805%2980018-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Fjm7009414&amp;key=1665333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Fjm7009414&amp;key=1%3ACAS%3A528%3ADyaK38Xkt1ChtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1991&pages=941-948&author=C.+A.+Dinarello&title=Inflammatory+cytokines%3A+Interleukin-1+and+Tumor+Necrosis+Factor+as+Effector+Molecules+in+Autoimmune+Diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammatory cytokines:  interleukin-1 and tumor necrosis factor as effector molecules in autoimmune diseases</span></div><div class="casAuthors">Dinarello, Charles A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Immunology</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">941-8</span>CODEN:
                <span class="NLM_cas:coden">COPIEL</span>;
        ISSN:<span class="NLM_cas:issn">0952-7915</span>.
    </div><div class="casAbstract">The nature of the events that ppt. autoimmune diseases varies.  Interleukin-1 and tumor necrosis factor do not ppt. autoimmune diseases but rather act as effector mols.  They induce eicosanoid and NO synthesis, stimulate collagenases and collagen synthesis, and trigger the genes for other cytokines, namely interleukin-2, interleukin-6 and interleukin-8.  The ability to block interleukin-1 with the receptor antagonist, and tumor necrosis factor with sol. receptors, has given investigators specific tools to test the role of these two cytokines in the pathol. processes of autoimmune disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhF6Z-Gd_1RrVg90H21EOLACvtfcHk0lhFiYuKXMDaow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xkt1ChtLs%253D&md5=9124ac01336892ed242ed4583f14b4c6</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1016%2FS0952-7915%2805%2980018-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0952-7915%252805%252980018-4%26sid%3Dliteratum%253Aachs%26aulast%3DDinarello%26aufirst%3DC.%2BA.%26atitle%3DInflammatory%2520cytokines%253A%2520Interleukin-1%2520and%2520Tumor%2520Necrosis%2520Factor%2520as%2520Effector%2520Molecules%2520in%2520Autoimmune%2520Diseases%26jtitle%3DCurr.%2520Opin.%2520Immunol.%26date%3D1991%26volume%3D3%26spage%3D941%26epage%3D948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Palladino, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahjat, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theodorakis, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moldawer, L. L.</span><span> </span><span class="NLM_article-title">Anti-TNF-α Therapies: The Next Generation</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">736</span><span class="NLM_x">–</span> <span class="NLM_lpage">746</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Fjm7009414&amp;key=10.1038%2Fnrd1175" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Fjm7009414&amp;key=12951580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Fjm7009414&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvVWlsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=736-746&author=M.+A.+Palladinoauthor=F.+R.+Bahjatauthor=E.+A.+Theodorakisauthor=L.+L.+Moldawer&title=Anti-TNF-%CE%B1+Therapies%3A+The+Next+Generation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-TNF-α therapies: the next generation</span></div><div class="casAuthors">Palladino, Michael A.; Bahjat, Frances Rena; Theodorakis, Emmanuel A.; Moldawer, Lyle L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">736-746</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The functioning of the immune system is finely balanced by the activities of pro-inflammatory and anti-inflammatory mediators or cytokines.  Unregulated activities of these mediators can lead to the development of serious inflammatory diseases.  In particular, enhanced tumor-necrosis factor-α (TNF-α) synthesis is assocd. with the development of rheumatoid arthritis, psoriatic arthritis, and inflammatory bowel disease.  Inhibiting TNF-α activities in these diseases has been remarkably successful.  However, the current injectable protein therapies have assocd. risks and limitations.  An oral, small mol. that regulates TNF-α biol. could either replace the injectables or provide better disease control when used alone or in conjunction with existing therapies.  Here, the authors discuss the present understanding of TNF-α-mediated biol. and the current injectable therapies in clin. use, and focus on some of the new therapeutic approaches with oral, small-mol. inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmD8W7lUANYrVg90H21EOLACvtfcHk0lhFiYuKXMDaow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvVWlsLc%253D&md5=700fdae848391fbc910b5538217be0f8</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1038%2Fnrd1175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1175%26sid%3Dliteratum%253Aachs%26aulast%3DPalladino%26aufirst%3DM.%2BA.%26aulast%3DBahjat%26aufirst%3DF.%2BR.%26aulast%3DTheodorakis%26aufirst%3DE.%2BA.%26aulast%3DMoldawer%26aufirst%3DL.%2BL.%26atitle%3DAnti-TNF-%25CE%25B1%2520Therapies%253A%2520The%2520Next%2520Generation%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2003%26volume%3D2%26spage%3D736%26epage%3D746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Braddock, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, A.</span><span> </span><span class="NLM_article-title">Targeting IL-1 in Inflammatory Disease: New Opportunities for Therapeutic Intervention</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">10</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=1-10&author=M.+Braddockauthor=A.+Quinn&title=Targeting+IL-1+in+Inflammatory+Disease%3A+New+Opportunities+for+Therapeutic+Intervention"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBraddock%26aufirst%3DM.%26aulast%3DQuinn%26aufirst%3DA.%26atitle%3DTargeting%2520IL-1%2520in%2520Inflammatory%2520Disease%253A%2520New%2520Opportunities%2520for%2520Therapeutic%2520Intervention%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D1%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Westra, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Limburg, P. C.</span><span> </span><span class="NLM_article-title">p38 Mitogen-Activated Protein Kinase (MAPK) in Rheumatoid Arthritis</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">867</span><span class="NLM_x">–</span> <span class="NLM_lpage">874</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=867-874&author=J.+Westraauthor=P.+C.+Limburg&title=p38+Mitogen-Activated+Protein+Kinase+%28MAPK%29+in+Rheumatoid+Arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWestra%26aufirst%3DJ.%26aulast%3DLimburg%26aufirst%3DP.%2BC.%26atitle%3Dp38%2520Mitogen-Activated%2520Protein%2520Kinase%2520%2528MAPK%2529%2520in%2520Rheumatoid%2520Arthritis%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D867%26epage%3D874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Salituro, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Germann, U. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bemis, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, M. S.</span><span> </span><span class="NLM_article-title">Inhibitors of p38 MAP Kinase: Therapeutic Intervention in Cytokine-Mediated Diseases</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">807</span><span class="NLM_x">–</span> <span class="NLM_lpage">823</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Fjm7009414&amp;key=10495353" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Fjm7009414&amp;key=1%3ACAS%3A528%3ADyaK1MXlvFWqtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1999&pages=807-823&author=F.+G.+Salituroauthor=U.+A.+Germannauthor=K.+P.+Wilsonauthor=G.+W.+Bemisauthor=T.+Foxauthor=M.+S.+Su&title=Inhibitors+of+p38+MAP+Kinase%3A+Therapeutic+Intervention+in+Cytokine-Mediated+Diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of p38 MAP kinase: therapeutic intervention in cytokine-mediated diseases</span></div><div class="casAuthors">Salituro, Francesco G.; Germann, Ursula A.; Wilson, Keith P.; Bemis, Guy W.; Fox, Ted; Su, Michael S.-S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">807-823</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review with 91 refs.  P38 MAP kinase is a member of the family of kinases which mediate intracellular transduction pathways.  The activation of this particular MAP kinase pathway is in response to a broad variety of extracellular stimuli.  Subsequent downstream events triggered by p38 activation result in the prodn. of IL-1 and TNF-α, suggesting that inhibition of this enzyme may provide a useful therapeutic target for intervention in various diseases mediated by these cytokines.  Understanding the biol. consequences of p38 activation and inhibition has been the subject of intensive research over the past several years and there is now ample evidence to suggest that inhibition of this enzyme represents a valid approach for target intervention in various cytokine-mediated diseases.  Crystal structures of both apo enzyme and enzyme bound to various ligands in conjunction with site specific mutagenesis studies have provided a wealth of information regarding the interactions necessary to result in potent inhibition and selectivity from other kinases.  This information has proven useful towards the anal. of previously reported compds. and will provide addnl. insight towards the design of new compds. and building upon existing SAR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSaK3z0Hlrx7Vg90H21EOLACvtfcHk0lhzUxUFKmO52A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlvFWqtLs%253D&md5=fe744a5cb2b84f70e147be1a6e9e0a5a</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSalituro%26aufirst%3DF.%2BG.%26aulast%3DGermann%26aufirst%3DU.%2BA.%26aulast%3DWilson%26aufirst%3DK.%2BP.%26aulast%3DBemis%26aufirst%3DG.%2BW.%26aulast%3DFox%26aufirst%3DT.%26aulast%3DSu%26aufirst%3DM.%2BS.%26atitle%3DInhibitors%2520of%2520p38%2520MAP%2520Kinase%253A%2520Therapeutic%2520Intervention%2520in%2520Cytokine-Mediated%2520Diseases%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D1999%26volume%3D6%26spage%3D807%26epage%3D823" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Foster, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halley, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Souness, J. E.</span><span> </span><span class="NLM_article-title">Potential of p38 Inhibitors in the Treatment of Rheumatoid Arthritis</span> <span class="citation_source-journal">Drug News Perspect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">488</span><span class="NLM_x">–</span> <span class="NLM_lpage">497</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Fjm7009414&amp;key=12937622" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Fjm7009414&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmsFKktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2000&pages=488-497&author=M.+L.+Fosterauthor=F.+Halleyauthor=J.+E.+Souness&title=Potential+of+p38+Inhibitors+in+the+Treatment+of+Rheumatoid+Arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Potential of p38 inhibitors in the treatment of rheumatoid arthritis</span></div><div class="casAuthors">Foster, Martyn L.; Halley, Frank; Souness, John E.</div><div class="citationInfo"><span class="NLM_cas:title">Drug News & Perspectives</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">488-497</span>CODEN:
                <span class="NLM_cas:coden">DNPEED</span>;
        ISSN:<span class="NLM_cas:issn">0214-0934</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review, with 64 refs.  Rheumatoid arthritis (RA) is a chronic debilitating disease estd. to afflict 1-3% of the world population.  Although palliative treatments (nonsteroidal anti-inflammatory drugs or NSAIDs) are widely prescribed, there are currently only a few treatments that can modify the insidious progression of the disease (disease-modifying antirheumatic drugs or DMARDs), which frequently leads to phys. incapacitation and, on occasion, death.  Proinflammatory cytokines such as tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) are implicated in the disease onset and in the progression of bone and joint destruction that characterizes chronic RA.  P38 is an intracellular mitogen/stress-activated protein kinase (MAPK/SAPK) that regulates both the release and the actions of TNF-α and IL-1β.  Inhibition of p38 kinase is thus an important potential target for novel DMARDs.  Following the pioneering work conducted at SmithKline Beecham and elucidation of the roles of p38 with potent and selective inhibitors such as SB-203580, many pharmaceutical companies have embarked upon p38 synthetic programs, as indicated by the ever-increasing no. of patents in this domain.  At Aventis, a rapid parallel synthesis project led to the identification of RPR-200765A, a potent and selective p38 inhibitor of the lipopolysaccharide-induced release of TNF-α in vitro in mononuclear phagocytes and in vivo in the rat.  It also reduces disease incidence and progression in the rat streptococcal cell wall arthritis model when administered orally in either a prophylactic or a therapeutic dosing regimen.  Development of p38 inhibitors has been slow, probably because of toxicol. problems, which might explain why only two oral p38 inhibitors, SB-242235 and VX-745, have advanced into clin. development.  In the present article, the preclin. data exemplified in studies on RPR-200765A indicating why p38 inhibitors are attracting so much attention as potential novel anti-RA drugs are reviewed.  Current information on the different structural classes of p38 inhibitors is presented and possible reasons for the delays in their development are critically discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPsDRV9bCN37Vg90H21EOLACvtfcHk0ljySsf2SbKhhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmsFKktg%253D%253D&md5=b634b7ab2f3e8fd6747c4889e324f3a3</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFoster%26aufirst%3DM.%2BL.%26aulast%3DHalley%26aufirst%3DF.%26aulast%3DSouness%26aufirst%3DJ.%2BE.%26atitle%3DPotential%2520of%2520p38%2520Inhibitors%2520in%2520the%2520Treatment%2520of%2520Rheumatoid%2520Arthritis%26jtitle%3DDrug%2520News%2520Perspect.%26date%3D2000%26volume%3D13%26spage%3D488%26epage%3D497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Kumar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, J</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. C.</span><span> </span><span class="NLM_article-title">P38 MAP Kinases: Key Signaling Molecules as Therapeutic Targets for Inflammatory Diseases</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">717</span><span class="NLM_x">–</span> <span class="NLM_lpage">726</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=717-726&author=S.+Kumarauthor=J+Boehmauthor=J.+C.+Lee&title=P38+MAP+Kinases%3A+Key+Signaling+Molecules+as+Therapeutic+Targets+for+Inflammatory+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DBoehm%26aufirst%3DJ%26aulast%3DLee%26aufirst%3DJ.%2BC.%26atitle%3DP38%2520MAP%2520Kinases%253A%2520Key%2520Signaling%2520Molecules%2520as%2520Therapeutic%2520Targets%2520for%2520Inflammatory%2520Diseases%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2003%26volume%3D2%26spage%3D717%26epage%3D726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Saklatvala, J.</span><span> </span><span class="NLM_article-title">The p38 MAP kinase pathway as a therapeutic target in inflammatory disease</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">372</span><span class="NLM_x">–</span> <span class="NLM_lpage">377</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=16&amp;doi=10.1021%2Fjm7009414&amp;key=10.1016%2Fj.coph.2004.03.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=8&amp;doi=10.1021%2Fjm7009414&amp;key=15251131" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=32&amp;doi=10.1021%2Fjm7009414&amp;key=1%3ACAS%3A528%3ADC%252BD2cXls1Wgu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=372-377&author=J.+Saklatvala&title=The+p38+MAP+kinase+pathway+as+a+therapeutic+target+in+inflammatory+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4dR"><div class="casContent"><span class="casTitleNuber">4d</span><div class="casTitle"><span class="NLM_cas:atitle">The p38 MAP kinase pathway as a therapeutic target in inflammatory disease</span></div><div class="casAuthors">Saklatvala, Jeremy</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">372-377</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with refs.  The p38 MAPK signalling pathway plays an important role in inflammation and other physiol. processes.  Specific inhibitors of p38 α and β MAPK block prodn. of the major inflammatory cytokines (i.e. tumor necrosis factor-α and interleukin-1) and other proteins (e.g. cyclooxygenase-2), and are anti-inflammatory in animal models of disease.  A major function of the pathway is post-transcriptional control of inflammatory gene expression.  Many of the mRNAs are unstable (or untranslatable) because of AU-rich elements in the 3'untranslated region.  Signalling in the p38 pathway counteracts these and stabilizes the mRNAs by preventing their otherwise rapid de-adenylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpglO4EVBhJ-LVg90H21EOLACvtfcHk0ljySsf2SbKhhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXls1Wgu7s%253D&md5=5678936250f1dbc9c27707bd7edf6108</span></div><a href="/servlet/linkout?suffix=cit4d&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2004.03.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2004.03.009%26sid%3Dliteratum%253Aachs%26aulast%3DSaklatvala%26aufirst%3DJ.%26atitle%3DThe%2520p38%2520MAP%2520kinase%2520pathway%2520as%2520a%2520therapeutic%2520target%2520in%2520inflammatory%2520disease%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2004%26volume%3D4%26spage%3D372%26epage%3D377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Kumar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blake, S. M.</span><span> </span><span class="NLM_article-title">Pharmacological Potential of p38 MAPK Inhibitors</span> <span class="citation_source-journal">Handbook Exp. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">167</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">83</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4e&amp;dbid=16&amp;doi=10.1021%2Fjm7009414&amp;key=10.1007%2F3-540-26670-4_4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4e&amp;dbid=32&amp;doi=10.1021%2Fjm7009414&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFCn" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2005&pages=65-83&author=S.+Kumarauthor=S.+M.+Blake&title=Pharmacological+Potential+of+p38+MAPK+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4eR"><div class="casContent"><span class="casTitleNuber">4e</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological potential of p38 MAPK inhibitors</span></div><div class="casAuthors">Kumar, S.; Blake, S. M.</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue">Inhibitors of Protein Kinases and Protein Phosphates</span>),
    <span class="NLM_cas:pages">65-83</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">0171-2004</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  A key component of the intracellular signaling pathways involved in cellular response to environmental stress and inflammatory cytokines is the p38 family of mitogen-activated protein kinases (MAPKs).  Of the four isoforms of the p38 family of MAPKs identified thus far, p38α is the most characterized enzyme.  Since the discovery of p38α MAPK as a target of a series of compds. that inhibited the prodn. of inflammatory cytokines, an intense effort has been applied to further identify, develop, and refine highly potent and selective inhibitors of this enzyme.  In addn., availability of p38α MAPK inhibitors has allowed the investigators to dissect this signaling pathway and to examine its role in various pathologies.  A large body of biochem. as well as genetic evidence indicates a crit. role of p38α MAPK in both the prodn. of inflammatory cytokines such as interleukin (IL)-1 and tumor necrosis factor (TNF) and subsequent signaling initiated in response to these cytokines.  This suggests that inhibition of p38α MAPK pathway will have utility in pathol. settings where tissue inflammation and pro-inflammatory cytokines have been implicated.  Indeed, several p38α MAPK inhibitors have been shown to be efficacious in preclin. animal models of a variety of diseases, including rheumatoid arthritis, pulmonary diseases, neuronal protection, and cancer.  In the past few years, several groups have advanced inhibitors into early clin. studies for rheumatoid arthritis, but none thus far has reached the crit. phase III efficacy stage.  In this chapter, we review.  The p38 MAPK pathway and pharmacol. potential of p38α MAPK inhibitors in various pathologies with particular emphasis on inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3KHIOOv2-uLVg90H21EOLACvtfcHk0lhBQ468LCyOqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFCn&md5=ee807b0804df8944e482514b34d3461b</span></div><a href="/servlet/linkout?suffix=cit4e&amp;dbid=16384&amp;doi=10.1007%2F3-540-26670-4_4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F3-540-26670-4_4%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DBlake%26aufirst%3DS.%2BM.%26atitle%3DPharmacological%2520Potential%2520of%2520p38%2520MAPK%2520Inhibitors%26jtitle%3DHandbook%2520Exp.%2520Pharmacol.%26date%3D2005%26volume%3D167%26spage%3D65%26epage%3D83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Fijen, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zijlstra, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Boer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spanjersberg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, Tervaert, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Werf, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lightenberg, J. J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tulleken, J. E.</span><span> </span><span class="NLM_article-title">Suppression of the Clinical and Cytokine Response to Endotoxin by RWJ-67657, a p38 Mitogen-Activated Protein-Kinase Inhibitor, in Healthy Human Volunteers</span> <span class="citation_source-journal">Clin. Exp. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Fjm7009414&amp;key=10.1046%2Fj.1365-2249.2001.01485.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Fjm7009414&amp;key=11359438" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Fjm7009414&amp;key=1%3ACAS%3A528%3ADC%252BD3MXktl2kt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2001&pages=16-20&author=J.+W.+Fijenauthor=J.+G.+Zijlstraauthor=P.+De+Boerauthor=R.+Spanjersbergauthor=J.+W.+Cohen%2C+Tervaertauthor=T.+S.+van+der+Werfauthor=J.+J.+M.+Lightenbergauthor=J.+E.+Tulleken&title=Suppression+of+the+Clinical+and+Cytokine+Response+to+Endotoxin+by+RWJ-67657%2C+a+p38+Mitogen-Activated+Protein-Kinase+Inhibitor%2C+in+Healthy+Human+Volunteers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Suppression of the clinical and cytokine response to endotoxin by RWJ-67657, a p38 mitogen-activated protein-kinase inhibitor, in healthy human volunteers</span></div><div class="casAuthors">Fijen, J. W.; Zijlstra, J. G.; De Boer, P.; Spanjersberg, R.; Tervaert, J. W. Cohen; Van Der Werf, T. S.; Ligtenberg, J. J. M.; Tulleken, J. E.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and Experimental Immunology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">16-20</span>CODEN:
                <span class="NLM_cas:coden">CEXIAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-9104</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">Sepsis resulting in multiorgan failure and death is still a major problem in intensive care medicine, despite extensive attempts to interfere in the supposed underlying mechanism of a deranged immune system.  This is not only due to the persistent lacunae in knowledge about the immune system in sepsis but also due to the lack of sufficient instruments for intervention.  Inhibitors of the p38 mitogen-activated protein kinase (p38MAPK) have been used to study the signalling pathway of the immune response.  In vitro and animal studies have demonstrated that blocking p38MAPK could mitigate the pro-inflammatory response and improve survival after endotoxemia.  Using an endotoxemia model in healthy human volunteers, the authors evaluated the attenuation of clin. and cytokine response to endotoxin after inhibition of p38MAPK by an oral dose of RWJ-67657, a pyrindinyl imidazole.  They measured the clin. parameters temp., blood pressure, and heart rate.  The proinflammatory cytokines tumor necrosis factor α, interleukin 6, and interleukin 8 were measured by ELISA at various points during a 24-h period.  Drug toxicity was evaluated by routine clin. and lab. examns.  After a single dose of RWJ-67657, the temp. and blood pressure response remained at the basal level.  The inhibition of TNF α, IL 6, and IL 8 response was dose-dependent.  With the max. dosage, redn. in peak serum levels of the proinflammatory cytokines was >90%.  There was no drug-related toxicity.  Interpretation: Inhibition of p38MAPK by RWJ-67657 might be a tool to intervene in the deranged immune response in sepsis and other inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYVGs4rg1_z7Vg90H21EOLACvtfcHk0lhBQ468LCyOqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXktl2kt74%253D&md5=3ced1727cb4676ae20a794c8c02946cb</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2249.2001.01485.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2249.2001.01485.x%26sid%3Dliteratum%253Aachs%26aulast%3DFijen%26aufirst%3DJ.%2BW.%26aulast%3DZijlstra%26aufirst%3DJ.%2BG.%26aulast%3DDe%2BBoer%26aufirst%3DP.%26aulast%3DSpanjersberg%26aufirst%3DR.%26aulast%3DCohen%252C%2BTervaert%26aufirst%3DJ.%2BW.%26aulast%3Dvan%2Bder%2BWerf%26aufirst%3DT.%2BS.%26aulast%3DLightenberg%26aufirst%3DJ.%2BJ.%2BM.%26aulast%3DTulleken%26aufirst%3DJ.%2BE.%26atitle%3DSuppression%2520of%2520the%2520Clinical%2520and%2520Cytokine%2520Response%2520to%2520Endotoxin%2520by%2520RWJ-67657%252C%2520a%2520p38%2520Mitogen-Activated%2520Protein-Kinase%2520Inhibitor%252C%2520in%2520Healthy%2520Human%2520Volunteers%26jtitle%3DClin.%2520Exp.%2520Immunol.%26date%3D2001%26volume%3D124%26spage%3D16%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Branger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van den Blink, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weijer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madwed, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bos, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yong, C.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polmar, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olszyna, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hack, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Deventer, S. J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peppelenbosch, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Poll, T.</span><span> </span><span class="NLM_article-title">Anti-Inflammatory Effects of a p38 Mitogen-Activated Protein Kinase Inhibitor During Human Endotoxemia</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">168</span><span class="NLM_x">, </span> <span class="NLM_fpage">4070</span><span class="NLM_x">–</span> <span class="NLM_lpage">4077</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2002&pages=4070-4077&author=J.+Brangerauthor=B.+van+den+Blinkauthor=S.+Weijerauthor=J.+Madwedauthor=C.+L.+Bosauthor=A.+Guptaauthor=C.-L.+Yongauthor=S.+H.+Polmarauthor=D.+P.+Olszynaauthor=E.+C.+Hackauthor=S.+J.+H.+van+Deventerauthor=M.+P.+Peppelenboschauthor=T.+van+der+Poll&title=Anti-Inflammatory+Effects+of+a+p38+Mitogen-Activated+Protein+Kinase+Inhibitor+During+Human+Endotoxemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBranger%26aufirst%3DJ.%26aulast%3Dvan%2Bden%2BBlink%26aufirst%3DB.%26aulast%3DWeijer%26aufirst%3DS.%26aulast%3DMadwed%26aufirst%3DJ.%26aulast%3DBos%26aufirst%3DC.%2BL.%26aulast%3DGupta%26aufirst%3DA.%26aulast%3DYong%26aufirst%3DC.-L.%26aulast%3DPolmar%26aufirst%3DS.%2BH.%26aulast%3DOlszyna%26aufirst%3DD.%2BP.%26aulast%3DHack%26aufirst%3DE.%2BC.%26aulast%3Dvan%2BDeventer%26aufirst%3DS.%2BJ.%2BH.%26aulast%3DPeppelenbosch%26aufirst%3DM.%2BP.%26aulast%3Dvan%2Bder%2BPoll%26aufirst%3DT.%26atitle%3DAnti-Inflammatory%2520Effects%2520of%2520a%2520p38%2520Mitogen-Activated%2520Protein%2520Kinase%2520Inhibitor%2520During%2520Human%2520Endotoxemia%26jtitle%3DJ.%2520Immunol.%26date%3D2002%26volume%3D168%26spage%3D4070%26epage%3D4077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hale, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trollinger, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rihanek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manthey, C. L.</span><span> </span><span class="NLM_article-title">Differential Expression and Activation fo p38 Mitogen-Activated Protein Kinase α, β, γ, and δ in Inflammatory Cell Lineages</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">162</span><span class="NLM_x">, </span> <span class="NLM_fpage">4246</span><span class="NLM_x">–</span> <span class="NLM_lpage">4252</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=162&publication_year=1999&pages=4246-4252&author=K.+K.+Haleauthor=D.+Trollingerauthor=M.+Rihanekauthor=C.+L.+Manthey&title=Differential+Expression+and+Activation+fo+p38+Mitogen-Activated+Protein+Kinase+%CE%B1%2C+%CE%B2%2C+%CE%B3%2C+and+%CE%B4+in+Inflammatory+Cell+Lineages"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHale%26aufirst%3DK.%2BK.%26aulast%3DTrollinger%26aufirst%3DD.%26aulast%3DRihanek%26aufirst%3DM.%26aulast%3DManthey%26aufirst%3DC.%2BL.%26atitle%3DDifferential%2520Expression%2520and%2520Activation%2520fo%2520p38%2520Mitogen-Activated%2520Protein%2520Kinase%2520%25CE%25B1%252C%2520%25CE%25B2%252C%2520%25CE%25B3%252C%2520and%2520%25CE%25B4%2520in%2520Inflammatory%2520Cell%2520Lineages%26jtitle%3DJ.%2520Immunol.%26date%3D1999%26volume%3D162%26spage%3D4246%26epage%3D4252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Allen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hambor, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNeish, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabel, C. A.</span><span> </span><span class="NLM_article-title">Deficiency of the Stress Kinase p38α Results in Embryonic Lethality: Characterization of the Kinase Dependence of Stress Responses of Enzyme-deficient Embryonic Stem Cells</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">191</span><span class="NLM_x">, </span> <span class="NLM_fpage">859</span><span class="NLM_x">–</span> <span class="NLM_lpage">869</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=191&publication_year=2000&pages=859-869&author=M.+Allenauthor=L.+Svenssonauthor=M.+Roachauthor=J.+Hamborauthor=J.+McNeishauthor=C.+A.+Gabel&title=Deficiency+of+the+Stress+Kinase+p38%CE%B1+Results+in+Embryonic+Lethality%3A+Characterization+of+the+Kinase+Dependence+of+Stress+Responses+of+Enzyme-deficient+Embryonic+Stem+Cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DM.%26aulast%3DSvensson%26aufirst%3DL.%26aulast%3DRoach%26aufirst%3DM.%26aulast%3DHambor%26aufirst%3DJ.%26aulast%3DMcNeish%26aufirst%3DJ.%26aulast%3DGabel%26aufirst%3DC.%2BA.%26atitle%3DDeficiency%2520of%2520the%2520Stress%2520Kinase%2520p38%25CE%25B1%2520Results%2520in%2520Embryonic%2520Lethality%253A%2520Characterization%2520of%2520the%2520Kinase%2520Dependence%2520of%2520Stress%2520Responses%2520of%2520Enzyme-deficient%2520Embryonic%2520Stem%2520Cells%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2000%26volume%3D191%26spage%3D859%26epage%3D869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Fearns, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kline, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gram, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Padova, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zurini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulevitch, R. J.</span><span> </span><span class="NLM_article-title">Coordinate Activation of Endogenous p38α, β, γ, and δ by Inflammatory Stimuli</span> <span class="citation_source-journal">J. Leukocyte Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">705</span><span class="NLM_x">–</span> <span class="NLM_lpage">711</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=8&amp;doi=10.1021%2Fjm7009414&amp;key=10811012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=32&amp;doi=10.1021%2Fjm7009414&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjsVKnt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2000&pages=705-711&author=C.+Fearnsauthor=L.+Klineauthor=H.+Gramauthor=F.+Di+Padovaauthor=M.+Zuriniauthor=J.+Hanauthor=R.+J.+Ulevitch&title=Coordinate+Activation+of+Endogenous+p38%CE%B1%2C+%CE%B2%2C+%CE%B3%2C+and+%CE%B4+by+Inflammatory+Stimuli"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6cR"><div class="casContent"><span class="casTitleNuber">6c</span><div class="casTitle"><span class="NLM_cas:atitle">Coordinate activation of endogenous p38α, β, γ, and δ by inflammatory stimuli</span></div><div class="casAuthors">Fearns, C.; Kline, L.; Gram, H.; Di Padova, F.; Zurini, M.; Han, J.; Ulevitch, R. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Leukocyte Biology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">705-711</span>CODEN:
                <span class="NLM_cas:coden">JLBIE7</span>;
        ISSN:<span class="NLM_cas:issn">0741-5400</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">The p38 family of mitogen-activated protein kinases is believed to mediate a variety of leukocyte responses to pro-inflammatory stimuli.  There are four members of the p38 family, and although activation of the different members has been studied in transiently transfected cells much less is known about activation of the endogenous p38s, particularly in myeloid lineage cells.  To investigate activation of endogenous p38s, we have made monoclonal antibodies specific for each p38 and have used these antibodies to study p38 activation by pro-inflammatory stimuli in several human monocytic cell lines.  Without stimulation endogenous p38α kinase activity was readily detectable, whereas that of p38β, γ, and δ was barely measurable.  In response to inflammatory stimuli, we obsd. a time- and dose-dependent activation of all four p38s.  The kinetics of activation of each of the p38s were similar for each stimulus used, suggesting a common upstream activation pathway.  Simultaneous activation of the p38s suggests that all four may be important in inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpo-y1kpHdw8bVg90H21EOLACvtfcHk0ljWjKZ-eztOUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjsVKnt7s%253D&md5=3a5eafdd8d239bff6252fe43f8e4d48a</span></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFearns%26aufirst%3DC.%26aulast%3DKline%26aufirst%3DL.%26aulast%3DGram%26aufirst%3DH.%26aulast%3DDi%2BPadova%26aufirst%3DF.%26aulast%3DZurini%26aufirst%3DM.%26aulast%3DHan%26aufirst%3DJ.%26aulast%3DUlevitch%26aufirst%3DR.%2BJ.%26atitle%3DCoordinate%2520Activation%2520of%2520Endogenous%2520p38%25CE%25B1%252C%2520%25CE%25B2%252C%2520%25CE%25B3%252C%2520and%2520%25CE%25B4%2520by%2520Inflammatory%2520Stimuli%26jtitle%3DJ.%2520Leukocyte%2520Biol.%26date%3D2000%26volume%3D67%26spage%3D705%26epage%3D711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="note"><p class="first last">For reviews detailing the current small molecule p38 kinase inhibitor field see</p></div><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hynes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leftheris, K.</span><span> </span><span class="NLM_article-title">Small Molecule p38 Inhibitors: Novel Structural Features and Advances from 2002–2005</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">967</span><span class="NLM_x">–</span> <span class="NLM_lpage">985</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Fjm7009414&amp;key=10.2174%2F1568026054985920" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Fjm7009414&amp;key=16178741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Fjm7009414&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFeitrbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=967-985&author=J.+Hynesauthor=K.+Leftheris&title=Small+Molecule+p38+Inhibitors%3A+Novel+Structural+Features+and+Advances+from+2002%E2%80%932005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule p38 inhibitors: Novel structural features and advances from 2002-2005</span></div><div class="casAuthors">Hynes, John, Jr.; Leftheris, Katerina</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">967-985</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The discovery and development of selective, efficacious, and safe small mol. p38 mitogen-activated protein kinase inhibitors for the treatment of inflammatory diseases remains the focus of many pharmaceutical research programs.  Advances in small mol. p38 inhibitor design in potency and oral efficacy have been accelerated with the large no. of available inhibitor-enzyme x-ray structures.  These advances have allowed for the discovery of diverse sets of inhibitors with the opportunity to map inhibitor interactions and design selective inhibitors.  This review covers recent compd. disclosures in the patent and published literature over the last three years.  Many disclosures represent new chemotypes as well as creative modifications of known structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXWto2uZjwJrVg90H21EOLACvtfcHk0liqyj4hhDRXYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFeitrbP&md5=e8a3966e7f270b6171b95f306d3fc341</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.2174%2F1568026054985920&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026054985920%26sid%3Dliteratum%253Aachs%26aulast%3DHynes%26aufirst%3DJ.%26aulast%3DLeftheris%26aufirst%3DK.%26atitle%3DSmall%2520Molecule%2520p38%2520Inhibitors%253A%2520Novel%2520Structural%2520Features%2520and%2520Advances%2520from%25202002%25E2%2580%25932005%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D967%26epage%3D985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wagner, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufer, S.</span><span> </span><span class="NLM_article-title">Small Molecular Anti-Cytokine Agents</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">62</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Fjm7009414&amp;key=10.1002%2Fmed.20042" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=1-62&author=G.+Wagnerauthor=S.+Laufer&title=Small+Molecular+Anti-Cytokine+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1002%2Fmed.20042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20042%26sid%3Dliteratum%253Aachs%26aulast%3DWagner%26aufirst%3DG.%26aulast%3DLaufer%26aufirst%3DS.%26atitle%3DSmall%2520Molecular%2520Anti-Cytokine%2520Agents%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2006%26volume%3D1%26spage%3D1%26epage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Lee, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominguez, C.</span><span> </span><span class="NLM_article-title">MAP Kinase p38 Inhibitors: Clinical Results and an Intimate Look at Their Interactions with p38α Protein</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2979</span><span class="NLM_x">–</span> <span class="NLM_lpage">2994</span><div class="note"><p class="first last">. Additional references for the compounds in Figure 1.</p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=16&amp;doi=10.1021%2Fjm7009414&amp;key=10.2174%2F092986705774462914" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=8&amp;doi=10.1021%2Fjm7009414&amp;key=16378500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=32&amp;doi=10.1021%2Fjm7009414&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Grt7jF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=2979-2994&author=M.+R.+Leeauthor=C.+Dominguez&title=MAP+Kinase+p38+Inhibitors%3A+Clinical+Results+and+an+Intimate+Look+at+Their+Interactions+with+p38%CE%B1+Protein"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7cR"><div class="casContent"><span class="casTitleNuber">7c</span><div class="casTitle"><span class="NLM_cas:atitle">MAP kinase p38 inhibitors: Clinical results and an intimate look at their interactions with p38α protein</span></div><div class="casAuthors">Lee, Matthew R.; Dominguez, Celia</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">2979-2994</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Mitogen-activated protein kinase p38 is a serine/threonine kinase originally isolated from lipopolysaccharide (LPS) stimulated monocytes.  There are four isoforms p38α, p38β, p38γ, and p38δ.  The most thoroughly studied isoform is p38α, whose activation has been obsd. in many hematopoietic and non-hematopoietic cell types upon appropriate stimuli.  Subsequently, p38α kinase has been shown to be involved in the biosynthesis of TNFα and IL-1β at the translational and transcriptional level.  MAP kinase p38α represents a point of convergence for multiple signaling processes that are activated in inflammation and thus a key potential target for the modulation of cytokine prodn.  The discovery and publication of p38α and the pyridinyl-imidazole inhibitor initiated a huge effort by many companies to develop p38α inhibitors as potential treatment for inflammatory diseases.  Herein we provide a brief overview of recent reported clin. results for AMG 548, BIRB 796, VX 702, SCIO 469, and SCIO 323.  However, our focus will be on the binding modes of these inhibitors and other p38 inhibitors in the recent literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZSldsfUAO6bVg90H21EOLACvtfcHk0liqyj4hhDRXYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Grt7jF&md5=eb21253fcc2df76280cd9a1812ed1015</span></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=10.2174%2F092986705774462914&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986705774462914%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DM.%2BR.%26aulast%3DDominguez%26aufirst%3DC.%26atitle%3DMAP%2520Kinase%2520p38%2520Inhibitors%253A%2520Clinical%2520Results%2520and%2520an%2520Intimate%2520Look%2520at%2520Their%2520Interactions%2520with%2520p38%25CE%25B1%2520Protein%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2005%26volume%3D12%26spage%3D2979%26epage%3D2994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7d"><span><span class="NLM_label">(d) </span>Compound-006 <span class="NLM_contrib-group">Devraj, R. V.</span><span> </span><span class="NLM_article-title">Discovery and Development of Orally Active p38 Kinase Inhibitors as Anti-TNF Agents</span>. Absracts of Papers, 229th National Meeting of the American Chemical Society, San Diego, CA,<span class="NLM_x"> </span><span class="NLM_year">2004</span><span class="NLM_x">; </span>MEDI 296.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=R.+V.+Devraj&title=Discovery+and+Development+of+Orally+Active+p38+Kinase+Inhibitors+as+Anti-TNF+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DDevraj%26aufirst%3DR.%2BV.%26atitle%3DDiscovery%2520and%2520Development%2520of%2520Orally%2520Active%2520p38%2520Kinase%2520Inhibitors%2520as%2520Anti-TNF%2520Agents%26jtitle%3DAbsracts%2520of%2520Papers%252C%2520229th%2520National%2520Meeting%2520of%2520the%2520American%2520Chemical%2520Society%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Miwatashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arikawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotani, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naruo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asahi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohkawa, S.</span><span> </span><span class="NLM_article-title">Novel Inhibitor of p38 MAP Kinase as an Anti-TNFα Drug: Discovery of <i>N</i>-[4-[2-ethyl-4-(3-methylphenyl)-1,3-thiazol-5-yl]-2-pyridyl]benzamide (TAK-715) as a Potent and Orally Active Anti-rheumatoid Arthritis Agent</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">5966</span><span class="NLM_x">–</span> <span class="NLM_lpage">5979</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050165o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=5966-5979&author=S.+Miwatashiauthor=Y.+Arikawaauthor=E.+Kotaniauthor=M.+Miyamotoauthor=K.+Naruoauthor=H.+Kimuraauthor=T.+Tanakaauthor=S.+Asahiauthor=S.+Ohkawa&title=Novel+Inhibitor+of+p38+MAP+Kinase+as+an+Anti-TNF%CE%B1+Drug%3A+Discovery+of+N-%5B4-%5B2-ethyl-4-%283-methylphenyl%29-1%2C3-thiazol-5-yl%5D-2-pyridyl%5Dbenzamide+%28TAK-715%29+as+a+Potent+and+Orally+Active+Anti-rheumatoid+Arthritis+Agent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7e&amp;dbid=16384&amp;doi=10.1021%2Fjm050165o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050165o%26sid%3Dliteratum%253Aachs%26aulast%3DMiwatashi%26aufirst%3DS.%26aulast%3DArikawa%26aufirst%3DY.%26aulast%3DKotani%26aufirst%3DE.%26aulast%3DMiyamoto%26aufirst%3DM.%26aulast%3DNaruo%26aufirst%3DK.%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DAsahi%26aufirst%3DS.%26aulast%3DOhkawa%26aufirst%3DS.%26atitle%3DNovel%2520Inhibitor%2520of%2520p38%2520MAP%2520Kinase%2520as%2520an%2520Anti-TNF%25CE%25B1%2520Drug%253A%2520Discovery%2520of%2520N-%255B4-%255B2-ethyl-4-%25283-methylphenyl%2529-1%252C3-thiazol-5-yl%255D-2-pyridyl%255Dbenzamide%2520%2528TAK-715%2529%2520as%2520a%2520Potent%2520and%2520Orally%2520Active%2520Anti-rheumatoid%2520Arthritis%2520Agent%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D5966%26epage%3D5979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Dugar, S.</span><span> </span><span class="NLM_article-title">Discovery of p38-alpha MAP Kinase Inhibitor SCIO-469</span>.  <span class="citation_source-journal">Inflammation Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_issue">(Suppl 2)</span><span class="NLM_elocation-id">Abs 1027</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2005&issue=%28Suppl+2%29&author=S.+Dugar&title=Discovery+of+p38-alpha+MAP+Kinase+Inhibitor+SCIO-469"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDugar%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520p38-alpha%2520MAP%2520Kinase%2520Inhibitor%2520SCIO-469%26jtitle%3DInflammation%2520Res.%26date%3D2005%26volume%3D54%26issue%3D%2528Suppl%25202%2529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Leftheris, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyckman, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussain, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hynes, J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letourneau, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metzger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriarty, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riviello, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimshock, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wityak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrobleski, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillooly, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuster, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diller, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doweyko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sack, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldwin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henderson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schieven, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, M.</span><span> </span><span class="NLM_article-title">The Discovery of Orally Active Triaminotriazine Aniline Amides as Inhibitors of p38 MAP Kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">6283</span><span class="NLM_x">–</span> <span class="NLM_lpage">6291</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049521d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6283-6291&author=K.+Leftherisauthor=G.+Ahmedauthor=R.+Chanauthor=A.+J.+Dyckmanauthor=Z.+Hussainauthor=K.+Hoauthor=J.+Hynesauthor=J.+Letourneauauthor=W.+Liauthor=S.+Linauthor=A.+Metzgerauthor=K.+J.+Moriartyauthor=C.+Rivielloauthor=Y.+Shimshockauthor=J.+Wenauthor=J.+Wityakauthor=S.+T.+Wrobleskiauthor=H.+Wuauthor=J.+Wuauthor=M.+Desaiauthor=K.+M.+Gilloolyauthor=T.+H.+Linauthor=D.+Looauthor=K.+W.+McIntyreauthor=S.+Pittauthor=D.+R.+Shenauthor=D.+J.+Shusterauthor=R.+Zhangauthor=D.+Dillerauthor=A.+Doweykoauthor=J.+Sackauthor=J.+Baldwinauthor=J.+Barrishauthor=J.+Doddauthor=I.+Hendersonauthor=S.+Kannerauthor=G.+L.+Schievenauthor=M.+Webb&title=The+Discovery+of+Orally+Active+Triaminotriazine+Aniline+Amides+as+Inhibitors+of+p38+MAP+Kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm049521d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049521d%26sid%3Dliteratum%253Aachs%26aulast%3DLeftheris%26aufirst%3DK.%26aulast%3DAhmed%26aufirst%3DG.%26aulast%3DChan%26aufirst%3DR.%26aulast%3DDyckman%26aufirst%3DA.%2BJ.%26aulast%3DHussain%26aufirst%3DZ.%26aulast%3DHo%26aufirst%3DK.%26aulast%3DHynes%26aufirst%3DJ.%26aulast%3DLetourneau%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DMetzger%26aufirst%3DA.%26aulast%3DMoriarty%26aufirst%3DK.%2BJ.%26aulast%3DRiviello%26aufirst%3DC.%26aulast%3DShimshock%26aufirst%3DY.%26aulast%3DWen%26aufirst%3DJ.%26aulast%3DWityak%26aufirst%3DJ.%26aulast%3DWrobleski%26aufirst%3DS.%2BT.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DDesai%26aufirst%3DM.%26aulast%3DGillooly%26aufirst%3DK.%2BM.%26aulast%3DLin%26aufirst%3DT.%2BH.%26aulast%3DLoo%26aufirst%3DD.%26aulast%3DMcIntyre%26aufirst%3DK.%2BW.%26aulast%3DPitt%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DD.%2BR.%26aulast%3DShuster%26aufirst%3DD.%2BJ.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DDiller%26aufirst%3DD.%26aulast%3DDoweyko%26aufirst%3DA.%26aulast%3DSack%26aufirst%3DJ.%26aulast%3DBaldwin%26aufirst%3DJ.%26aulast%3DBarrish%26aufirst%3DJ.%26aulast%3DDodd%26aufirst%3DJ.%26aulast%3DHenderson%26aufirst%3DI.%26aulast%3DKanner%26aufirst%3DS.%26aulast%3DSchieven%26aufirst%3DG.%2BL.%26aulast%3DWebb%26aufirst%3DM.%26atitle%3DThe%2520Discovery%2520of%2520Orally%2520Active%2520Triaminotriazine%2520Aniline%2520Amides%2520as%2520Inhibitors%2520of%2520p38%2520MAP%2520Kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D6283%26epage%3D6291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Hunt, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitt, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borzilleri, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gullo-Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fargnoli, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fink, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, W.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortillo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vite, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wautlet, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhide, R.</span><span> </span><span class="NLM_article-title">Discovery of the Pyrrolo[2,1-f][1,2,4]triazine Nucleus as a New Kinase Inhibitor Template</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">4054</span><span class="NLM_x">–</span> <span class="NLM_lpage">4059</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049892u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=4054-4059&author=J.+T.+Huntauthor=T.+Mittauthor=R.+Borzilleriauthor=J.+Gullo-Brownauthor=J.+Fargnoliauthor=B.+Finkauthor=W.-C.+Hanauthor=S.+Mortilloauthor=G.+Viteauthor=B.+Wautletauthor=T.+Wongauthor=C.+Yuauthor=Z.+Zhengauthor=R.+Bhide&title=Discovery+of+the+Pyrrolo%5B2%2C1-f%5D%5B1%2C2%2C4%5Dtriazine+Nucleus+as+a+New+Kinase+Inhibitor+Template"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm049892u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049892u%26sid%3Dliteratum%253Aachs%26aulast%3DHunt%26aufirst%3DJ.%2BT.%26aulast%3DMitt%26aufirst%3DT.%26aulast%3DBorzilleri%26aufirst%3DR.%26aulast%3DGullo-Brown%26aufirst%3DJ.%26aulast%3DFargnoli%26aufirst%3DJ.%26aulast%3DFink%26aufirst%3DB.%26aulast%3DHan%26aufirst%3DW.-C.%26aulast%3DMortillo%26aufirst%3DS.%26aulast%3DVite%26aufirst%3DG.%26aulast%3DWautlet%26aufirst%3DB.%26aulast%3DWong%26aufirst%3DT.%26aulast%3DYu%26aufirst%3DC.%26aulast%3DZheng%26aufirst%3DZ.%26aulast%3DBhide%26aufirst%3DR.%26atitle%3DDiscovery%2520of%2520the%2520Pyrrolo%255B2%252C1-f%255D%255B1%252C2%252C4%255Dtriazine%2520Nucleus%2520as%2520a%2520New%2520Kinase%2520Inhibitor%2520Template%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D4054%26epage%3D4059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><div class="note"><p class="first last">30% of the parent drug was remaining after 30 min of incubation in mouse liver microsomes</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=30%25+of+the+parent+drug+was+remaining+after+30+min+of+incubation+in+mouse+liver+microsomes."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dunpublished%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><div class="note"><p class="first last">See ref <a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">9</a></p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=See+ref+9."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dunpublished%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Hynes, J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doubleday, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyckman, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godfrey, J. D.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosso, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiau, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leftheris, K.</span><span> </span><span class="NLM_article-title">N-Amination of Pyrrole and Indole Heterocycles with Monochloramine (NH<sub>2</sub>Cl)</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">1368</span><span class="NLM_x">–</span> <span class="NLM_lpage">1371</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo035587p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm7009414&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkt1Gktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2004&pages=1368-1371&author=J.+Hynesauthor=W.+W.+Doubledayauthor=A.+J.+Dyckmanauthor=J.+D.+Godfreyauthor=J.+A.+Grossoauthor=S.+Kiauauthor=K.+Leftheris&title=N-Amination+of+Pyrrole+and+Indole+Heterocycles+with+Monochloramine+%28NH2Cl%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">N-Amination of pyrrole and indole heterocycles with monochloramine (NH2Cl)</span></div><div class="casAuthors">Hynes, John, Jr.; Doubleday, Wendel W.; Dyckman, Alaric J.; Godfrey, Jollie D., Jr.; Grosso, John A.; Kiau, Susanne; Leftheris, Katerina</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1368-1371</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A survey of several electrophilic ammonia reagents for the N-amination of indole- and pyrrole-contg. heterocycles revealed that monochloramine was an excellent reagent for this transformation.  Pyrroles and indoles, contg. a variety of substitution, were aminated on the nitrogen to give N-aminopyrroles, e.g., I, and N-aminoindoles, e.g., II.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYnh0gDOLFm7Vg90H21EOLACvtfcHk0lgVyRwpzSbLbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkt1Gktg%253D%253D&md5=1af624e88095b0c4571861e7bfbc0a1b</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjo035587p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo035587p%26sid%3Dliteratum%253Aachs%26aulast%3DHynes%26aufirst%3DJ.%26aulast%3DDoubleday%26aufirst%3DW.%2BW.%26aulast%3DDyckman%26aufirst%3DA.%2BJ.%26aulast%3DGodfrey%26aufirst%3DJ.%2BD.%26aulast%3DGrosso%26aufirst%3DJ.%2BA.%26aulast%3DKiau%26aufirst%3DS.%26aulast%3DLeftheris%26aufirst%3DK.%26atitle%3DN-Amination%2520of%2520Pyrrole%2520and%2520Indole%2520Heterocycles%2520with%2520Monochloramine%2520%2528NH2Cl%2529%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2004%26volume%3D69%26spage%3D1368%26epage%3D1371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><div class="note"><p class="first last">Consistent with our previous observations (e.g., <b>3b</b> to <b>3a</b>), conversion of the C5′ methyl hydroxamate of <b>11b</b> to an alkyl amide (methyl, ethyl) resulted in a >80-fold decrease in p38α kinase inhibition (data not shown).</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Consistent+with+our+previous+observations+%28e.g.%2C+3b+to+3a%29%2C+conversion+of+the+C5%E2%80%B2+methyl+hydroxamate+of+11b+to+an+alkyl+amide+%28methyl%2C+ethyl%29+resulted+in+a+%3E80-fold+decrease+in+p38%CE%B1+kinase+inhibition+%28data+not+shown%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dunpublished%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Liverton, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butcher, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claiborne, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claremon, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Libby, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitzenberger, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selnick, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tebben, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varga, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agarwal, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dancheck, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forsyth, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frantz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanlon, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harper, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofsess, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">; Kostura, Ma.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OʼNeill, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orevillo, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolando, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahly, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visco, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OʼKeefe, S. J.</span><span> </span><span class="NLM_article-title">Design and synthesis of potent, selective and orally bioavailable tetrasubstituted imidazole inhibitors of p38 mitogen-activated kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">2190</span><span class="NLM_x">–</span> <span class="NLM_lpage">2180</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=2190-2180&author=N.+J.+Livertonauthor=J.+W.+Butcherauthor=C.+F.+Claiborneauthor=D.+A.+Claremonauthor=B.+E.+Libbyauthor=K.+T.+Nguyenauthor=S.+M.+Pitzenbergerauthor=H.+G.+Selnickauthor=G.+R.+Smithauthor=A.+Tebbenauthor=J.+P.+Vaccaauthor=S.+L.+Vargaauthor=L.+Agarwalauthor=K.+Dancheckauthor=A.+J.+Forsythauthor=D.+S.+Fletcherauthor=B.+Frantzauthor=W.+A.+Hanlonauthor=C.+F.+Harperauthor=S.+J.+Hofsessauthor=Ma.+%3B+Kosturaauthor=J.+Linauthor=S.+Luellauthor=E.+A.+O%CA%BCNeillauthor=C.+J.+Orevilloauthor=M.+Pangauthor=J.+Parsonsauthor=A.+Rolandoauthor=Y.+Sahlyauthor=D.+M.+Viscoauthor=S.+J.+O%CA%BCKeefe&title=Design+and+synthesis+of+potent%2C+selective+and+orally+bioavailable+tetrasubstituted+imidazole+inhibitors+of+p38+mitogen-activated+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26aulast%3DButcher%26aufirst%3DJ.%2BW.%26aulast%3DClaiborne%26aufirst%3DC.%2BF.%26aulast%3DClaremon%26aufirst%3DD.%2BA.%26aulast%3DLibby%26aufirst%3DB.%2BE.%26aulast%3DNguyen%26aufirst%3DK.%2BT.%26aulast%3DPitzenberger%26aufirst%3DS.%2BM.%26aulast%3DSelnick%26aufirst%3DH.%2BG.%26aulast%3DSmith%26aufirst%3DG.%2BR.%26aulast%3DTebben%26aufirst%3DA.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DVarga%26aufirst%3DS.%2BL.%26aulast%3DAgarwal%26aufirst%3DL.%26aulast%3DDancheck%26aufirst%3DK.%26aulast%3DForsyth%26aufirst%3DA.%2BJ.%26aulast%3DFletcher%26aufirst%3DD.%2BS.%26aulast%3DFrantz%26aufirst%3DB.%26aulast%3DHanlon%26aufirst%3DW.%2BA.%26aulast%3DHarper%26aufirst%3DC.%2BF.%26aulast%3DHofsess%26aufirst%3DS.%2BJ.%26aulast%3D%253B%2BKostura%26aufirst%3DMa.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DLuell%26aufirst%3DS.%26aulast%3DO%25CA%25BCNeill%26aufirst%3DE.%2BA.%26aulast%3DOrevillo%26aufirst%3DC.%2BJ.%26aulast%3DPang%26aufirst%3DM.%26aulast%3DParsons%26aufirst%3DJ.%26aulast%3DRolando%26aufirst%3DA.%26aulast%3DSahly%26aufirst%3DY.%26aulast%3DVisco%26aufirst%3DD.%2BM.%26aulast%3DO%25CA%25BCKeefe%26aufirst%3DS.%2BJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520potent%252C%2520selective%2520and%2520orally%2520bioavailable%2520tetrasubstituted%2520imidazole%2520inhibitors%2520of%2520p38%2520mitogen-activated%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D2190%26epage%3D2180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Fitzgerald, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaller, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pikounis, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OʼKeefe, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scapin, G.</span> <span class="citation_source-journal">Nat. Struc. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">764</span><span class="NLM_x">–</span> <span class="NLM_lpage">769</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=16&amp;doi=10.1021%2Fjm7009414&amp;key=10.1038%2Fnsb949" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=8&amp;doi=10.1021%2Fjm7009414&amp;key=12897767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=32&amp;doi=10.1021%2Fjm7009414&amp;key=1%3ACAS%3A528%3ADC%252BD3sXms1GktrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Fitzgerald%2C+C.+E.%3B+Patel%2C+S.+B.%3B+Becker%2C+J.+W.%3B+Cameron%2C+P.+M.%3B+Zaller%2C+D.%3B+Pikounis%2C+V.+B.%3B+O%CA%BCKeefe%2C+S.+J.%3B+Scapin%2C+G.Nat.+Struc.+Biol.+2003%2C+10%2C+764%E2%80%93769"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14bR"><div class="casContent"><span class="casTitleNuber">14b</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for p38α MAP kinase quinazolinone and pyridol-pyrimidine inhibitor specificity</span></div><div class="casAuthors">Fitzgerald, Catherine E.; Patel, Sangita B.; Becker, Joseph W.; Cameron, Patricia M.; Zaller, Dennis; Pikounis, Vasilis Bill; O'Keefe, Stephen J.; Scapin, Giovanna</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">764-769</span>CODEN:
                <span class="NLM_cas:coden">NSBIEW</span>;
        ISSN:<span class="NLM_cas:issn">1072-8368</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The quinazolinone and pyridol-pyrimidine classes of p38 MAP kinase inhibitors have a previously unseen degree of specificity for p38 over other MAP kinases.  Comparison of the crystal structures of p38 bound to four different compds. shows that binding of the more specific mols. is characterized by a peptide flip between Met109 and Gly110.  Gly110 is a residue specific to the α, β and γ isoforms of p38.  The δ isoform and the other MAP kinases have bulkier residues in this position.  These residues would likely make the peptide flip energetically unfavorable, thus explaining the selectivity of binding.  To test this hypothesis, we constructed G110A and G110D mutants of p38 and measured the potency of several compds. against them.  The results confirm that the selectivity of quinazolinones and pyridol-pyrimidines results from the presence of a glycine in position 110.  This unique mode of binding may be exploited in the design of new p38 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpb5LnKf2_OqbVg90H21EOLACvtfcHk0lgVyRwpzSbLbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXms1GktrY%253D&md5=85e063241af29ee0461a42e6d90514ba</span></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1038%2Fnsb949&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsb949%26sid%3Dliteratum%253Aachs%26aulast%3DFitzgerald%26aufirst%3DC.%2BE.%26aulast%3DPatel%26aufirst%3DS.%2BB.%26aulast%3DBecker%26aufirst%3DJ.%2BW.%26aulast%3DCameron%26aufirst%3DP.%2BM.%26aulast%3DZaller%26aufirst%3DD.%26aulast%3DPikounis%26aufirst%3DV.%2BB.%26aulast%3DO%25CA%25BCKeefe%26aufirst%3DS.%2BJ.%26aulast%3DScapin%26aufirst%3DG.%26jtitle%3DNat.%2520Struc.%2520Biol.%26date%3D2003%26volume%3D10%26spage%3D764%26epage%3D769" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14c"><span><span class="NLM_label">(c) </span><div class="note"><p class="first last">For a review of p38 inhibitor-protein kinase complexes see:</p></div><span class="NLM_contrib-group">Wrobleski, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doweyko, A. M.</span><span> </span><span class="NLM_article-title">Structural Comparison of p38 Inhibitor-Protein Complexes: A Review of Recent p38 Inhibitors Having Unique Binding Interactions</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1005</span><span class="NLM_x">–</span> <span class="NLM_lpage">1016</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14c&amp;dbid=16&amp;doi=10.1021%2Fjm7009414&amp;key=10.2174%2F1568026054985894" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14c&amp;dbid=8&amp;doi=10.1021%2Fjm7009414&amp;key=16178743" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14c&amp;dbid=32&amp;doi=10.1021%2Fjm7009414&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFeitrbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=1005-1016&author=S.+T.+Wrobleskiauthor=A.+M.+Doweyko&title=Structural+Comparison+of+p38+Inhibitor-Protein+Complexes%3A+A+Review+of+Recent+p38+Inhibitors+Having+Unique+Binding+Interactions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14cR"><div class="casContent"><span class="casTitleNuber">14c</span><div class="casTitle"><span class="NLM_cas:atitle">Structural comparison of p38 inhibitor-protein complexes: A review of recent p38 inhibitors having unique binding interactions</span></div><div class="casAuthors">Wrobleski, Stephen T.; Doweyko, Arthur M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1005-1016</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Small mol. inhibition of protein kinases in the treatment of significant diseases such as cancer, Alzheimer's disease, diabetes, and rheumatoid arthritis has attracted significant attention over the past two decades and has clearly become one of the most significant challenges for drug discovery in the 21st century.  While the recent identification of 518 different kinases in the human genome has offered a wealth of opportunities for drug intervention in the treatment of these diseases, it has also created a daunting challenge with respect to selective kinase inhibition as a viable strategy in target-based drug design.  Over the past decade, the design and development of a small mol. that selectively inhibits the p38 mitogen activated protein (MAP) kinase has clearly emerged as one.  This review will focus on the comparison of the x-ray crystal structures and binding models of the most recent p38 inhibitor-enzyme complexes and the identification of the structural elements and interactions that may be important in providing inhibitor potency and selectivity toward the p38 MAP kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTUmGGtEwCPbVg90H21EOLACvtfcHk0lgJuPZWgqX7-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFeitrbJ&md5=5add0d628abece6a2e15675e575cd97e</span></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=10.2174%2F1568026054985894&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026054985894%26sid%3Dliteratum%253Aachs%26aulast%3DWrobleski%26aufirst%3DS.%2BT.%26aulast%3DDoweyko%26aufirst%3DA.%2BM.%26atitle%3DStructural%2520Comparison%2520of%2520p38%2520Inhibitor-Protein%2520Complexes%253A%2520A%2520Review%2520of%2520Recent%2520p38%2520Inhibitors%2520Having%2520Unique%2520Binding%2520Interactions%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D1005%26epage%3D1016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Leftheris, K.;</span> et al. <div class="note"><p class="first last">unpublished results</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Leftheris%2C+K.%3B+et+al.+unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dunpublished%26sid%3Dliteratum%253Aachs%26aulast%3DLeftheris%26aufirst%3DK." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Cambanis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobre, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niculescu-Duvaz, I.</span><span> </span><span class="NLM_article-title">Potential anticancer agents. V. Aromatic nitrogen mustards related to 3-[N,N-bis(2-chloroethyl)amino]-4-methylbenzoic acid</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1969</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">4</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00301a043" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1969&pages=161-4&author=A.+Cambanisauthor=V.+Dobreauthor=I.+Niculescu-Duvaz&title=Potential+anticancer+agents.+V.+Aromatic+nitrogen+mustards+related+to+3-%5BN%2CN-bis%282-chloroethyl%29amino%5D-4-methylbenzoic+acid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm00301a043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00301a043%26sid%3Dliteratum%253Aachs%26aulast%3DCambanis%26aufirst%3DA.%26aulast%3DDobre%26aufirst%3DV.%26aulast%3DNiculescu-Duvaz%26aufirst%3DI.%26atitle%3DPotential%2520anticancer%2520agents.%2520V.%2520Aromatic%2520nitrogen%2520mustards%2520related%2520to%25203-%255BN%252CN-bis%25282-chloroethyl%2529amino%255D-4-methylbenzoic%2520acid%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1969%26volume%3D12%26spage%3D161%26epage%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Fink, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vite, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mastalerz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadow, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leavitt, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crews, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitt, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vyas, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokarski, J. S.</span><span> </span><span class="NLM_article-title">New dual inhibitors of EGFR and HER2 protein tyrosine kinases</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">4774</span><span class="NLM_x">–</span> <span class="NLM_lpage">4779</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=4774-4779&author=B.+E.+Finkauthor=G.+D.+Viteauthor=H.+Mastalerzauthor=J.+F.+Kadowauthor=S.+Kimauthor=K.+J.+Leavittauthor=K.+Duauthor=D.+Crewsauthor=T.+Mittauthor=T.+W.+Wongauthor=J.+T.+Huntauthor=D.+M.+Vyasauthor=J.+S.+Tokarski&title=New+dual+inhibitors+of+EGFR+and+HER2+protein+tyrosine+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFink%26aufirst%3DB.%2BE.%26aulast%3DVite%26aufirst%3DG.%2BD.%26aulast%3DMastalerz%26aufirst%3DH.%26aulast%3DKadow%26aufirst%3DJ.%2BF.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DLeavitt%26aufirst%3DK.%2BJ.%26aulast%3DDu%26aufirst%3DK.%26aulast%3DCrews%26aufirst%3DD.%26aulast%3DMitt%26aufirst%3DT.%26aulast%3DWong%26aufirst%3DT.%2BW.%26aulast%3DHunt%26aufirst%3DJ.%2BT.%26aulast%3DVyas%26aufirst%3DD.%2BM.%26aulast%3DTokarski%26aufirst%3DJ.%2BS.%26atitle%3DNew%2520dual%2520inhibitors%2520of%2520EGFR%2520and%2520HER2%2520protein%2520tyrosine%2520kinases%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D4774%26epage%3D4779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Borzilleri, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, Z.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wautlet, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortillo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeyaseelan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukral, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamath, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vyas, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokarski, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fargnoli, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhide, R. S.</span><span> </span><span class="NLM_article-title">Design, Synthesis, and Evaluation of Orally Active 4-(2,4-Difluoro-5-(methoxycarbamoyl)phenylamino)pyrrolo[2,1-f][1,2,4]triazines as Dual Vascular Endothelial Growth Factor Receptor-2 and Fibroblast Growth Factor Receptor-1 Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">3991</span><span class="NLM_x">–</span> <span class="NLM_lpage">4008</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0501275" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=3991-4008&author=R.+M.+Borzilleriauthor=X.+Zhengauthor=L.+Qianauthor=C.+Ellisauthor=Z.-W.+Caiauthor=B.+S.+Wautletauthor=S.+Mortilloauthor=R.+Jeyaseelanauthor=D.+W.+Kukralauthor=A.+Furaauthor=A.+Kamathauthor=V.+Vyasauthor=J.+S.+Tokarskiauthor=J.+C.+Barrishauthor=J.+T.+Huntauthor=L.+J.+Lombardoauthor=J.+Fargnoliauthor=R.+S.+Bhide&title=Design%2C+Synthesis%2C+and+Evaluation+of+Orally+Active+4-%282%2C4-Difluoro-5-%28methoxycarbamoyl%29phenylamino%29pyrrolo%5B2%2C1-f%5D%5B1%2C2%2C4%5Dtriazines+as+Dual+Vascular+Endothelial+Growth+Factor+Receptor-2+and+Fibroblast+Growth+Factor+Receptor-1+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm0501275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0501275%26sid%3Dliteratum%253Aachs%26aulast%3DBorzilleri%26aufirst%3DR.%2BM.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DQian%26aufirst%3DL.%26aulast%3DEllis%26aufirst%3DC.%26aulast%3DCai%26aufirst%3DZ.-W.%26aulast%3DWautlet%26aufirst%3DB.%2BS.%26aulast%3DMortillo%26aufirst%3DS.%26aulast%3DJeyaseelan%26aufirst%3DR.%26aulast%3DKukral%26aufirst%3DD.%2BW.%26aulast%3DFura%26aufirst%3DA.%26aulast%3DKamath%26aufirst%3DA.%26aulast%3DVyas%26aufirst%3DV.%26aulast%3DTokarski%26aufirst%3DJ.%2BS.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DHunt%26aufirst%3DJ.%2BT.%26aulast%3DLombardo%26aufirst%3DL.%2BJ.%26aulast%3DFargnoli%26aufirst%3DJ.%26aulast%3DBhide%26aufirst%3DR.%2BS.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Evaluation%2520of%2520Orally%2520Active%25204-%25282%252C4-Difluoro-5-%2528methoxycarbamoyl%2529phenylamino%2529pyrrolo%255B2%252C1-f%255D%255B1%252C2%252C4%255Dtriazines%2520as%2520Dual%2520Vascular%2520Endothelial%2520Growth%2520Factor%2520Receptor-2%2520and%2520Fibroblast%2520Growth%2520Factor%2520Receptor-1%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D3991%26epage%3D4008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Otwinowski, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minor, W.</span><span> </span><span class="NLM_article-title">Processing X-ray data collected in oscillation mode</span> <span class="citation_source-journal">Methods Enzymol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">326</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=1996&pages=307-326&author=Z.+Otwinowskiauthor=W.+Minor&title=Processing+X-ray+data+collected+in+oscillation+mode"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOtwinowski%26aufirst%3DZ.%26aulast%3DMinor%26aufirst%3DW.%26atitle%3DProcessing%2520X-ray%2520data%2520collected%2520in%2520oscillation%2520mode%26jtitle%3DMethods%2520Enzymol.%26date%3D1996%26volume%3D276%26spage%3D307%26epage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Sack, J. S.; Kish, K. F.; Pokross, M.; Duke, G. J.; Xie, D.; Tredup, J. A.; Kiefer, S. E.; Newitt, J.</span><div class="note"><p class="first last">unpublished results</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Sack%2C+J.+S.%3B+Kish%2C+K.+F.%3B+Pokross%2C+M.%3B+Duke%2C+G.+J.%3B+Xie%2C+D.%3B+Tredup%2C+J.+A.%3B+Kiefer%2C+S.+E.%3B+Newitt%2C+J.unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dunpublished%26sid%3Dliteratum%253Aachs%26aulast%3DSack%26aufirst%3DJ.%2BS." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i69"><a href="/doi/suppl/10.1021/jm7009414">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_87780"></div></div></div></div></div><hr /></hr><p class="last">Table of HPLC purity analysis or combustion analysis of key compounds and final X-ray crystallographic refinement statistics. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm7009414/suppl_file/jm7009414-file002.pdf">jm7009414-file002.pdf (201.43 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm7009414&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Fjm7009414%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2008.51.issue-1%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm7009414" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                505KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67995afeec1b3d0c","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
